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Abstract 
Prions are highly resistant to common proteases and conventional sterilisation processes. 
Consequently, prion infectivity is destroyed by methods such as incineration, alkaline and 
thermal hydrolysis. These harsh, destructive and potentially hazardous methods are 
unsuitable for processing specified risk materials (SRM) and animal by-products, and in 
the decontamination of medical and laboratory devices, and prion contaminated 
environments. Thus an environmentally friendly, enzymatic degradation and 
decontamination process is a highly desirable alternative.  The structural similarity of prion 
and feather keratin suggests that feather degrading microorganisms have the potential to 
degrade prions. The objective of this research was to isolate and characterise microbial 
keratinase and to investigate its ability to degrade ME7 scrapie prion. Thirty two microbial 
strains were isolated on feather meal agar from primary effluent and farmyard wastes. One 
of the isolates, a Grams positive bacterium, demonstrated significant keratinolytic activity 
(11.00 ± 0.71 U/ml), and was investigated further. The isolate was identified by 16S rDNA 
and designated as Bacillus licheniformis N22, and was deposited in National Collection of 
Industrial Food and Marine Bacteria (NCIMB). The growth conditions for optimum 
keratinase synthesis in a minimal growth medium (MGM) were found to be pH 8.5, 50 oC, 
1.1 % (w/v) feather meal substrate and at incubation time of 32 h. The molecular weight of 
purified keratinase was ≈28 KDa as measured by SDS-PAGE and confirmed by MALDI-
TOF-MS. Optimum keratinase activity was obtained at pH 8.5 and 50 °C. This keratinase 
fully degraded recalcitrant melanised feather in 48 h, and also digested ME7 scrapie prion 
at 65 °C in 2 h to levels of PrPSc undetectable by western blot analysis. In a remarkable 
synergistic enzymatic preparation composed of keratinase and biosurfactant derived from 
Pseudomonas aeruginosa NCIMB 8626, ME7 scrapie prion was degraded to undetectable 
levels at 65 °C in 10 min. Interestingly biosurfactant alone showed no detectable activity 
on ME7 scrapie prion. Time-course degradation analysis showed progressive attenuation 
of PrPSc signal at 50 °C over time. Test of residual infectivity by standard cell culture assay 
showed that this enzymatic method completely destroyed standard sheep scrapie prion 
(SSBP/1) at 65 °C in 1 h. The mean survival time of mice challenged with enzyme-
digested inocula significantly increased from 278 ± 9 days to 334 ± 42 days compared to 
those inoculated intraperitoneally with neat ME7 scrapie (p = 0.008 at 95 % confidence 
interval). Furthermore, 47 % of all the mice in enzyme-digested group lacked detectable 
levels of PrPSc. These results suggest a substantial reduction in the infectious titre or 
complete destruction of ME7 prion infectivity by the enzymatic preparation.    Therefore, 
this mild enzymatic treatment method has potential applications for prion decontamination.
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Chapter 1: Introduction 
 
1.1 Transmissible spongiform encephalopathies (TSE)  
Transmissible Spongiform Encephalopathies (TSEs) or prion diseases are a group of 
closely related, progressive, incurable and invariably fatal neurodegenerative disorders that 
affect the central nervous system (CNS) of mammals (Collinge, 2001). TSEs are broadly 
classified into the human and animal forms (Table 1.1). The human forms are categorised 
according to their aetiology into sporadic, acquired and inherited TSE groups, and the 
animal forms are described according to their natural host types (Table 1.1) (WHO, 1999; 
Collinge, 2001).  
 
Table 1.1 TSEs classified according to the human and animal types, indicating the year it was first 
reported. The human types are categorised according to the aetiological groups and the animal 
forms according to their animal host types.  
Type  of human TSEs Aetiological groups 
1. Creutzfeldt-Jakob disease (CJD)  (1921) Sporadic disease 
• No known antecedent event 
• May occur by rare stochastic conversion 
of cellular prion protein 
2. Kuru (1957) 
3. Iatrogenic CJD (1974) 
4. Variant CJD (vCJD) (1996) 
Acquired disease 
• Acquired by contamination with the 
infectious agent 
5. Familial CJD   (1924) 
6. Gerstmann-Strussler-Scheinker  
     syndrome (GSS) (1936) 
7.  Fatal familial insomnia (FFI) (1986) 
8.  Sporadic fatal familial insomnia (1999) 
9.  Atypical prion disease (APD)  
Inherited disease 
• Genetically inherited 
• Specific gene mutations or insertion  
• Different clinical and pathological  
features depending on the  causative  
mutant gene 
Types of animal TSEs Natural hosts 
1. Scrapie (1732) Sheep and goat 
2. Transmissible mink Encephalopathy (TME) (1947) Mink 
3. Chronic wasting disease (CWD) (1967) Deer and elk. 
4. Bovine spongiform Encephalopathy (BSE) (1986) Cattle.  
5. Feline spongiform Encephalopathy (FSE) (1990) Domestic cats, puma, ocelot, tiger and cheetah. 
6. Exotic ungulate encephalopathy (1986) Identified in zoo animals e.g. kudu, gemsbok, 
nyala, eland, bison, ankole, Arabian oryx and 
scimitar.  
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TSEs are characterised by distinct clinical (e.g. rapid dementia, irritable demeanor, 
impaired movement and co-ordination, weight loss) and neuropathological (e.g. 
spongiform changes, amyloid plaque formation and accumulation of the prion agent) 
presentations (Prusiner, 1998; Collinge, 2001). Clinical signs in experimental rodents 
include truncal ataxia, forelimb flexion instead of extension when suspended by the tail, 
difficulty righting from a supine position, kyphosis (roundback), emaciation, lethargy, 
excitability, and generalised tremor and head bobbing (Prusiner et al, 2004; Pilon et al, 
2009). There is currently no prophylaxis or therapeutic intervention for these diseases 
(Collinge et al, 2009). Some examples of physical presentation of TSE in infected 
mammals are presented in Fig. 1.1.  
 
 
Fig. 1.1: Physical presentations of TSEs in mammals, showing scrapie in sheep, Kuru in human 
and BSE in cow. The sheep scrapie is characterised by loss of wool due to scratching and the Kuru 
and BSE characterised by significant weight loss. 
1.2   Nature of the infectious agent                                                                      
The nature of the infectious prion agent responsible for TSEs remain a complex and 
controversial biological phenomenon described by a number of competing hypotheses such 
as the viral, protein and multi-component hypotheses. 
1.2.1 Viral and Virinos hypotheses 
The viral hypothesis postulates that the infectious agent is a virus or is virus-like in nature, 
and is genetically capable of coding its own proteins (Chesebro et al, 1985; Manuelidis et 
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al, 2009). The argument for a viral hypothesis was based on the fact that the agent is 
infectious and able to cause disease characteristic of viruses. Also small nucleic acid has 
been reportedly found in purified infectious scrapie sample (Kellings et al, 1994). 
However, the viral hypothesis is untenable because prion infectivity could not be destroyed 
by processes which ordinarily destroy viruses and nucleic acids such as nuclease digestion, 
autoclaving, UV and ionizing radiation (Alper et al, 1978; Prusiner, 1982; Alper, 1993; 
Jackson et al, 2005). Also, no TSE specific nucleic acid consistently associated with the 
prion agent has been identified (Prusiner, 1998). Besides, the infectious agent is not 
structurally similar to viruses. 
The virinos hypothesis postulates that the infectious agent is a small informational 
molecule (mostly a piece of nucleic acid) which is too small to code its own protein 
(Dickinson and Outram, 1979), but which replicates by using the host made protein in 
which it is encapsulated (Kimberlin, 1982). Virinos are reported to withstand methods that 
destroy nucleic acid due to its small size and protective protein coat (Kimberlin, 1982). 
However, no nucleic acid has been found following nuclease digestion (Prusiner, 1998).  
Despite the setbacks to the viral and virinos hypotheses, there are still proponents who 
argue that diversity in prion strains and the reported presence of small quantities of nucleic 
acid in infectious samples support these hypotheses (Chesebro et al, 1985; Narang, 2002; 
Manuelidis et al, 2009). However, heritable information defining distinct prion strains have 
been found not to reside on some informational molecule but rather exclusively in the 
protein folding pattern (Safar et al, 1998; King and Diaz-Avarios, 2004; Tanaka et al, 
2004; Thackray et al, 2007). Therefore, the viral hypothesis remains unsubstantiated.  
1.2.2 Prion hypothesis 
Griffith (1967) first reported that the scrapie agent was probably a self-replicating protein. 
Subsequently, Stanley Prusiner and co-workers isolated the infectious agent by 
biochemical fractionation, and observed that it was inactivated by procedures that 
destroyed protein, suggesting that it was proteinaceous in nature (Prusiner, 1982; Bolton et 
al, 1982). Prusiner (1982) described the agent as proteinaceous infectious particle and 
named it ‘prion’. The prion (protein-only) hypothesis postulates that the infectious agent 
consists probably entirely of an abnormal protein conformer which is devoid of nucleic 
acid and yet able to replicate and propagate itself (Prusiner, 1982). Although the prion 
hypothesis was dismissed at the time as a biologically baseless aberration, a number of 
evidence supporting the hypothesis has accumulated over the years such as the discovery 
of the normal prion protein (Oesch et al, 1985) and prion protein encoding gene (Basler et 
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al, 1986), the effect of prion protein gene mutation on prion phenotyping (Hsiao et al, 
1990), generation of infectivity by alteration of the prion protein (Sigurdson et al, 2009), 
the absence of other detectable components such as nucleic acids in a highly purified prion, 
which co-purify with infectivity, and which exhibit a proportionality of concentration to 
infectivity titre (Gabizon et al, 1988), the inability to propagate infectivity in prion protein 
knockout mice (Bueler et al, 1993; Legname et al, 2004), conversion of normal prion 
protein to prions in cell-free experiments seeded with infectious prion (Caughey et al, 
1997) and in prion misfolding cyclic amplification (PMCA) (Saborio et al, 2001; Deleault 
et al, 2007), prion strain diversity resulting entirely from prion protein misfolding pattern 
(Prusiner, 1997; Caughey et al, 1998; Tanaka et al, 2004), generation of infectivity in vitro 
with natural and synthetic prion (King and Diaz-Avalos, 2004; Tanaka et al, 2004) and the 
presence of infectivity and transmissibility of amyloid forms of other protein misfolding 
diseases such as Alzheimer’s, Parkinson diseases and Huntington disease,  which provide 
evidence of protein-only transmission of biological information in the absence of nucleic 
acid (Cushman et al, 2010). Evidences for the prion hypothesis excludes possible 
pathologic and replicating role of small viruses, and clearly demonstrates that transmission 
of biological information and propagation of infectivity by protein in the absence of a 
nucleic acid template is possible. However, the prion hypothesis does not conclusively 
prove that prion is entirely the infectious agent, as clearly stated in its definition (Prusiner, 
1982).  
1.2.3 Multi-component hypothesis 
The multi-component hypothesis postulates that the infectious agent may be composed of 
multiple host components including lipids, polyanionic molecules, cell adhesion 
molecules, RNA and glycosaminoglycan (Deleault et al, 2007; Geoghegan et al, 2007; 
Caughey et al, 2009; Wang et al, 2010). These cofactors or accessories may be required for 
the formation of infectious prion and the efficient replication and propagation of prion 
infectivity. For example, a decrease in prion generation and amplification occured when 
purified prion protein was used as substrate instead of brain homogenate in in vitro 
experiment (Deleault et al, 2005). Similarly, in vitro conversion of normal prion protein to 
the infectious form using bacterially expressed hamster prion protein as substrate was less 
efficient than with brain homogenate (Atarashi et al, 2007). These examples suggest that 
additional components play an important role in the molecular events leading to the 
conversion, replication and propagation of prions.  
 
While the prion hypothesis remains important and fundamentally relevant, the multi-
component hypothesis is a complementing hypothesis which envisages broader 
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possibilities of the compositions and interactions of prions in a biological system. This is 
particularly important considering, for instance, that the presence of PrP or protease-
resistant PrP alone may not result in prion conversion and propagation of prion infectivity. 
Therefore, the protease-resistant PrP may not entirely represent the infectious agent. 
However, despite the various hypotheses put forward, the nature of the infectious agent 
remains highly complex and poorly understood. 
1.3 Prion protein 
Prion protein is a membrane-bound glycoprotein first described in 1985 (Oesch et al, 
1985), and which derives its name from the infectious agent ‘prion’ of TSEs (Prusiner, 
1982). The term prion protein (PrP) generally refers to both the normal cellular form 
designated PrPC and its pathological isoform designated PrPSc. The molecular weight of 
prion protein is 33-35 KDa. 
1.3.1 Cellular prion protein (PrPC) 
PrPC is a glycosyl-phosphatidyl inositol (GPI) anchored membrane protein encoded by the 
PrP gene (Basler et al, 1986; Stahl et al, 1987). In the intracellular milieu, PrPC is 
endocytosed via the clathrin-coated pits and then recycled back onto the plasma membrane 
(Shyng et al, 1994). PrPC is expressed in mammalian tissues and cells, and abundantly in 
the central nervous system (CNS) and lymphoid organs (Oesch et al, 1985; Antoine et al, 
2000; Li et al, 2001). PrPC has been detected in non-mammalian species such as birds 
(Gabriel et al, 1992), fishes (Rivera-Miller et al, 2003), chicken, turtle and frogs (Calzolai 
et al, 2005) and fungi such as Podospora anserine (Coustou et al, 1997). 
 1.3.1.1 Physiological functions of PrPC 
The evolutionarily conserved nature of the PrP gene (Oesch et al, 1991; Van Rheede et al, 
2003; Wei et al, 2008; Crozet et al, 2008) and the expression of PrPC in several 
mammalian and non-mammalian species, arguably suggest that it may play some important 
physiological role. However, the apparent lack of abnormal physical and physiological 
features in PrPC knockout mice suggests that PrPC is probably dispensable in physiological 
functioning (Bueler et al, 1992; Lipp et al, 1998).  
The central role of PrPC in prion pathogenesis has been demonstrated in cell-free 
conversion experiments in which PrPC substrate was necessary for prion replication to 
occur (Caughey et al, 1997; Kirby et al, 2006), and in transgenic mice in which PrPC over-
expression resulted in shortened disease incubation time (Fischer et al, 1996; Tamguney et 
al, 2006). Also, PrPC knockout mice were unable to propagate disease (Bueler et al, 1993; 
  
6 
Prcina and Kontsekova, 2011), which suggests that it plays important role in prion 
pathogenesis.  
The possible roles of PrPC in CNS and immune system functioning, for example in 
neuroprotection against apoptotic, oxidative and heat shock stress, trans-membrane 
signalling, memory formation and cognition and synaptic activity have been variously 
reported. PrPC reportedly mitigated Bax-mediated cell death in human neurons and in 
yeasts (Bounher et al, 2006), and protected MCF-7 cancer cells exposed to apoptosis-
inducing tumor necrosis factor (TNF-α) (Diarra-Mehrpour et al, 2004). It has been 
reported that cross-linking PrPC with antibody resulted in the activation of extracellular-
regulated kinase, NADPH oxidase and the production of reactive oxidase species, which 
suggests that PrPC functions as a receptor for trans-membrane signalling (Mouillet-Richard 
et al, 2002). Also, PrPC has been reported to play a role in memory formation and 
cognition (Criado et al, 2005).  
Evidence of PrPC role in immune system functioning has been shown by the abundant level 
of PrPC expression in dendritic cells (Martinez et al, 2006). The absence of PrPC in 
dendritic cells was found to result in a significant decrease in T cell response (Ballerini et 
al, 2006). Also, temporary inactivation of follicular dendritic cells delayed neuroinvasion 
of scrapie (Mabbott et al, 2000). Furthermore, PrPC involvement in synaptic activity has 
been shown by its ability to bind Alzheimer’s disease associated β-amyloid oligomer, and 
to act as a receptor militating against oligomer-induced synaptic dysfunction (Lauren et al, 
2009). Also, PrPC knockout mice were reported to show reduced sense of smell (judged by 
odour guidance test) compared to normal PrPC expressing mice as a result of aberrations in 
the synaptic transmission between olfactory bulb granule and mitral cells (Le Pichon et al, 
2009).   
In general, the rather extensive list of possible functions of PrPC arguably suggests that 
PrPC is either a vastly important multi-functional physiological protein or one which actual 
function is clearly undefined.   
1.3.1.2 Prion conversion and aggregation 
The normal form of prion protein, PrPC, is converted into an abnormal form, PrPSc, by the 
misfolding of α-helices of PrPC into β-sheets (Pan et al, 1993; Prusiner, 1998). It has been 
demonstrated that the plasma membrane is the primary site of prion conversion (Goold et 
al, 2011). During this conversion, the single disulphide bonds that links and stabilises the 
helices on the C-terminal region of PrPC remain intact (Huang et al, 1996; Herrmann and 
Caughey, 1998; Govaerts et al, 2004). The conversion and aggregation of PrPC to PrPSc is 
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broadly described by two mechanistic models: the template-assisted model [heterodimer 
model] (Prusiner, 1991) and the nucleated polymerisation model [seeded fibrillisation] 
(Jarret and Lansbury, 1993; Birkman and Riesner, 2008).  
The template-assisted model suggests that PrPSc serves as a template by which PrPC / PrPSc 
complex results in the conversion of PrPC to PrPSc (Fig 1.2A). The PrPC / PrPSc complex 
suggestively lowers high energy barrier that would ordinarily impede spontaneous PrPC to 
PrPSc conversion (Aguzzi et al, 2008).  The template-assisted model is exemplified by the 
cell-free conversion experiment in which radioactive labelled PrPC molecules seeded with 
PrPSc molecules result in radioactive labelled PrPSc molecules (i.e. radioactive labelled 
PrPC + PrPSc = PrPSc + radioactive labelled PrPSc) (Caughey et al, 1997).  
The nucleated polymerisation model suggests that PrPC and PrPSc are in a reversible 
thermodynamic equilibrium, co-existing in normal state, with the monomeric PrPSc having 
a tendency to aggregate into infectious PrPSc seed. The infectious seed then recruits more 
monomeric PrPSc at a faster rate and aggregates into amyloid, and the amyloid then 
fragments into more infectious seeds and so on (Fig 1.2B).  This model highlights that 
PrPSc aggregation is required in prion pathogenesis. The model is exemplified by the in 
vitro conversion of PrPC to PrPSc in protein misfolding cyclic amplification (PMCA) assay, 
where the PrPSc aggregate is fragmented by sonication yielding additional PrPSc as 
template for PrPC conversion (Caughey et al, 1997; Saborio et al, 2001). De novo 
generated PrPSc has shown replicating and pathologic properties as evidenced by in vivo 
propagation and neurological features (Castilla et al, 2005; Barria et al, 2009).  
Despite the seeming competence of PrPSc to conscript and convert PrPC, it has been 
suggested that other “partners in crime” are necessary for the conversion to occur 
(Caughey and Baron, 2006). A number of reports suggest that some hypothetical cofactors 
macromolecules such as glycosaminoglycans (Caughey et al, 1994; Hijazi et al, 2005; 
Silva et al, 2010), nucleic acids (Cordeiro et al, 2001; Deleault et al, 2003; Cordeiro et al, 
2005; Silva et al, 2008), and extracellular matrix molecules (Leucht et al, 2003; Qiao et al, 
2009) are involved in the efficient structural conversion process from PrPC to PrPSc, and 
indeed in prion pathogenesis. These cofactor molecules supposedly lower the Gibbs free 
energy barrier making unfolding, oligomerisation and spontaneous conversion of PrPC to 
PrPSc possible (Prusiner, 1998; Baskakov et al, 2004; Cordeiro and Silva, 2005). An 
example of the role of cofactors has been shown in cells, in which conversion and 
propagation of PrPSc was hindered by limiting the availability of cellular heparin sulphate 
(a glycosaminoglycans occurring in the cell membrane of most cells) (Ben Zakan et al, 
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2003; Hijazi et al, 2005). Despite the current knowledge of PrPC interactions and PrPSc 
formation, the underlying mechanisms for prion conversion remain unresolved.  
 
Fig. 1.2: Models for the conformational conversion of PrPC into PrPSc. A: the template assistance 
model postulates an interaction between exogenously introduced PrPSc and endogenous PrPC, 
which is induced to transform itself into further PrPSc. B: nucleation (Adapted from Aguzzi and 
Calella, 2009).  
1.3.2 Infectious prion protein (PrPSc) 
Infectious prion protein (PrPSc) derives from normal cellular prion protein (PrPC) after 
undergoing a post-translational conformational change, resulting in predominantly high β-
sheet content in its secondary structure (Pan et al, 1993; Prusiner, 1998). PrPSc is 
considered to be the main component of the infectious prion agent (Prusiner, 1982), and its 
misfolded pattern determinant of prion strain diversity (Prusiner, 1997; Caughey et al, 
1998; Tanaka et al, 2004). PrPSc is partially digested by proteinase K (PK), resulting in a 
PK resistant core (PrPres) consisting of amino acid residues 90 to 231, and molecular 
weight (MW) of approximately, 27-30 KDa (Prusiner et al, 1983; McKinley et al, 1983).  
1.3.2.1 Prion infectivity 
Prion infectivity is the characteristic of the prion agent that permits invasion, survival and 
replication, resulting in disease in a susceptible host. PrPSc and particularly its protease 
resistant core (PrPres) are generally considered as a surrogate marker for prion infectivity 
and disease. In principle, if PrPSc and PrPres constitute the main component of the 
infectious agent, their decreased concentration would almost certainly result in a 
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corresponding reduction in infectivity (Triantis et al, 2007). While a number of reports 
have shown strong correlation between PrPSc and infectivity (McKinley et al, 1983; 
Prusiner, 1991; Wadsworth, 2007), it has also been reported that PrPSc or PrPres does not 
always correlate with infectivity (Berardi et al, 2006; Barron et al, 2007; Lasmezas et al, 
1997; Tixador et al, 2010; Silveira et al, 2005; Edgeworth et al, 2009). For example, 
Somerville et al (2002) reported a >99.9 % loss of infectivity after heat treatment of 
scrapie at 100 oC whereas PrPSc abundance persisted.  On the contrary, infectivity has been 
reported in the absence of immunochemically detectable levels of PrPSc (Berardi et al, 
2006; Barron et al, 2007; Lasmezas et al, 1997). Also, protease-sensitive and soluble forms 
of PrPSc have been reported to be potentially infectious, so that the absence of detectable 
PrPres does not necessarily indicate absence of infectivity (Berardi et al, 2006).  
The variable reports of the relationship between prion infectivity and PrPSc cast doubts as 
to their actual relationship, and whether PrPSc entirely constitutes or indicates the presence 
of the infectious agent. Scherbel (2007) argues that the inability to detect PrPSc in prion 
infected brain homogenate may be as a result of low levels of PrPSc, presence of sub-
fractions of infectious prion protein undetectable by immunochemical method and 
presence of other infectious molecules or structure other than PrPSc, and therefore 
alternative markers of prion infectivity and more sensitive PrPSc detection methods are 
required. However, PrPSc and PrPres remain important and established biomarkers of prion 
infectivity and prion diseases. For example, a reduction or loss of PrPSc immunoreactivity 
detected by Western blotting most likely suggests a reduction or loss of infectivity, and 
hence Western blotting analysis could be a useful biochemical method for detection of 
PrPSc and evaluation of residual infectivity (Caughey et al, 1997; Triantis et al, 2007; 
Wadsworth, 2007). Therefore, procedures that destroy PrPSc and methods that measure and 
quantify PrPSc are central to prion degradation and residual infectivity evaluation.  
1.3.3 Structure and composition of prion protein 
Full length PrPC consists of two structurally well defined domains: a long amino-proximal 
(N-terminal) and carboxyl-proximal (C-terminal) domains (Fig. 1.3) (Aguzzi and Calella, 
2009). The N-terminal domain consists of the signal peptide (1-22 aa residues) which is 
usually cleaved during PrPC metabolism, and a flexible random coil sequence (23-124 aa 
residues) which contains several highly conserved metal-binding octapeptide repeats 
bordered by two positively charged clusters, CC1 (aa 23-27) and CC2 (aa 95-110) (Aguzzi 
and Calella, 2009). The metal binding property of octapeptide repeats is implicated in 
transformation and alteration of PrPC biochemical properties leading to PrPC stability and 
resistance to proteolysis, and may play a role in prion misfolding and prion pathogenesis 
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(Lehmann, 2002; Jackson et al, 2001; Choi et al, 2010).The N-terminal domain also 
contains a large bouquet of N-glycans attached to the PrPC molecules (Rudd et al, 1999), 
and sulphated glycans binding to the structures of this domain was reported to modulate 
PrPC conformational conversion and oligomerisation (Taubner et al, 2010), hence is central 
to PrPC function and prion pathogenesis (Laffont-Proust et al, 2006). The N- and C-
terminal domains are separated by a highly conserved hydrophobic segment (111-134 aa 
residues) (Aguzzi and Calella, 2009). 
 
The C-terminal domain is globular in nature and consists of a GPI anchor which results in 
cleavage of membrane anchor region (aa residues 231-254) during its attachment to PrPC, 
and a disulphide bond linking aa 178 and aa 213 which stabilises the domain. It also 
consists of two N-linked glycosylation sites in asparagine (asn) residues 181 and 197 (in 
human) and 180 and 196 (in mice) to which are attached different sugar types (Rudd et al, 
2001). The glycosyl groups confer PrPC with three different glycosylation forms namely 
unglycosylated, monoglycosylated and diglycosylated bands (Endo et al, 1989), which 
appear as lower, middle and upper bands respectively on PrP electrophoretic profiles 
(Parchi et al, 1996).  It has been reported that the second helix of the C-terminal and the 
unstructured N-terminal regions (Fig 1.4) play a critical role in pathogenic conformational 
conversion of PrPC (Ji and Zhang, 2009).   
 
 
Fig. 1.3: Outline of the primary structure of the cellular prion protein including post-translational 
modifications. Where, signal: signal peptide residue; CC1 and CC2: positively charged clusters; 
OR: octapeptide repeats; HC: conserved hydrophobic segment; S-S: single disulphide bond 
linkage; CHO: N-linked glycosylation sites; GPI: glycosyl-phosphatidyl inosital anchor; MA: 
Membrane anchor region (Adapted from Aguzzi and Calella, 2009).  
The cellular prion protein (PrPC) and the pathogenic form (PrPSc) are indistinguishable in 
their primary amino acid composition, but characteristically differ in their secondary 
conformations resulting from their α-helical (spiral form) and β-sheet (plane form) 
compositions. Nuclear magnetic resonance (NMR) studies suggest that the secondary 
structure of PrPC (Fig. 1.4) consists of three α-helices (aa residues 144 -154, 172- 193 and 
200- 227) and two very short β-sheets (aa residues 129-131 and 161-163), and a relatively 
unstructured N-terminus (Riek et al, 1997; James et al, 1997).  
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Fig. 1.4: Secondary structure of mouse prion protein showing three α-helices (represented in red) 
and two very short β-sheets (represented in yellow). Dotted line is unstructured N-terminus region 
(Adopted from Riek et al, 1997).  PrPC and PrPSc are differentiated by the amount of α-helices and 
β-sheets present. 
Fourier-transformed infrared and circular dichroism spectrometry studies suggest that PrPC 
is composed of approximately 42 % α-helical and 3 % β-sheet conformations, whereas 
PrPSc is composed of approximately 30 % α-helical and 43 % β-sheet conformation (Pan et 
al, 1993; Prusiner, 1998). The ratios of the α-helical and β-sheet content confer unique 
biological, biochemical and biophysical properties to both isoforms (Table 1.2). Clearly, 
high β-sheet conformation is an important characteristic of PrPSc and the primary building 
block of prion. The high β-sheet content in PrPSc results from the conformational transition 
of the hydrophobic region (amino acid residue ~90-140) of the PrPC helices resulting in its 
characteristic hydrophobic nature and resistance to proteolysis and common physical and 
chemical processes (McKinley et al, 1991; Taylor et al, 1999). It has been suggested that 
proteins with high β-sheet content are kinetically stable and extremely resistant to 
proteolysis by PK probably due to their rigid structure (Manning and Colon, 2004). The 
implications of a structurally stable and protease resistant infectious prion include 
perseverance in contaminated environments and materials, and the attendant risks of 
potential transmission within and between species (Georgsson et al, 2006; de Pedro-Cuesta 
et al, 2009).  
PrPSc is structurally similar to feather keratins by the prevalent nature and composition of 
high β-sheet abundance, which has become the basis for the hypothesis that feather 
degrading proteases such as keratinases are able to degrade prions (Shih, 2002; Langeveld 
et al, 2003) (see section 1.8). 
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Table 1.2: Biochemical and biophysical characteristics of PrPC and PrPSc 
Properties PrPC PrPSc 
Protein1,2 Normal cellular protein Abnormal disease-
associated protein 
Infectivity1,2 Not infectious Infectious, pathogenic 
Folding3,4 Predominantly α-helices Predominantly β-sheets 
Solubility5 Soluble (Hydrophilic) Insoluble (hydrophobic) 
PK digestion6 Sensitive Partially resistant 
Aggregation6,7 Not aggregated Tendency to aggregate 
Oesch et al (1985)1, Prusiner (1982)2, Pan et al (1999)3, Prusiner (1998)4, Mckinley et al (1991)5 Prusiner et 
al (1983)6,  Riesner (2003)7 
1. 4 Keratins: structure and composition 
Keratins are highly stable, insoluble fibrous proteins composed of tightly packed α-helix 
(α-keratin, e.g. hairs) or β-sheet (β-keratin, e.g. feathers) intertwined polypeptide chains 
which form dense network of intermediate filaments (IF) (Fig. 1.5). The intertwined 
polypeptide chains consist of helical rod domain and a structurally short non-helical head 
(amino) and tail (carboxyl) domains (Cohlberg, 1993). Keratins belong to type I (acidic 
keratins) and type II (basic keratins) intermediate filament proteins and have molecular 
weights of approximately 45 KDa and 55 KDa respectively. There are approximately 30 
different keratins which are generally grouped into epithelia keratins (in epithelia cells) and 
trichocytic keratins which make up hair, nails, horns and reptilian scale. Keratins are also 
classified as hard (those containing up to 5 % sulphur) and soft (those containing up to 1 % 
sulphur) keratins (Karthikeyan et al, 2007). 
 
 
 
 
 
 
 
 
 
 
Fig. 1.5: Microscopic details of dense network of keratin filaments in a cell (308 × 310 pixels). 
Image by Jamie Bush and John Schmidt (2006) (Source: http://en.wikipedia.org/wiki/Keratin, 
8/9/09). 
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Keratins consist of large proportion of the smallest amino acids such as glycine (with a 
side group of a single hydrogen atom) and alanine (with a small and non-charged methyl 
group). The stability of keratin depends on the composition and molecular conformation of 
its constituent amino acids (Bradbury, 1973), and on their intermolecular disulphide bond 
cross-linking (Wang et al, 2000). Hydrogen bonding between the amino and carboxyl 
groups of the peptide bonds on adjacent protein chains facilitates close alignment and 
strong binding in β-keratins (Bradbury, 1973). The tertiary structure of β-keratin is richly 
organised and stabilized by a high degree of cross-linking of disulfide bonds, and by 
hydrogen bonds and hydrophobic interactions (Murayama-Arai et al, 1983; Fuchs, 1995; 
Parry and North, 1998). These bonds together with its aggregated amyloid-like fibrillar 
structure confer keratin with its mechanical strength as well as chemical and enzymatic 
resistance (Alexander and Hudson, 1954; Fuchs, 1995). The highly stable and resilient 
nature of keratins is probably the reason why it is the main component of the epidermis and 
its appendages such as hair, nail, hoof, scale and feather. Fourier transform infrared (FT-
IR) and near infrared (NIR) suggest that β-sheet structure are stabilised by formic acid 
(Aluigi et al, 2007). However, it has not been reported whether the β-sheet structure of 
prion is similarly stabilised by formic acids or indeed any other such entities. 
Significant amount of keratins in the form of feathers, horns, hairs and hooves are 
generated as waste products from poultry, slaughterhouse, and leather processing industries 
(Onifade et al, 1988; Karthikeyan et al, 2007) which can be processed into protein rich 
livestock feed, fertilizers (Odetallah et al, 2003; Karthikeyan et al, 2007). Feather is 
composed of approximately 90 % pure keratin and consists predominantly of β-keratin 
(Fraser et al, 1972). Feather keratin (β-keratin) is highly stable due to its rich β-sheet 
constitution (Kelly et al, 2006; Kreplak et al, 2004), and hence most resistant to proteolysis 
(Fuchs, 1995). For this reason, it is used as a model substrate for the study of keratin 
degradation and as a substrate for routine study of hard-to-degrade proteins such as prions 
(Suzuki et al, 2006). Proteolytic microorganisms possessing feather degrading ability are 
considered as potential candidates for degradation of prions. The isolation and evaluation 
of prion degrading microorganisms and their proteases by procedures and assays that 
exploit their keratin degrading potentials is both safe and desirable, and was therefore 
explored in this study. 
1.4.1 Degradation of keratin  
Despite the stable structural composition of keratin, they are degraded by reducing agents 
such as thioglycolic acid, potassium cyanide, and sodium sulphide and sodium sulphite, 
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which rapidly degrade keratin under alkaline conditions by breaking the disulphide bonds 
that hold keratins together (Goddard and Michaelis, 1934). Also, oxidising agents such as 
bromine, permanganate and hydrogen peroxide slowly cleave keratins but not by breaking 
the disulphide bonds (Goddard and Michaelis, 1934). This therefore suggests that chemical 
degradation of keratins may occur by more than one mechanism.  
The major setbacks of chemical degradation of keratins, especially in large scale 
technological applications is that the keratinaceous material may be completely destroyed 
and polluting chemical by-products could impact adversely on the environment. For 
example, the chemical processing of hide in the leather industry using sodium sulphide, 
lime and other solvents result in offensive odour and pollution of tannery effluents (Kamini 
et al, 2010). These limitations have warranted considerable interest in microbial enzymes 
as viable alternative technology which could allow product recovery but with significantly 
reduced pollution load. For example, keratinases which hydrolyse keratin can be used for 
skin dehairing in the leather processing industry without the chemical pollution associated 
with sodium sulphide treatment (Macedo et al, 2008; Tiwary and Gupta, 2010). 
Degradation of keratin by certain specialised microorganisms have long been recognised as 
evidenced by the decomposition of feather keratin by some naturally occurring biological 
process in the environment (Noval and Nickerson, 1959); during which it is utilised as 
source of carbon and energy for growth and survival (Riffel and Brandelli, 2006; Joshi et 
al, 2007). Goddard and Michaelis (1934) reported that powerful protease and an enabling 
highly alkaline condition were a prerequisite for cleavage of disulphide bonds of keratins.  
 
A prototypical protease highly efficient in keratin degradation is proteinase keratin 
commonly abbreviated as proteinase K (PK). PK is a broad spectrum serine protease 
commonly used to digest protein in molecular biology and for characterisation of prion 
protein by virtue of its ability to completely degrade PrPC and partially degrade PrPSc 
(Prusiner et al, 1983; McKinley et al, 1983; Cronier et al, 2008; Safar et al, 2005; Tzanban 
et al, 2002; Pastrana et al, 2006). The general reaction mechanism for substrate 
degradation described for PK involves the attachment of the substrate to the substrate-
recognition site in the active site, formation of hydrogen bonds in the oxyanion hole and 
hydrolytic cleavage by the catalytic triad (Betzel et al, 1988). The ability of PK to degrade 
both native keratin and prions (Shih, 2002; Langeveld et al, 2003; Tsiroulnikov et al, 
2004) may relate to their similar structural composition, suggesting that they may be 
degraded by similar mechanisms. It is for this reason that β-sheet rich keratineous materials 
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are suitable non-infectious substrate for routine evaluation of prion degrading proteases 
such as keratinases. 
1.4.1.1 Keratinases 
Keratinases are a group of proteolytic enzymes with the ability to hydrolyze insoluble 
protein keratin more efficiently than other proteases (Onifade, 1998). Keratinases have also 
been defined as proteolytic enzymes that catalyse the cleavage and hydrolysis of keratins 
(The American Heritage Medical Dictionary, 2007). In all, keratinases are proteases 
involved in the degradation of keratins by hydrolysis of its constituent polypeptide 
substrates into smaller molecular units which are readily absorbed by the microbial cells 
resulting in organic matter turnover (Cohen, 1990).  
Keratinases are produced by several microbial species including fungi (kushwaha and 
Gupta, 2008; Bahuguna, and Kushwaha, 1989; Gradisar et al, 2005), actinomycetes 
(Gusterova et al, 2005; Mitsuiki et al, 2010; Montero-Barrientos et al, 2005) especially the 
Streptomyces genus (Korkmaz et al, 2003; Bockle et al, 1995; Chao et al, 2007; Esawy, 
2007; Bressollier et al, 1999; Tapia and Simoes, 2008) and Bacillus species  (William et al, 
1990; Ramnani et al, 2005; Manczinger et al, 2003; Olajuyigbe and Ajele, 2005) and 
archaea (Kublanov et al, 2009). Recently, keratinases from Pseudomonas aeruginosa KS-1 
(Sharma and Gupta, 2010) and Pseudomonas sp. MS21 (Tork et al, 2010) have also been 
reported. This is particularly interesting as Pseudomonas aeruginosa are prolific producers 
of biosurfactants known to enhance degradation of recalcitrant organic matter such as 
hydrocarbons (Noordman and Jassen, 2002; Soberon-chavez et al, 2005; Okoroma, 2006) 
[see section 1.7].  
 
Bacillus licheniformis are the most prolific keratinase producing bacteria and their 
proteases are known to be highly stable and significantly retain their activity in 
environments containing potentially inhibitory chemicals agents such as surfactants, 
magnesium and calcium ions, and sodium tripolyphosphate (Veith et al, 2004). Keratinase 
producing microbial species are isolated from various environmental sources including: 
soil (Korkmaz et al, 2003; Macedo et al, 2005), feather waste (Cai et al, 2008; Wang and 
Shih, 1999; Leterneou et al, 1998; Manczinger et al, 2003), poultry plant waste (Tapia et 
al, 2008), sea shore Eswary (2007) and cement of bathroom tile (Mitsuiki et al, 2010).  
 
Keratinases are characterised by their biochemical and biophysical properties (Goldstein, 
2007; Brandelli et al, 2010). Most keratinases thrive in alkaline and thermophilic 
environments (Williams et al, 1990; Bressollier et al, 1999; Korkmaz et al, 2003). The 
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molecular weight of reported keratinases is around 18 KDa and 280 KDa (Brandelli et al, 
2010). Keratinases are grouped according to their ability to hydrolyse specific substrates 
and their activity in the presence of certain chemical agents. Serine keratinase group is the 
most commonly found and is characteristically inhibited by phenylmethylsulfonyl fluoride 
(PMSF) and benzamidine (Giongo et al, 2007). The metalloproteases group are inhibited 
by ethylene diamine tetra acetic acid (EDTA) (Thys and Brandelli, 2006; Riffel et al, 
2007), and the serine metalloprotease keratinase are inhibited by both PMSF and EDTA 
(Tatineni et al, 2008).  
The chemical structure of Fervidobacterium pennivorans keratinase, Fervidolysin, mapped 
by crystallographic analysis (Fig 1.6) suggests that it is composed of four domains; a 
catalytic domain (CD), propeptide domain (PD), and two β-sandwiched domains (SD1 and 
SD2) held together by hydrogen bonds and hydrophobic interactions (Kim et al, 2004). It 
is further suggested that keratinases of molecular weight less than 35 KDa may contain 
only the catalytic domain (Kim et al, 2004). 
 
 
Fig.1.6: A 1.7Å resolution crystal structure of keratinase showing four domains: Catalytic domain 
(CD), propeptide domain (PD), and two β-sandwiched domains (SD1 and SD2), labelled according 
to corresponding colours. The active site catalytic triad consists of Ser389, His208 and Asp170. 
The PD-processing site at the boundary of PD and CD is indicated by red asterisks and calcium-
binding sites indicated by balls labelled Ca. (Kim et al, 2004). 
 
Considerable attention has been drawn to keratinases in recent years for their ability to 
degrade recalcitrant and environment polluting keratin wastes (feathers, hairs, and hooves) 
into useful end products. For example, keratinases convert feather wastes into nutritionally 
rich livestock feed (Chandrasekaran and Dhar, 1986; Shih and William, 1990; Onifade et 
al, 1998; Odetallah, et al, 2003) and slow-releasing organic fertilizers (Choi and Nelson, 
  
17 
1996). They are also becoming increasingly important for dehairing of hide in the leather 
processing industry (Mukhopadyay and Chandra, 1993; Macedo et al, 2005; Tiwary and 
Gupta, 2010) and for degrading prions (Shih, 2002; Langeveld et al, 2003; Tsiroulnikov et 
al, 2004; McLeod et al, 2004; Miwa et al, 2006). Keratinase of Bacillus licheniformis 
PWD-1 is one of the famously reported prion degrading enzyme, and was found to degrade 
prions more efficiently than PK when tested at the same levels of enzymatic units (Chen et 
al, 2005). However, the quest for prion degrading proteases has intensified in recent years 
(Muller-Hellwig et al, 2006; Yoshioka et al, 2007), and recently, genetically modified 
prion degrading proteases have been reported (Dickinson et al, 2009; Liang et al, 2010). 
The uses and potential applications of keratinases summarised according to their industrial 
applications (Brandelli et al, 2010) is presented in Table 1.3. 
 
Table 1.3: Potential applications of microbial keratinases grouped according to 
applications in different fields.  
Field Applications 
Agro industry - production of food hydrolysates 
- feed supplements 
- production of entomopathogens 
- production of nitrogen fertilizers 
Pharmaceutical/ 
biomedical 
- prion hydrolysis 
- enhanced drug delivery 
- dermatological treatment 
- cosmetics 
Industry - leather processing (Tannery) 
- fibre modification (Textile) 
- detergents 
- modification of protein functionality (foods) 
- biopolymers (Films, coating, glues) 
- wastewater treatment/waste management 
Biomass/bioenergy - bioconversion of keratinous wastes for  
Subsequent production of methane and biohydrogen. 
             Source: Brandelli et al (2010) 
1.4.1.2 Mechanisms of keratin degradation by keratinase  
The tight structural arrangement of keratin hinders proteolytic access to its cleavage sites 
such that it is degraded only by a few proteases, specifically keratinases. The structural 
configuration of keratinases enables the interaction with β-keratin and assist in 
disassembling of the layers of β-structures so that individual strands can be subsequently 
hydrolysed (Kim et al, 2004). The specific mechanism of keratin degradation by keratinase 
is still not well elucidated but appears to occur in two main steps: deamination and 
cleavage of disulphide bond. Deamination creates an alkaline environment needed for 
substrate swelling, sulphitolysis and proteolytic attack (Kunert, 1989; Kunert, 1992; 
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Kunert, 2000), where sulphitolysis is likely an essential step in the digestion of keratin 
which preceeds proteolysis (Monod, 2008). Deamination is therefore considered as the first 
step in keratin degradation and results in the pH increases observed during feather 
degradation by microorganisms of significant keratinolytic activity (Kunert, 2000; Kaul 
and Sumbali, 1997). The second step in the degradation process involves cleavage of the 
disulphide bonds which changes the conformation of keratin therefore exposing more sites 
to proteolytic attack (Gradisar et al, 2005; Cao et al, 2008). The release of soluble 
sulfhydryl compounds is regarded as an indication of disulphide cleavage during microbial 
decomposition of keratin (Goddard and Michaelis, 1934). However, Williams et al (1990) 
reported that keratinase degradation of keratins occured without an accompanying release 
of soluble sulfhydryl, which suggests that the degradation possibly follow different 
pathways, depending on the type and origin of the keratinase and the prevailing 
degradation conditions. Therefore, keratinases may show variable activity towards 
different keratin substrates as well as different prion strains. 
 
Degradation of keratin by keratinases may be enabled in the presence of reducing agents. 
Ramnani and Gupta (2007) reported that suitable reducing agents e.g. live cells or 
chemical reductants are required in the degradation of feather keratins by keratinases. Also, 
it has been reported that other enzymes such as reductases may be constitutively secreted 
with keratinases in fermentation culture (Yamamura et al, 2002; Esawy, 2007; Manczinger 
et al, 2003; Rodziewicz and Laba, 2008; Brandelli, 2008), or the presence of microbial 
consortium (Ichida et al, 2001) are required in the degradation of keratin in which case 
each enzyme or member organism contributes toward the degradation process perhaps via 
different pathways. However, it could be argued that the degradation of keratins by 
purified keratinases indicates that a reducing agent, multiple enzymes or indeed a 
microbial consortium may not necessarily be required for keratin degradation to occur (Lin 
et al, 1992; Bressolier et al, 1999; Anbu et al, 2005), but could play a role in stimulating 
enzyme activity resulting in enhanced degradation rate. 
Considering that keratinases selectively degrade β-keratin by processes that break the 
stabilising bonds of the β-sheet structure (Burtt and Ichida, 2001; Fuchs, 1995), it is 
reasonable to hypothesise that the β-sheet structure of prions can be degraded by similar 
degradation mechanisms. 
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1.5  Challenges of prion contamination 
1.5.1 Risks of medical therapy  
The BSE epidemic in the UK (1989-1999) raised significant public awareness of TSEs. As 
at 1999, the number of confirmed BSE cases was 176,299 (AHVLA, 2011), and 
approximately 2 million cattle were estimated to have been potentially infected with BSE 
(Smith and Bradley, 2003). In addition, approximately 1.5 million potentially infected 
cattle were estimated to have passed into the human food chain and potentially consumed 
by millions of UK residents (Donnelly et al, 2002). Epidemiological and laboratory 
evidence of a causal link between BSE and vCJD (Brown et al, 1987; Bruce et al, 1997; 
Hill et al, 1997) therefore implies that large number of UK population may have been 
exposed to the BSE agent and could potentially develop prion disease.  
A total of 172 definite/probable cases of vCJD deaths have been reported in the UK since 
1990, out of the 1587 documented CJD related deaths (NCJDRSU, 2011). However, UK 
national vCJD prevalence study estimated (95 % confidence interval) that between 49 and 
692 people per million of UK population (Hilton et al, 2004) or 109 people per million of 
UK population (de Marco et al, 2010) may be asymptomatic vCJD carriers. These data 
invariably suggest a significant impact on public health as a direct consequence of BSE 
contamination through consumption of infected cattle (SEAC, 2010; Belay and 
Schonberger, 2005), or transfusion of blood received from infected individuals (Wroe et al, 
2006; HPA Press Office, 2009; NCJDRSU, 2011), or treatment with blood product 
received from infected individuals (Peden et al, 2010) or iatrogenic transmission through 
surgical instruments contaminated by infected individuals (Collins et al, 1999; Belay and 
Schonberger, 2005). Unfortunately, there are no reliable preclinical screening methods for 
vCJD, so that asymptomatic carriers may continue to donate blood and organs or undergo 
surgical intervention, thereby exposing more people to vCJD risk. Invasive surgical 
intervention potentially poses a higher risk of iatrogenic vCJD (Garske et al, 2006; 
Wadsworth et al, 2007) and CJD (WHO, 1999; Collins et al, 1999; de Pedro-Cuesta et al, 
2011) transmission, for reasons which include direct exposure of tissues to the prion agent, 
and because intra-species transmission is generally more efficient.  
1.5.2 Prions and the environment  
Prions are emerging environmental contaminants (Snow et al, 2007). The possible routes 
of prion deposition in the environment includes sheddings of diseased animals (urine, 
faeces, saliva, blood), decomposing carcases, carcases disposed in landfills, composting of 
carcases, wastewater from rendering plants and slaughter houses, effluent from hospital 
and research facilities and land spreading of biosolids (Mathiason et al, 2006; Kirchmayr et 
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al, 2006; Hinckley et al, 2008; Haley et al, 2009). For example, at the onset of the BSE 
crisis in the UK, an estimated 6000 suspected BSE infected carcases were disposed off in 
59 landfill sites (The Environment Agency, 1997; Saunders et al, 2008), which may pose 
potential prion contamination risks to the environment as current knowledge of prion 
behaviour indicates. Therefore, appropriate risk assessment to determine the fate of the 
prions in these environments may be required. 
 
Prion in the environment poses potential health risks to man and animals. Ingestion of 
prion contaminated soil and vegetation during foraging constitutes potential TSE risk, 
especially in the light of oral transmissibility of scrapie and chronic wasting disease 
(CWD) (Hadlow et al, 1982; Miller et al, 2004; Sigurdson et al, 1999; O’Rourke et al, 
1997), which highlights the risks of TSE transmission through ingestion of prion 
contaminated vegetation and soil-bound prion during foraging (Beyer et al, 1994; Johnson 
et al, 2007; Seidel et al, 2007). Therefore, prion contaminated environment poses 
agricultural challenges for farmed animals (sheep and deer) industry and sustainability 
challenges for free-ranging animals (deer and elk) population. There is also potential risk 
to humans exposed to such environment, or who may consume the meat of animals 
infected through such environment.  
1.5.3 Resilience of the TSE agent and its implications   
The TSE agent is resistant to common endogenous and environmental proteases, and 
withstands conventional physical and chemical sterilisation, inactivation and 
decontamination procedures (Taylor et al, 1994; Taylor et al, 1999; Kimberlin et al, 1983; 
Brown et al, 1982; McDonnell and Burke, 2003; Edgeworth et al, 2011). The TSE agent 
binds avidly to metal, glass and plastic surfaces (Zobeley et al, 1999; Flechsig et al, 2001; 
Weissmann et al, 2002; Yan et al, 2004). Autoclave sterilisation (moist heat-based 
inactivation) of prion contaminated metal have been reported to result to greater 
attachment and stabilisation of the prion agent making it refractory to inactivation 
(Flechsig et al, 2001; Zobeley et al, 1999; Walker et al, 2007; Fernie et al, 2007). These 
findings suggest that prion contaminated medical devices (surgical and dental instruments) 
processed by routine cleaning procedure may still retain prion infectivity and hence 
constitute potential route of vCJD and CJD transmission through reuse of such instruments 
hence prion contaminated surgical instruments remain a potential source of iatrogenic 
transmission (WHO, 1999), and for this reason, effective decontamination of reusable 
medical devices remain a crucial and desirable aspect of instrument management in 
modern surgical practice.  
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Prions deposited in the environment, for example in soil, remain highly stable and retain its 
infectivity and hence the environment is a stable reservoir of prion infectivity (Wiggens, 
2008; Johnson et al, 2007; Saunders et al, 2009; Tamgüney et al, 2009; Maddison et al, 
2010; Wilham et al, 2010). For example, scrapie prion interred in soil for three years 
retained about 50 % of its infectivity (Brown and Gajdusek, 1991). Furthermore, an 
epidemiological study of scrapie has shown persistence of the scrapie agent under 
environmental conditions for at least 16 years (Georgsson et al, 2006). The persistence of 
prions in the environment suggests that it is not readily degraded by environmental 
proteases.  
Resilience of the scrapie agent may also account for the recurrence of prion infection in 
disease-free livestock re-introduced into environment that previously held scrapie 
contaminated flock (Georgsson et al, 2006). Persistence of soil-bound CWD agent in the 
environment have been implicated in the horizontal transmission of CWD resulting in the 
CWD problem plaguing both farmed and free-ranging deer and elk in endemic proportions 
in parts of Canada and the United States (Miller et al, 2004). Clearly, CWD poses 
significant public health and economic concerns for deer and elk farming, as well as a 
threat to both human and animal health similar to BSE and scrapie. 
In the absence of reliable methods for detecting TSE in asymptomatic hosts, and as 
medical intervention for prion diseases remain elusive, control of TSE related risks and the 
development and improvement of decontamination practices remain a responsible option 
(Walker et al, 2008). Therefore, decontamination methods that are able to effectively 
destroy the prion agent at point sources including surgical and laboratory instruments, soil, 
farm implements, carcases, and effluent from meat processing remain highly desirable.  
1.6 Prion decontamination 
Prion decontamination generally refers to a reduction in prion titre, or removal of prion 
infectivity or biological activity by processes such as detachment, destabilisation 
(inactivation) and degradation, which causes an irreversible alteration of the chemical 
structure of prions (Croud et al, 2008). Detachment and stabilisation may occur in the 
absence of prion degradation (Lemmer et al, 2004) which may account for loss of PrPSc 
while infectivity remains. However, the terms prion decontamination, inactivation and 
degradation are used interchangeably. The resilient nature of the TSE agent has meant that 
stringent decontamination methods are often required to destroy its infectivity. 
In 1960, Pattison and Millson reported that scrapie prion was resistant to formalin and heat 
treatment. The reasons for this resilience nature was attributed to it proteinaceous nature 
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and the high β-sheet structural composition (Taylor, 1991; McKinley et al, 1991). The 
misfolded structure of prions is stabilised by disulphide bonds, so that physical and 
chemical processes which unfold (unfolding agents) and cleave disulphide bond 
(disulphide bond reductases) may invariably alter its chemical characteristics, resulting in 
the loss of prion infectivity. Physical processes that could unfold prions include: heat 
treatment, pH adjustment (<3 or >9), ultrasonic energy, infrared, electromechanical and 
microwave radiation, high pressure, electrical and magnetic fields, energetic vibration 
(magnetic or vortex stirring), electronic beam irradiation, and laser treatment], and the 
chemical processes that unfold prions include: treatments with organic solvents and 
solutes, chaotropic agents, chemical surfactants, inorganic salts, and agents that cleave 
disulphide bonds such as thioglycol.  
1.6.1 Chemical and physical prion decontamination methods 
The commonly reported prion decontamination methods includes chemical and physical 
treatments such as dry heat treatment, steam autoclaving and radio-frequency gas-plasma 
treatments, and treatments with acidic SDS, formic acid, peracetic acid, 2 N sodium 
hydroxide, and sodium hypochlorite solution (bleach) containing 20,000 ppm active 
chlorine and combination of these components (Ernest and Race, 1993; Taylor, 1999; 
Lemmer et al, 2004; Baxter et al, 2005, Peretz et al, 2006). The World Health Organisation 
(WHO) recommendation for prion decontamination include porous load autoclaving at 134 
oC for 18 min and immersing contaminated material in 1 M NaOH and/or 20,000 ppm 
NaOCl for 1 h at 20 oC (WHO, 1999). Similar chemical and physical treatment methods 
are recommended by the Society of Healthcare Epidemiology of America (SHEA) in its 
guideline for disinfection and sterilisation of prion-contaminated medical devices (Rutala 
and Weber, 2010). The methods considered to be most reliable for effective prion 
destruction are incineration (Defra, 2005; Jennette, 2002), thermal hydrolysis (Somerville 
et al, 2009) and alkaline hydrolysis (Thacker and Kastner, 2004; Kalambura et al, 2005; 
Yokoyama et al, 2006).  
1.6.1.1  Limitations of physical and chemical decontamination methods 
The chemical and physical prion decontamination methods are harsh, potentially hazardous 
and destructive, and hence are unsuitable for important applications such as 
decontamination of delicate medical devices, and recoverable animal by-products (e.g. 
specified risk materials [SRM]) and carcases. For example, the WHO recommended 
protocol for prion decontamination has been shown to corrode and blacken steel surfaces 
of medical instruments causing irreversible damaging effects (Fig. 1.6) (Brown et al, 
2005). 
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High temperature (134 oC) autoclaving is the UK hospital standard for decontamination of 
surgical instruments, the effectiveness of which remains questionable (Taylor, 1999; 
McDonnell and Burke, 2003; Edgeworth et al, 2011). For example, surgical instruments 
decontaminated by the routine hospital process were found to retain significant amounts of 
protein (Murdoch et al, 2006), and prion is particularly known to adhere to steel surfaces. 
The spongiform encephalopathy advisory committee (SEAC) in its guideline for assessing 
and comparing the efficacy of decontamination methods recommends that an effective 
decontamination method requires to achieve at least a five-log reduction in infectivity 
(SEAC, 2006). Such a method would also need to achieve at least one-log reduction in 
infectivity greater than the ID50. The standard autoclaving procedure (121 oC, 15 min) has 
been reported to achieve between two- and three-log reductions in infectivity. A similar 
level was reported for rodent-adapted human prion treated with 1 M NaOH for 1 h or 
autoclaving at 134 oC for 18 min (Lawson et al, 2007). The use of higher sterilisation 
temperature over extended incubation time (up to 30 min), such as those used in the UK 
hospital instrument sterilisation has been reported to achieve a four-log reduction 
(Kimberlin et al, 1983; Taguchi et al, 1991) which suggests that current UK hospital 
sterilisation standard falls short of the desirable standard and hence reuse of contaminated 
medical devices sterilised by the existing method could constitute healthcare risks. Prion 
decontamination with chlorine at concentrations up to 5000 ppm for 30 min also achieved 
a four-log reduction in infectivity (Brown et al, 1982). Only very high chlorine 
concentrations up to 10,000 ppm achieved more than four-log reduction in infectivity 
(Rutala and Weber, 2001). These reports suggest that most of the current chemical and 
physical prion decontamination methods such as treatment with NaOH, NaOCl and 
autoclaving may not be effective.  
 
Fig. 1.7: Mayo–Hager carbide-faced needle holders showing severe corrosion and blackening after 
immersion in bleach for 1 h (The instrument on the top, labeled 3), and autoclaving five times in 
1N NaOH (The instrument below, labeled T) respectively (Brown et al, 2005). 
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The use of huge amounts of chemical agents for prion decontamination, especially in large 
scales application constitutes potential health hazards relating to spillage, and emission of 
noxious and irritating gases. Another problem is the handling and disposal of high levels of 
chemical contaminated effluents and hydrolysates which may end up in the environment 
(Sehulster, 2004; Greenlee et al, 2008). Furthermore, incompletely destroyed prion 
released into the environment could potentially constitute a pathway for prion 
contamination. 
The decontamination of prion infected tissues by alkaline hydrolysis (Kalambura et al, 
2005; Yokoyama et al, 2006) results in by-products that are extremely degraded and have 
high residual salt concentration, therefore retaining little commercial value (Coll et al, 
2007). For these reasons, alkaline hydrolysis is unsuitable for application in the rendering 
of recoverable SRM and carcases which, for example, is an estimated 17 million tonnes in 
the EU alone (Taylor and Woodgate, 2003). Therefore, rendering processes that effectively 
destroy prion infectivity but allows recovery of full value of recoverable protein-rich 
products is economically and environmentally valuable and desirable.  
In the UK and Canada, the approved method for disposal of TSE infected carcasses is 
incineration (UK animal by-products regulations 2005; Canadian Food Inspection Agency, 
2006). Incineration is considered to be most effective method for prion destruction in non-
recoverable materials, although some reports suggests that it may not be completely 
effective for the destruction of the prion agent (Brown et al, 1990; Brown et al, 2004; 
Woodward, 2004). Incineration is impractical for the decontamination of recoverable and 
reusable materials (e.g. animal by-products), surgical and laboratory instruments, soil-
bound prion, vegetation and farm infrastructure (Saunders et al, 2008). Incineration is also 
not a practical solution during large outbreak of BSE, scrapie or CWD requiring mass 
culling. In addition to environmental impact, and regulatory considerations, capacity 
limitation and the operational cost of running such facilities is high.  
In general, it could be argued that chemical and physical prion decontamination methods 
are harsh, potentially hazardous, environmentally polluting, and inappropriate for use in 
decontamination of delicate and recoverable materials, and may not be highly effective for 
complete destruction of prion infectivity. In addition, prion contaminated environments 
cannot be easily and practicably remediated by chemical and physical prion 
decontamination procedures. Therefore, appropriate remediation measures are required to 
decontaminate prion contaminated environment and materials without the limitations 
associated with most physical and chemical methods. In this vein, enzymatic (microbial) 
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degradation appears to be the most plausible approach (Huang et al, 2007; Rapp et al, 
2006; Saunders et al, 2011). This method while potentially able to destroy prion infectivity 
is less likely to destroy the decontaminated material, and it is also the most practicable 
approach for application in the remediation of prion contaminated environment without 
destroying the environmental biota and/or ecology. 
1.6.2 Enzymatic degradation of prions 
The enzymatic inactivation of prions was listed as one of the science objectives and targets 
in the UK Transmissible Spongiform Encephalopathy Directorate (2003-2006) Science 
Strategy (Defra, 2003). The Alberta Prion Research Institute (APRI) Canada, who co- 
funded this work with Middlesex University, London, UK is also committed to the 
prospects of enzymatic prion inactivation as an integral part of its overall prion research 
strategy for the inactivation of prion in the environment. 
The earliest reports of enzymatic degradation of the prion were the inactivation of the 
scrapie agent by the protease, pronase (Cho, 1983), and the degradation of the BSE agent 
by a combined heat and enzymatic treatment, in which BSE infected brain homogenate 
was preheated at 115 oC for 40 min followed by digestion with keratinase of Bacillus 
licheniformis PWD-1 for 4 h (Shih, 2002). Subsequently, the degradation of prions by 
enzymatic methods and methods that combine other treatment (physical and chemical) 
methods have been widely reported (Hui et al, 2004; McLeod et al, 2004; Jackson et al, 
2005; Lawson et al, 2007; Yoshioka et al, 2007; Croud et al, 2008, Mitsuiki et al, 2010).  
Similar to the method reported by Shih (2002), BSE prion infected brain homogenate was 
digested for 1 h with Bacillus licheniformis PWD-1 keratinase at 50 oC after heat pre-
treatment for 40 min at 115 oC (pressure, 75 KPa) (Langeveld et al, 2003). In this 
experiment, the digestion time was reduced to 1 h and strong chemical detergent (N-
laurylsarcosine) was included in the heat pre-treatment step. Relatively weaker detergents 
such as Triton X-100 and Sodium deoxycholate resulted in reduced digestion efficiency, 
highlighting the important role of detergents in enzymatic prion degradation mechanisms. 
Although undetectable levels of PrPSc was achieved under these conditions as determined 
by western blot analysis,   no test of residual infectivity were reported to verify the efficacy 
of this method.  
Enzymatic decontamination of MBM containing amyloid prion protein by the proteases of 
anaerobic thermophilic prokaryotes (Thermoanaerobacter S290, Thermosipho VC15, and 
Thermococcus VC13) and soil mesophilic bacterium (Streptomyces subsp. S6) was 
reported by Tsiroulnikov et al (2004). The supernatants of Thermoanaerobacter subsp. 
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S290 and Streptomyces subsp. S6 effectively and rapidly hydrolysed mouse-adapted BSE 
(6PB1) PrPres resulting in a significant 85 % and 88 % loss of PrP signal intensity after 
digestion at 60 oC and 30 oC respectively for 24 h.  Although all the reported strains S290, 
S6, VC13 and VC15 hydrolysed feather keratin, VC13 and VC15 showed weak activity 
towards mouse-adapted 6PB1 BSE strain at low incubation temperatures, but showed 
higher activity towards MBM protein at 80 oC compared to S290 and S6 (Tsiroulnikov et 
al, 2004). The weak activity by VC13 and VC15 at lower temperature was attributed to 
protease inhibition, protease inactivation by small brain molecules or by detergents 
resulting from the purification of PrPres. Also, the protease, VersazymeTM, was reported to 
rapidly diffuse into bone and soft tissue particles of MBM in 30 min and 4 h respectively 
and hence able to potentially solubilise and inactivate the prion agent (Coll et al, 2007). 
The prospects of safe and efficient decontamination of MBM and SRM imply the recovery 
of huge amounts of useful and economically viable resources which would normally end 
up in incinerators and landfills. 
BSE-passaged mouse brain homogenate digested with the thermostable protease, 
properase, at 65 oC for 30 min and pH 12, resulted in loss of prion infectivity and a slight 
increase in disease incubation time in a bioassay from 120 ± 8.5 days for untreated sample 
to 147.5 ± 7.71 days for the enzyme treated sample (McLeod et al, 2004). Prior to 
intracerebral inoculation, the digested sample was further heated to 100 oC in order to 
inactivate the enzyme. Such high temperature treatment on its own could significantly 
denature prions, reduce infectivity and cause loss of PrPSc immunoreactivity (Somerville et 
al, 2002; Taylor et al, 2002).  However, the extent to which the reported loss of prion 
infectivity is attributable to protease inactivating temperature was not defined.  
An enzyme-detergent degradation method which combined proteinase K and pronase in 
the presence of SDS has been reported to completely destroy infectivity of metal-bound 
vCJD-infected brain homogenate (Jackson et al, 2005). The method required heat pre-
treatment of the prion infected material in 2 % SDS at 100 oC for 15 min, and then cooled 
to room temperature followed by sequential treatment with PK and pronase at 30 min 
intervals. An alteration of the treatment sequence, for instance, treating the digest with 
pronase before PK resulted in reduced degradation efficiency. Similarly, an enzyme-
detergent degradation method in which rodent-adapted human prion was digested at 50- 60 
oC for 30 min, followed by autoclaving of the digest has been described (Lawson et al, 
2007). Furthermore, a prion degrading composition comprising an effective amounts of an 
oxidizing agent, surfactant and one or more proteases was reported to completely destroy 
prion when digested at ≥ 50 oC for ≥ 20 min (Croud et al, 2008). In the described methods, 
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sequential application of the composite degradation agents was necessary in order to 
achieve optimal synergistic effect, and to prevent inhibition of protease activity. However, 
such sequential, multi-step procedure for enzymatic decontamination of prion is complex 
and impractical for commercial application (Edgeworth et al, 2009).  
Protease of Bacillus licheniformis MSK-103 was reported to inactivate sheep, mouse and 
hamster prion brain homogenate (1 %) in 20 h at 37 oC in the absence of heat pre-treatment 
or detergent (Miwa et al, 2006). This protease (optimum pH 9-10 and optimum 
temperature 60-70 oC) was reported to degrade prion more effectively than Bacillus 
licheniformis PWD-1 keratinase.  The protease of Bacillus Thermoproteolyticus Rokko 
was also reported to sufficiently degrade prion, but only in the presence of SDS, a neutral 
salt (required to activate the enzyme) and a metal ion (Miwa et al, 2006). In another study, 
the protease of Bacillus licheniformis MSK-103 exhibited high degradation activity against 
scrapie (Sc237 brain homogenate) and BSE prions, degrading them to undetectable levels 
at 37 oC in 1 h and 50 oC in 20 h respectively, at pH 9-10, without pre-treatment of the 
prion sample or addition of detergent (Yoshioka et al, 2007). However, the high pH 
digestion conditions may have resulted in alkaline hydrolysis of the prion substrate. In a 
follow-up study, a combined treatment of MSK-103 protease and SDS at 50 oC for 20 h 
reduced infectivity of the scrapie brain homogenate, resulting in a survival rate of 40 % in 
bioassay in which  the digest was inoculated in Tg52NSE mice, and experiment terminated 
at 600 days (Yoshioka et al 2007). Also, this protease was reported to degrade scrapie 
prion agent bound to plastic surface more effectively than both PWD-1 keratinase and PK 
(Yoshioka et al, 2007). Alkaline proteases E77 from Streptomyces sp (Hui et al, 2004) and 
NAPase from Nocardiopsissp TOA-1 (Mitsuiki et al, 2006) were also reported to degrade 
scrapie prion within 3 min at 60 oC and pH >10 without any further chemical and physical 
treatments. In addition, six proteolytic microorganisms isolated from cheese were 
identified to degrade scrapie-infected hamster (strain 263K) in 24 h at 30 oC and pH 8 
(Muller-Hellwig et al, 2006). 
Pilon et al (2009) reported that mouse-adapted scrapie prion brain homogenate digested 
with serine protease subtilisin 309 (from Bacillus clausii) at 55 oC under mild alkaline 
condition (pH 7.9) for 14 h, and inoculated in a mouse bioassay, resulted in a survival rate 
of 52 % in the challenged animals (C57Bl/6 mice), with mean incubation periods of 213 ± 
0 days for untreated (positive control) samples and 248 ± 8 days for treated samples. 
Clearly, some attenuation of the prion infectivity resulted in extended incubation time in 
the experimental group. Although this result was described as statistically significant 
(P<0.001) compared to control, the authors suggest that greater enzymatic degradation 
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efficiency could be achieved at higher pH (>9) and temperature conditions, and increased 
enzyme concentration.  
Recently, a Bacillus lentus subtilisin strain has been genetically modified to synthesise an 
alkaline protease, MC3, of high proteolytic activity. This protease was reported to 
inactivate BSE 301V infectious mouse brain homogenate to immunochemically 
undetectable levels at 60 oC, pH (≥12) for 30 min (Dickinson et al, 2009). VM mice 
inoculated with the MC3-digested material achieved a survival rate of 66.6 %, compared to 
proteinase K digested substrate, suggesting that a considerable reduction in prion 
infectivity was achieved.    
Destruction of prion infectivity by enzymatic digestion suggests that composting could be 
an important method for disposal of prion contaminated carcasses. Composting of scrapie 
infected sheep has been reported by Huang et al (2007) in which scrapie infected tissue 
was buried in compost piles. The compost temperature reached 60 oC and remained so for 
two weeks before gradually declining to ambient temperature. After 180 days, the tissue 
weight reduced and PrPSc was degraded to undetectable levels, clearly indicating 
significant microbial activity. Furthermore, degradation of scrapie prion in 90 days at a 
sustained temperature of 60 oC has recently been reported (Huang et al, 2010). Triantis et 
al (2007) also reported the composting of CWD-infected elk and deer brain homogenate at 
55 oC resulting in partial or complete loss of PrPSc as determined by Western blot analysis. 
In these studies, no tests of residual infectivity were conducted to validate the efficacy of 
this method. However, these results suggest that proteolytic microorganisms that thrive at 
composting temperature range may be important for effective degradation of scrapie prions 
under composting conditions. Therefore, composting of prion infected carcasses could be 
highly important during disease outbreaks. Although composting is a potential method for 
disposing carcases (Glanville et al, 1997) and is an approved method in Canada for 
disposal of TSE infected carcases (Canadian Food Inspection Agency, 2006), large scale 
composting may be problematic both in terms of practicality and efficiency and if not fully 
degraded may constitute a potential contaminant to the local environment. 
In summary, most of the reported enzymatic prion degradation methods require that the 
prion substrate be rendered proteolyticly susceptible by high temperatures heat 
pretreatment, addition of chemical surfactant/detergent, denaturants and/or oxidizing 
agents, incubation in high alkaline condition, digestion for long period of time, or by 
combining of some of these conditions (Langeveld et al, 2003; McLeod et al, 2004; 
Jackson et al, 2005; Croud et al, 2008). These conditions are harsh, environmentally and 
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economically unsustainable and limit potential practical application of the enzymatic prion 
degradation method (Pilon et al, 2009). Therefore, an enzymatic degradation method that 
combines moderate pH and temperature conditions, short digestion time, and degradable, 
non-toxic biological detergents will be potentially useful and highly desirable. Such a 
method has to be simple, practical, safe, cost effective, environmentally friendly and 
commercially plausible. 
1.6.2.1 Mechanism of enzymatic degradation of prion  
Enzymatic degradation of prions generally involves unfolding of the β-sheet structure of 
PrPsc and breaking of disulphide and hydrogen bonds (Langeveld et al, 2003). Therefore, 
processes that unfold proteins, promote disruption of hydrogen and disulphide bonds and 
enhance solubilisation would potentially facilitate enzymatic degradation of prions. Such 
processes including heat denaturation, acidic or alkaline hydrolysis, and solubilisation by 
detergents, singly or synergistically increase proteolytic access into the prion matrix and 
hence greater proteolytic attack (Dickinson et al, 2009; Lawson et al, 2007; Oesch et al, 
1994; McLeod et al, 2004, Bolton et al, 1984). It could be argued however that the 
underlying mechanistic pathway of enzymatic prion degradation may vary according to the 
specific enzymes, prion strains and digestion processes involved.  
1.6.2.2 Factors that affect enzymatic degradation 
The enzymatic degradation of prions is affected by factors such as variability of PrPSc 
susceptibility to proteolytic attack (Fernie et al, 2007), state and matrix of prion material 
(whether they are intact tissues, fat laden particles or homogenate) (Murayama et al, 2006; 
Coll et al, 2007), rate of enzymatic activity and digestion conditions (Fichet et al, 2004; 
Fichet et al, 2007; Giles et al, 2008). Enzymatic activity, for instance, could be reduced or 
lost by heat denaturation, presence of excess surfactants, and enzyme autolysis. Therefore, 
an effective and desirable enzymatic degradation method has to be robust and useful for 
various prion decontamination applications. 
1.7 Biosurfactants 
Biosurfactants or microbial surfactants are extracellular or membrane-associated 
amphiphilic surface-active biomolecules produced by a variety of microorganisms such as 
bacteria, yeast and fungi (Rosenberg, 1986; Hommel, 1990; Muthusamy et al, 2008). 
Pseudomonas aeruginosa for example is a prolific producer of biosurfactants (Edward and 
Hayashi, 1965; Hisatsuka et al, 1971; Soberon-Chavez et al, 2005). Biosurfactants are 
classified into glycolipids, lipopeptides, phospholipids, polymeric and particulate forms 
depending on their chemical composition and structure (Rosenberg and Ron, 1999).  
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Generally, biosurfactants are composed of a hydrophilic (head) and hydrophobic (tail) 
moieties (Desai and Banat, 1997; Nitschke and Coast, 2007). The hydrophilic moiety is 
usually a carbohydrate, amino acid, phosphate, cyclic peptide, carboxylic acid, or alcohol, 
and the hydrophobic moiety is mostly a long-chain fatty acid, or fatty acid derivatives such 
as hydroxyl fatty acid or α-alkyl-β-hydroxy fatty acid. The complete structure of 
rhamnolipid, a glycolipid biosurfactant of Pseudomonas aeruginosa (Fig. 1.7) was 
described by Edward and Hayashi (1965).  
Biosurfactants are characteristically able to reduce viscosity, lower surface and interfacial 
tension, and also able to stimulate desorption rate, substrate dispersion, flocculation, cell 
aggregation and emulsification (Karanth et al, 2005; Volkering et al, 1998; Haferburg et 
al, 1986). These properties have been explored for various industrial applications.  
 
Fig. 1.8: Structure of rhamnolipid biosurfactant from Pseudomonas aeruginosa consisting of two 
rhamnose subunits that are linked to two β-hydroxydecanoic acid in a side chain.  
 
In the petroleum industry, biosurfactants have application for enhanced oil recovery from 
reservoirs, transportation and pipelining of oil and cleaning of oil barges and tanks due to 
their ability to reduce viscosity of heavy oil (Desai and Banat, 1997; Wang et al, 2007). 
Their ability to increase the surface area of recalcitrant hydrophobic compounds such as 
hydrocarbons and pesticides in soil and water environments enable microbial access and 
enhanced degradation of such compounds, hence it is useful for environmental 
bioremediation applications (Noordman and Jassen, 2002; Ochsner and Reiser, 1995; 
Deziel et al, 1996; Kosaric, 2001; Okoroma, 2006). The anti-microbial, anti-viral, anti-
tumor, and anti-adhesive activities of biosurfactants are also becoming increasingly 
important (Cao et al, 2009; Benincasa et al, 2004; Soberon-Chavez et al, 2005; 
Brzozowski et al, 2011). For example, the anti-adhesive property is useful for inhibiting 
bacterial adherence to steel surfaces and reducing formation of biofilms (Bagge et al, 2001; 
Muthusamy et al, 2008; Brzozowski et al, 2011). They are therefore used to impregnate 
medical equipment surfaces to reduce adherence of pathogen and formation of biofilms 
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(Velraeds et al, 1997; Rodrigues et al, 2006). Biosurfactants are also used in the 
agricultural industry for biocontrol and in the food processing industry as emulsification 
and de-emulsification agents. They have also found important applications in cosmetic, 
pharmaceutical and therapeutic products (Nitschke and Coast, 2007; Singh et al, 2007; 
Muthusamy et al 2008).  
Biosurfactants are a preferred environmentally friendly alternative to chemical surfactants 
because of their high detergency, high surface and interfacial activity, low toxicity, unique 
structure and temperature and pH tolerance (Muthusamy et al, 2008). For example, 
biosurfactants of Pseudomonas aeruginosa have been reported to lower surface tension of 
water from 72 mN/m to 25 mN/m (Hisatsuka et al, 1971); whereas the chemical surfactant 
SDS was only able to lower surface tension to 37 mN/m. In general, biosurfactants are 
more effective and efficient than chemical surfactants, and their critical micelle 
concentration (CMC) is about 10-40 times lower, hence less biosurfactant is required to 
achieve a maximum decrease in surface tension (Desai and Banat, 1997). 
Currently, there is no reported use of biosurfactant in prion degradation. However, there 
has been varying reports of the effects of chemical surfactants/detergents on prion 
infectivity. For example, it has been reported that surfactant/detergent increased apparent 
titre of PrPSc preparation (Somerville and Carp, 1983) and increased resistance to prion 
inactivation during steam sterilization (Yan et al, 2004), whereas Tixador et al (2010) 
reported that detergents did not alter infectivity estimates when used to solubilise prion. 
However, the important role of surfactants/detergents in enzymatic prion degradation has 
been severally reported (Jackson et al, 2005; Lawson et al, 2007; Yoshioka et al, 2007). 
Considering the biochemical properties of biosurfactants and their advantages over 
chemical surfactants, they are potentially important alternative for use in the enzymatic 
degradation of prions.   
1.8 Research hypotheses for this study 
Infectious prion protein (PrPSc) is structurally similar to feather keratin in terms of its β-
sheet content (Shih, 2002; Langeveld et al, 2003; Tsiroulnikov et al, 2004). Feathers 
consist of approximately 90 % keratin protein (Fraser et al, 1972), and its β-sheet 
conformation confers it with mechanical strength and stability, and resistance to 
degradation by common proteases. Despite the relative abundance of feathers in nature, 
they do not persist in the environment suggesting their removal by some naturally 
occurring processes which have been attributed to feather degrading microorganisms 
(Noval and Nickerson, 1959). It is therefore hypothesised that owing to the structural 
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resemblance of infectious prion agent (PrPSc) and feather keratin, feather degrading 
microorganisms, specifically their specially expressed enzymes, are potentially able to 
hydrolyse feather keratin and prion substrates. It is further hypothesised that the ability of 
feather degrading microorganisms to grow and hydrolyse feather keratin substrate could be 
used as a basis for screening feather degrading microorganisms and evaluation of their 
proteolytic enzymes.  
1.9 Aim and Objectives 
The aim of this research was to investigate the potential of a novel bacterial keratinase to 
degrade pathogenic prion protein, specifically, ME7 scrapie infected brain homogenate.  
The specific objectives of this research were to: 
1. isolate, identify and characterise proteolytic microorganisms of significant 
keratinolytic activity from primary effluent and farmyard wastes. 
2. optimise process for the production, purification, characterisation and evaluation of  
keratinase. 
3. investigate the effectiveness of the produced keratinase in the in vitro degradation 
of melanised feather keratin and ME7 scrapie prion, and to optimise the 
degradation conditions.  
4. conduct ex vivo scrapie cell assay and  in vivo mouse bioassay to evaluate residual 
infectivity of keratinase-digested scrapie prion, and to determine the efficacy of this 
enzymatic treatment for degradation of scrapie prion.  
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Chapter 2: Materials and methods 
 
2.1 Experimental approach 
In order to find keratinases of prion degrading potential, an experimental approach was 
designed which included the isolation and characterisation of proteolytic bacteria and their 
keratinases, investigation of keratinase’s ability to degrade feather keratin and scrapie 
prion, optimisation of the degradation method and evaluation of residual infectivity by cell 
culture assay and mouse bioassay. This chapter is divided into three main experimental 
stages: isolation and characterisation of proteolytic microorganisms, keratinase and 
biosurfactant, degradation of keratin substrates and scrapie prion by keratinase, and 
residual infectivity evaluation of keratinase-digested scrapie prions. An overview of the 
experimental approach is presented in Fig. 2.1, with each experimental stage distinguished 
by different colour fills. All materials used in the experiments are described in the 
procedure for individual experiments. 
2.2 Isolation and characterisation of proteolytic microorganisms, 
keratinase and biosurfactant 
2.2.1 Isolation of microbial strains  
Farmyard waste (Tork et al, 2010) and sewage sludge (Drouin et al, 2008; Abdul-Hafez 
and El-Sharoumy, 1990) are important sources of microbial population and extracellular 
proteases, and feather degrading bacteria utilise feather meal as growth substrate (Brandelli 
and Riffel, 2005). To isolate potential feather degrading bacteria, environmental samples 
were collected from primary effluent (Deepham Sewage Treatment Facility, Thames 
Water, Edmonton, North London, UK) and poultry/animal wastes (A.K Woods Poultry 
Farm, Fold Farm Partners and Leamon Pig Farm Ltd, UK). The samples were diluted and 
plated out in feather meal agar (FMA) plates composed of agar and 10 % commercial 
feather meal (Chettles Ltd, UK) made up in Minimum Growth Medium (MGM). The 
Minimum Growth Medium (phosphate basal solution) was composed of (in g/l): NaCl, 0.5; 
KH2PO4, 0.7; K2HPO4, 1.4;   MgSO4.7H2O, 0.1; pH 7 (Wang and Shih, 1999). The plates 
were incubated at 30 °C, 37 °C and 50 °C in a Binder incubator (Binder, USA) and 
sampled at 24, 48 and 72 h. Single colonies were passaged twice on FMA plates to obtain 
purified microbial strains. The purified isolates were cultured in nutrient broth and stored 
in 0.5 ml aliquots in liquid nitrogen at - 196 °C. 
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Flowchart of experimental approach 
 
 
 
  
 
 
 
 
 
  
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.1: Flowchart of experimental approach detailing experimental stages from microbial 
isolation to application of enzymatic product (keratinase) in degradation of ME7 scrapie prion 
strain. 
MICROBIAL ISOLATION 
SCREENING FOR 
PROTEOLYSIS  
STRAIN IDENTIFICATION 
AND CHARACTERISATION 
ENZYMATIC 
DEGRADATION TESTS 
FERMENTATION CULTURE 
OPTIMISATION 
 
BIOSURFACTANT 
PRODUCTION AND 
CHARACTERISATION 
KERATINASE PURIFICATION 
AND CHARACTERISATION 
• Farmyard waste and primary effluent sources 
• Isolation on feather meal agar 
 
• Spot inoculation assay 
• Hydrolysis ring assay 
• Morphological (colour, opacity, shape etc) 
• Physiological (Temperature, pH, salt concentration) 
• Biochemical (catalase reaction, oxidase reaction, 
motility, acid tests etc) 
• Molecular phenotyping and phylogenetic tree 
• Spectral mass fingerprint 
Factors: Temperature, pH, substrate concentration 
• Spot inoculation and hydrolysis ring assays 
• pH-Incubation time plot 
• pH kinetic curve 
• Keratinase assay 
• Biosurfactant protein and rhamnose concentration 
• Supernatant recovery and concentration 
  Centrifugation and Ultrafiltration 
• Purification 
 Step-wise feedback model  
• Purity and molecular weight determination 
 SDS-PAGE and MALDI-TOF MS 
• Determination of protein concentration 
• Thermal stability evaluation 
• Effect of chemical and biological agents 
• Peptide mass fingerprinting 
• Keratin azure  
 Physical observation and activity 
measurement 
• Melanised feather  
 Qualitative and quantitative evaluation 
• Scrapie prion  
 Western Blot analyses 
 
• Standardisation of keratin azure 
• Determination of conditions for keratinase assay 
 
STANDARDISATION OF 
KERATINASE ASSAY  
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• Keratinase assay 
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 INFECTIVITY • Western Blot analyses 
• Mouse bioassay 
• Scrapie cell assay 
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2.2.2 Fermentation culture and crude enzyme extraction  
Important biomolecules such as proteases are synthesised in fermentation cultures by the 
metabolic conversion of growth substrates. Crude enzyme extract is then obtained by 
centrifugation and filtration to remove microbial cells and other debris. MGM (10 ml) 
supplemented with 1.1 % commercial feather meal was autoclaved and inoculated with a 
loopful (approximately 20 µl) of single colony grown on nutrient agar plate (preculture) 
and incubated at 250 rpm for 16 h at the isolation temperature. One ml of the preculture 
was inoculated into 50 ml of growth medium (main culture) and incubated for 24 h at pH 
8. Crude enzyme extract was recovered by centrifugation of the culture medium at 4750 g 
for 20 min in Rotina 420R centrifuge (Hettich, Germany) and the supernatant collected and 
ultra-filtered under vacuum through the 0.45 µm sterile membrane (Pall Corporation, 
USA). Bacillus licheniformis PWD-1 (ATCC 53757) was also grown in MGM 
supplemented with 0.5 % feather meal at 50 °C for 24 h (Wang and Shih, 1999) and crude 
keratinase was extracted as described above. The microbial cells and the crude enzyme 
extracts were used to screen for proteolysis. 
2.2.3 Screening for proteolytic microorganisms  
2.2.3.1 Spot inoculation assay 
The spot inoculation assay is a casein-agar method for detecting proteolytic bacteria by 
their ability to hydrolyse and utilise casein as growth substrate. Screening for proteolytic 
microbial isolates was conducted by the spot inoculation assay and evaluated according to 
cell growth and hydrolysis of casein substrate. The casein-agar plates were prepared as 1% 
(w/v) each of casein (Fisher Scientific, UK) and agar (Oxoid, UK) mixed in sterile 
deionised water. The mixture was autoclaved at 121 oC and 10.26 bar) for 15 min in 
Priorclave autoclave (Priorclave, UK), allowed to cool to 50 °C and dispensed into plates. 
One loopful (approximately 20 µl) of a single bacterial colony was inoculated at a spot 
onto casein-agar plates and incubated for 24 h at 37 °C and 50 °C. Similarly, screening for 
proteolysis was demonstrated with some known microbial strains: Pseudomonas 
aeruginosa NCTC 10662, Escherichia coli NCTC 10418, Staphylococcus aureus NCTC 
6571, Bacillus subtilis NCTC 10400 and Bacillus stearothermophilus NCTC 10007 
(Health Protection Agency, UK).  
2.2.3.2 Hydrolysis ring assay  
The hydrolysis ring assay is a casein-agar based method that is useful for characterising 
crude enzyme extract by the extent of a “hydrolysis ring”. To determine proteolytic activity 
of crude enzyme extracts, wells were aseptically made in casein-agar plates using a sterile 
7 mm diameter puncher. The wells were inoculated with 100 µl of crude culture extract 
  
36 
and incubated at 30 °C, 37 °C, and 50 °C for 24 h and the hydrolysis ring indicating 
proteolytic activity were compared. Validation experiment for hydrolysis ring assays was 
performed at 1:0; 1:10; 1:100; and 1:1000 dilutions of crude extract incubated at 50 °C for 
24 h, and the hydrolysis ring diameters were measured to compare proteolytic activity. 
2.2.4 Standardisation of keratin azure substrate  
Keratin azure is a suitable substrate for evaluating keratinolysis. However, commercial 
keratin azure (Sigma-Aldrich, UK) has been found to be heterogeneous resulting in 
variability in activity measurement. Standardisation of the substrate is therefore required to 
enable consistent and reliable keratinase activity measurement within and between 
samples. Keratin azure was incubated with 5 times the volume of distilled water it 
displaces for 1 h at 50 °C and 250 rpm in a shaking incubator (Stuart, UK). The reaction 
mixture was then centrifuged at 4750 g for 10 min and the absorbance (A595) of the 
supernatant measured with Helios Epsilon Spectrophotometer (ThermoFisher, UK). The 
keratin azure was further washed with distilled water by shaking vigorously for 1 min. The 
procedure was repeated until the absorbance readings of the wash solution remained 
constant. The treatment effluent was drained and keratin azure dried in an oven overnight 
at 30 °C. Difference in the treated and untreated keratin azure was determined using the 
Mann-Whitney Test. 
2.2.5 Screening for keratinolysis and selection of working isolate  
2.2.5.1 Keratinase assay 
Keratinase assay is a specific and quantitative test for measuring keratinase activity, 
enabling definitive comparison of different keratinases. To measure keratinase activity, 
treated keratin azure [0.4 % (w/v)] was added to 0.8 ml of 10 mM Tris HCl (pH 8.5) and 
0.2 ml crude keratinase extract added and the reaction mixture was incubated at 50 oC for 1 
h in a rotary shaker at 250 rpm. The reaction was stopped with 0.2 ml of 10 % (v/v) 
Trichloroacetic acid (TCA) and the mixture was centrifuged at 9300 g for 20 min in an 
Eppendorf S1500 refrigerated microcentrifuge (Eppendorf, Germany). The absorbance of 
the supernatant was measured at A595 for keratinase activity. One unit of keratinase activity 
(U) was defined as the amount of protease producing an absorbance change of 0.01 units 
(A595). The control experiments were (a) reaction mixture without crude keratinase 
(enzyme activity control) and (b) reaction mixture without keratin azure substrate (crude 
extract absorbance control).  
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2.2.5.2  Proteinase K calibration curve 
Proteinase K (PK) is an important enzyme for the degradation and characterisation of prion 
protein. The PK calibration curve relates PK and keratinase by their activity on keratin 
azure substrate, and hence useful for establishing a baseline for identifying potential prion 
protein degrading keratinases. PK activity on keratin azure substrate was measured for PK 
concentrations in the range of 0-1 mg/ml, and calibration curve constructed as activity 
(U/ml) against PK concentration (mg/ml). 
2.2.6 Microbial identification and characterisation  
2.2.6.1 Morphological, physiological and biochemical tests 
2.2.6.1.1 Colony morphology 
Morphological characteristics of bacteria colony such as shape, colour, opacity, size, 
shape, elevation, edge and smell are used to identify and classify bacteria. To determine 
colonial morphology, cell culture of the selected strain was incubated for 24 h and then 
serially diluted and plated on nutrient agar plates to produce single colonies. The colonial 
morphology was then observed and described. 
2.2.6.1.2  Gram staining 
Gram staining is used for classifying bacteria on the basis of their forms and cellular 
morphologies. Gram stain segregates all bacteria into two large groups; those that retain 
the purple colour of the primary stain (crystal violet) on the cell wall are described as 
Gram-positive and those that retain the pink color of the counterstain (safrinin) are Gram-
negative. To carry out Gram staining, a small amount of culture was added to a drop of 
water on the slide and spread to an even thin film with an inoculation loop, and then fixed 
on the slide by air-drying and then over a gentle flame.  The slide was flooded with crystal 
violet for 1 min, rinsed with water, and flooded with iodine (iodine is a mordant that binds 
the crystal violet to peptidoglycan layer of gram-positive cell wall) and rinsed again with 
water after 1 min. The slide was then flooded with alcohol (a decolourizer that removes 
stain from the gram-negative cells), rinsed with water after 10 seconds (leaving the 
decolourizer too long may remove stain from the Gram-positive cells as well), flooded 
with safrinin and rinsed with water after 1 min. The slide was dried and viewed under oil 
immersion (1000 × TM) with a bright-field compound microscope (Meiji, UK). 
2.2.6.1.3  Endospore test 
Endospores are small and typically oval-shaped dormant cells which are formed by 
sporulation of stressed cells due to extreme environmental conditions such as high 
temperatures and changes in pH, absence of growth nutrient and presence of inhibitory 
chemical substances. Endospores lack metabolism and reproduction but return to active 
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and productive (vegetative) state when favourable conditions return. Endospore test is used 
to identify bacteria of the genera Bacillus and Clostridium which are usually endospore 
forming, and generally appear green under the microscope while vegetative cells appear as 
pink. 
To test for endorspores, a strip of blotting paper was laid over a prepared slide (same as in 
2.2.6.1.2) and then placed over a screened water bath.  The blotting paper was saturated 
with the primary stain, malachite green and allowed to sit over the steaming water bath for 
5 min. Stain was re-applied when it was beginning to dry out. The blotting paper was 
removed and the slide rinsed with water until the water ran clear. The slide was then 
flooded with the safrinin for 20 seconds and rinsed in water. The specimen was then 
viewed under oil immersion using a light microscope (magnification of 1000 × TM) 
(Meiji, UK). 
2.2.6.1.4  Anaerobic growth  
Anaerobic bacteria are those able to grow without oxygen or in the presence of other 
electron acceptors. It is an important characteristic for distinguishing and identifying 
bacteria. The anaerobic growth test was perfomed by streaking Nutrient Agar plate with 
cells from a fully grown colony and incubated at 50 oC for 48 h in an anaerobic vessel 
(Becton Dickinson, USA), and observed for cell growth. Absence of growth indicates that 
the organism is an aerobe and vice versa.  
2.2.6.1.5  Motility test 
Motility test is used to identify and characterise organisms according to the nature of their 
movement in a suspension or growth in a solid medium. Motile organisms such as 
Escherichia Coli, Pseudomonas aeruginosa and Bacillus species (except Bacillus. 
anthracis and Bacillus cerus) move randomly throughout a liquid suspension when viewed 
under a microscope. Non-motile organisms such as Staphylococcus, Streptococcus or 
Micrococcus either move with Brownian motion or are motionless. In a solid medium, 
motile organisms form a diffuse growth zone around an inoculum stab whereas non-motile 
organisms form a single line growth along the original inoculum stab. To test for cell 
motility, cell suspension was prepared in a sterile tube with two drops (approximately 0.1 
ml) of sterile distilled water. One drop was transferred onto a microscope slide and 
overlaid with a cover glass. The slide was examined under a light microscope 
(magnification 400×) (Meiji, UK).  
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2.2.6.1.6  Oxidase test  
Oxidase test is used to screen for bacteria that produce the enzyme cytochrome oxidase C; 
one of the enzymes in the bacterium electron transport system. Oxidase enzyme activity 
indicates that the bacterium is an aerobe or facultative anaerobe. It is used to identify 
bacteria species which belong mainly to the Enterobacteriaceae and Pseudomonas genus.  
To test for oxidase reaction, Dryslide oxidase test kit (Difco, USA) was smeared with 
bacteria colony and observed for oxidase reaction after 2 min as recommended by the 
manufacturer. The test is said to be positive when a dark purple colour develops. 
2.2.6.1.7  Catalase test 
Catalase is the enzyme that breaks hydrogen peroxide (H2O2) into water and oxygen (2 
H2O2 + 2O2). Bacteria are identified and characterised on the basis of catalase reaction. For 
catalase reaction, a microbial colony was smeared on a clean glass slide, and a drop of 3 % 
hydrogen peroxide was added. The formation of foam and release of bubbles from oxygen 
indicated a positive catalase reaction. 
2.2.6.1.8  Triple Sugar Iron Test (TSI) 
This is a combined test for detecting a bacterium ability to hydrolyse glucose, lactose and 
sucrose, and also for detecting the reduction of sulphur to hydrogen sulphide (H2S). The 
TSI medium consists of lactose (1 %), sucrose (1 %) and small amount of glucose (0.1 %), 
as well as ferrous sulphate and pH indicator phenol red. To perform TSI test, the TSI slant 
was stab-inoculated followed by streaking the inocula across the slant surface and 
incubated at 50 oC for 24 h. A red/yellow (Slant/butt of tube) colour indicates glucose 
fermentation, and black precipitate in the medium indicates iron reduction.  
2.2.6.1.9  Nitrate to nitrite reduction 
The nitrate reduction test is used to detect reduction of nitrate (NO3-) to nitrite (NO2-). This 
is a common reaction of most bacteria present in soil. To test for nitrate reduction, nitrate 
broth was inoculated aseptically and incubated at 50 oC for 24 h. After the incubation, a 
dropful each of sulphanilic acid and α-naphthylamine were added. A colour change to red 
indicated a positive nitrate reduction and absence of a colour change would indicate there 
was no nitrate reduction or that further reduction of nitrite to ammonia or other compounds 
had occurred. In the absence of colour change, addition of small amount of zinc powder 
would catalyse nitrate to nitrite conversion and colour change to red, which would confirm 
a negative nitrate reduction. 
2.2.6.1.10  Voges-Proskauer (VP) Test 
The Voges-Proskauer (VP) test detects the production of non-acidic or neutral end product 
such as butanediol and acetoin (acetylmethyl carbinol) following glucose fermentation. 
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The VP broth was inoculated with fresh inoculum from a young culture and incubated at 
50 oC for 24 h. To develop the test, α-naphtol (5 %) and potassium hydroxide (40 %) were 
added. A colour change to pink-burgundy indicated a positive test. 
2.2.6.1.11  Indole production 
The indole production test detects the ability of a bacterium to convert tryptophan into 
indole by degrading the amino acid tryptophan. To test for indole production, tube of 
tryptone was inoculated with a small amount of pure culture and incubated at 50 oC for 24 
h. Then 5 drops of kovacs reagent [Conc. HCl (25 mL); iso-amy alcohol (75 mL) and para-
Dimethylaminobenzaldehyde (5 g)] was added directly to the tube. A positive indole test is 
indicated by the formation of a pink to red colour in the reagent layer on top of the medium 
within seconds of adding the reagent. The reagent layer remains yellow to lightly cloudy 
for a negative indole reaction. Most Bacillus species are indole negative.                                              
2.2.6.1.12  Arginine hydrolase test 
The arginine hydrolase test detects the ability of arginine hydrolase to release ammonium 
from arginine. The release of ammonium into the culture broth results in an alkaline 
medium. To perform the arginine hydrolase test, Peptone (0.1 g), NaCl (0.5 g), K2HPO4 
(0.03 g), agar (0.3 g) were made up in 100 ml distilled water and autoclaved. This was 
allowed to cool to 55-50 oC and phenol red (0.001 g) and DL-Arginine HCl (1 g) were 
added and mixed. This was dispensed into test tubes and allowed to solidify. The tubes 
were stab-inoculated with bacteria from a fresh culture and tube covered with a few mL of 
sterile mineral oil, and incubated at 50 oC for 48 h. A deep pink colour indicated a positive 
reaction. 
2.2.6.1.13  Urea hydrolysis test 
The urea hydrolysis test detects the ability of urease to hydrolyse urea into ammonia (NH4) 
and carbon dioxide (CO2) i.e. (NH4)2CO + CO → CO2 + 2NH3. Christensen’s urea agar 
was prepared with peptone (1 g), dextrose (1 g), NaCl (5 g), potassium phosphate, 
monobasic (2 g), urea (20 g), phenol red (0.012 g), and agar (20 g). The urea base was 
prepared by mixing all constituents except agar in 100 mL distilled water and filter 
sterilised through 0.45 µm pore size filter. Agar was suspended in 900 ml distilled water, 
stirred to dissolve and autoclaved. Upon cooling to around 55 oC, the urea base was added 
and properly mixed. This was then dispensed into sterile tubes, slanted and allowed to 
solidify. The slant surface of the yellow-orange coloured medium was streaked with 
inoculums and incubated at 50 oC for 24 h. A colour change to bright pink indicated the 
hydrolysis of urea to ammonia. 
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2.2.6.1.14  Effect of salt concentration and pH on N22 growth 
Salt concentration and pH are important physiological characteristics that affect cell 
growth and survival. To determine this effect, Nutrient agar plates with Sodium Chloride 
(NaCl) concentration (2-12 %) were prepared and inoculated with isolate N22 and 
observed for cell growth in 24 h. Also, nutrient broth (pH 4-13) were prepared and 
inoculated with single colony of N22 and incubated for 24 h. The cultures were plated on 
nutrient agar plates and observed for cell growth at 24 h.  
2.2.6.2  Molecular identification (phenotyping)  
Molecular phenotyping is the identification and classification of microorganisms according 
to their ribosomal DNA (rDNA) sequences. The distinct sequence information for 
individual microorganism enables identification up to species and strain level. 16S rDNA 
full gene sequencing was carried out with MicroSeqTM service (National Collections of 
Industrial Food and Marine Bacteria, UK). DNA was extracted from microbial culture and 
the 16S gene amplified by PCR. Cycle sequence analysis was performed on the ABI 
sequencer. The generated sequence was compared with sequence on the MicroSeqTM 
database and public databases to produce top sequence matches and a phylogenetic tree. 
2.2.6.3  Microbial spectral mass profiling 
Microbial spectral mass profiling is an emerging method for identifying microorganisms 
according to their unique characteristic mass spectral represented mainly by mass peaks of 
ribosomal proteins (Suh et al, 2005; Maier and Kostrzewa, 2007). Using Matrix-Assisted 
Laser Desorption and Ionisation Time-of-flight Mass Spectrometry (MALDI-TOF-MS) 
method, the protein molecules are co-crystallised with organic matrix (e.g. cyano-4-
hydroxycinnamic acid), and the highly conjugated molecules are desorped into gas phase, 
undergoing little fragmentation, by pulsed laser (Guerrera and Kleiner, 2005; Kieman et al, 
2007). The molecules are ionised (in the ionisation chamber) and separated according to 
their charge and mass (in the mass analyser). The emerging ion is detected as electrical 
signals by an electron detector, and the data processed and presented in height and 
intensity, according to their relative abundance, on a mass spectrum. 
   
To generate microbial spectral mass profile,  single colony of bacteria cultured on nutrient 
agar plate were extracted with 1 ml of acetonitrile and 70 % formic acid (1:1) mixture to 
obtain whole cell protein . The extracted protein sample (1µl) was conjugated with (1µl) α-
cyano-4-hydroxycinnamic acid (HCCA) matrix (Sigma, USA) and analysed by MALDI-
TOF MS (AXIMA CFR, Shimadzu Biotech) to generate the microbial spectral mass 
profile. 
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2.2.7 Optimisation of keratinase production 
Several factors such as temperature, pH, and growth substrate significantly influence the 
synthesis of proteases in a fermentation culture (Singh et al, 1975; Wang and Shih, 1999; 
Yamamura et al, 2002). A proper balance of these factors results in optimum synthesis of 
specific proteases of interest. To determine the optimisation conditions for keratinase 
production, fermentation cultures were setup at temperatures (37 oC and 50 oC); pH (7, 8.5 
and 10) and substrate concentration (0.8 %, 1.1 % and 1.4 %). Optimal pH was determined 
for culture pH 4 to 13 at incubation time of 10, 24 and 32 h. The final pH of the culture 
broths were measured at 32 h. All experiments were carried out in triplicates. Test of 
significant difference for the optimisation conditions in keratinase production was 
performed using One-way ANOVA. Spot inoculation assay was set up and incubated at 25 
oC, 30 oC, 37 oC, 40 oC, 50 oC, 60 oC, 70 oC and 80 °C for 24 h to determine optimum 
temperature of growth and expression of keratinase activity.  
2.2.8  Purification and characterisation of keratinase 
2.2.8.1 Purification of keratinase 
Crude culture supernatant normally comprises of complex mixture of enzymes, nucleic 
acid, cells and debris. Recovery of the biomolecules of interest is accomplished by 
separation and purification processes. Cells, debris and other solid particles are removed by 
centrifugation and filtration, and the cell-free culture concentrated and purified according 
to protein size, physico-chemical properties and binding affinity.  
In order to purify keratinase, cell-free crude keratinase extract was concentrated in a 
Centriconplus-70 centrifugal filter device of molecular weight cut-off of 10 KDa 
(Millipore Inc.). The concentrated retentate was recovered after centrifugation at 4750 ×g 
for 45 min, and purified with the HiTrap Blue HP prepacked purification column (GE 
Healthcare Bio-sciences). The column material consists of resins (Blue sepharose) to 
which ligand (Cibacron TM Blue F3G-A dye) is covalently attached via the triazine part of 
the dye molecule, and has affinity for a wide range of enzymes. The column was 
equilibrated with 10 column volume of binding buffer (50 mM KH2PO4, pH 7.0). The 
concentrated supernatant sample was adjusted to the composition of binding buffer by 
diluting the sample with the binding buffer, and then applied to the column at a rate of 0.5 - 
1 ml/min with a syringe and the fraction PSC was collected. The column was then eluted 
with the binding buffer (50 mM KH2PO4, pH 7.0) and the fraction BF collected and once 
the eluent became clear, the column was eluted with the elution buffer (50 mM KH2PO4, 
1.5 M KCl, pH 7.0) and 5 ml fraction (EF) was collected.  
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A step-wise feedback purification model (Fig. 2.2) was developed to increase purification 
yield.The purification column was cleaned with 2 % alcohol after each purification cycle, 
washed through with the binding buffer and the fraction PSC (Fig. 2.2) re-introduced for 
subsequent purification cycle. Equivalent fractions of BF and EF from the three 
purification cycles were pooled, concentrated and characterised. The samples were then 
aliquoted and those for immediate use (up to 8 weeks) were stored at 4 oC and those for 
long storage at -38 oC. 
 
 
 
HiTrap column→ 
 
 
 
 
 
 
 
 
 
 
                    1st cycle                                     2nd cycle                                  3rd cycle 
 
Fig. 2.2:  Schematic diagram of the step-wise feedback purification model showing three 
purification cycles and the purification fractions PSC (collected after passing the concentrated 
crude supernatant through the column), BF (collected after flushing column with binding buffer) 
and EF (purified fraction collected after eluting column with elution buffer). The PSC fraction was 
re-introduced into the purification column during subsequent purification cycles. The numerical 
suffices indicate the number of purification cycle. 
2.2.8.2 Characterisation of keratinase 
2.2.8.2.1  Molecular weight 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) is a commonly 
used method for proteins separation and determination of molecular weight (Laemmli, 
1970). The protein sample becomes negatively charged by attaching to SDS anions, so that 
the sample undergoing electrophorises is separated according to the size (molecular 
weight) of the protein molecule, in which the smaller particles move faster through the gel.  
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To determine the molecular weight of  purified keratinase, a 12 % gel was prepared as 
follows: The stacking gel (3 % polyacrylamide) solution contained H2O (3.65 ml); stacking 
buffer (1.5 ml); protogel (0.8 ml); 10 % ammonium persulphate (APS) (37.5 µl); and 
Tetramethylethylenediamine (TEMED) (5 µl), and the resolving gel (12 % 
polyacrylamide) solution composed of H2O (6 ml); resolving buffer (4 ml); protogel (6.25 
ml); 10 % APS (75 µl); and TEMED (10 µl). The casting chamber was set up and the 
bottom and corners sealed with 1 % agarose. The resolving gel solution was added to cover 
¾ of the cast and topped with distilled water. The gel was allowed to set for about 35 min 
and the water drained. The stacking gel was added to fill the cast to the top and well comb 
inserted and the gel allowed to set. The electrophoresis chamber was set up with the gel in 
place and the chamber filled with running buffer. The comb was removed to reveal the 
lanes and the protein sample (10 µl) gently loaded with fine long pipette placed close to the 
bottom of the wells. The electrophoresis unit was run at 150 V (constant voltage) and 200 
mA for 50 min to separate the protein sample. The gel was carefully removed and placed 
in a plastic tub and the staining solution added and allowed to shake overnight at 35 rpm. 
The staining solution was decanted and destaining solution added and microwaved for 5 
min. This was repeated once and destaining continued with shaking at 35 rpm until gel was 
sufficiently clear and the molecular weight bands clearly visible. The gel was then drained 
and sandwiched in transparent paper and scanned. Molecular weight band was traced 
against standard molecular weight markers (15 KDa-120 KDa).  
To determine the molecular weight of the protein sample by MALDI-TOF MS, the purified 
keratinase sample (1 µl) was conjugated with 1 µl of sinapinic acid matrix (Sigma-Aldrich, 
USA) on a metal plate and allowed to crystallise at room temperature. Mass spectrum was 
acquired by MALDI-TOF MS (AXIMA CFR, Shimadzu Biotech) set on linear mode and 
power of 90 and with minimum smoothing. 
2.2.8.2.2  Protein concentration 
Protein concentration is a measure of protein abundance in sample solution, and is also 
used for assessing the success of a purification process and alongside enzyme activity can 
be used to calculate specific activity. Protein concentration is commonly measured by the 
Bradford Reagent method which is based on the binding of Commassie Brilliant Blue dye 
to protein resulting in a colour change that is quantified by spectrophotometry (Bradford, 
1976). The dye donates free electron which interact with ionisable groups of the protein, 
causing disruption of the proteins primary structure and exposure of its hydrophobic 
pockets.These pockets bind to the non-polar regions of the dye, bringing the positive amine 
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groups close to the negative charge of the dye, and thus stabilises the blue dye. The amount 
of complex formed in the solution is measured as the protein concentration.  
To measure protein concentration, protein sample (0.1 ml) was mixed with 3 ml of 
Bradford reagent and incubated at room temperature for 20 min at room temperature. The 
sample mixture was transferred to semi-micro cuvettes and the absorbance measured 
spectrophotometrically at 595 nm. The concentrations of the samples were derived using 
standard calibration curve prepared with Bovine Serum Albumin (BSA) of concentration 
range of 0-2 mg/ml.  
2.2.8.2.3 Peptide mass fingerprinting of keratinase 
Peptide mass fingerprinting is an analytical technique in which protein is cleaved into 
peptides which are measured according to their mass, and their specific peptide sequence 
used to identify and characterise protein. Purified keratinase was digested with 0.1mg/ml 
of trypsin (Sigma, UK) at 37 oC for 1 h. The digested sample (1 µl) was conjugated with 1 
µl of sinapinic acid matrix and analysed by MALDI-TOF MS to map tryptic peptide mass 
fingerprints. The resulting mass spectrum was searched on mascot (Matrix Data Science) 
to identify possible matches. 
2.2.8.2.4  pH condition for optimum keratinase activity 
Optimum pH condition of keratinase is the pH lat which its highest activity is achieved. To 
determine the optimum pH condition for keratinase, the reaction buffer for keratinase assay 
was adjusted to pH 7.5, 8.5, 9 and 10, and the activity of crude keratinase measured as 
described in section 2.2.5.1. 
2.2.8.2.5  Thermal stability of keratinase 
Enzymes can easily loose their activity under thermally unfavourable conditions. To 
determine the thermal stability of this keratinase, purified sample was stored at 4 oC for up 
to 8 weeks and the keratinase activity measured at intervals over the period to determine 
residual activity and thus the stability of the enzyme. 
2.2.8.2.6  Effects of chemical agents on keratinase activity 
Chemical agents such as Ethylenediaminetetraacetic Acid (EDTA), Dithiothreitol (DTT) 
and Sodium dodecyl sulphate (SDS) and Triton X-100 affect the activity of different 
keratinases variably. To determine their individual effect on crude keratinase, 1ml of 
EDTA (5 mM), DTT (5 mM), Triton X-100 (0.1 %) and SDS (0.1 %) were each mixed 
separately with 1 ml of crude keratinase and incubated at 50 oC for 15 min. The residual 
keratinase activity was then measured using 0.2 ml of the pre-incubated samples in 
keratinase assay (section 2.2.5.1). The sample that was used in the control experiment 
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(crude keratinase without any agent) was prepared the same way with crude keratinase and 
Tris HCl (pH 8.5) buffer (reaction buffer of the keratinase assay). Similar volumes were 
used to ensure equal dilution of the crude keratinase and they were also pre-incubated 
under similar conditions. 
2.2.9  Production and characterisation of biosurfactant 
2.2.9.1 Production of biosurfactant 
Rhamnolipid biosurfactant of Pseudomonas aeruginosa NCIMB 8626 was produced in the 
Basal Mineral Medium (BSM) as described in Zhang et al (2005). The BSM was 
composed of (g/l): Sodium nitrate (NaNO3, 4.0); Sodium chloride (NaCl, 1.0); Potassium 
chloride (KCl, 1.0); Calcium chloride dehydrate (CaCl2.2H2O = 0.1); Dihydrogen 
potassium phosphate or phosphoric acid (KH2PO4, 3.0); Di-sodium hydrogen 
orthophosphate 12-hydrate (Na2HPO4.12H2O, 3.0); Magnesium sulfate (MgSO4, 0.2); Iron 
(II) sulfate or ferrous sulphate (FeSO4.7H2O, 0.001), and trace element stock solution, 2 
ml. The trace element stock solution was composed of (g/l): Iron (III) chloride hexahydrate 
or Ferric chloride (FeCl3.6H2O, 0.08); Zinc sulphate heptahydrate (ZnSO4.7H2O, 0.75); 
Cobalt (II) chloride 6-water (CoCl.6H2O, 0.08); Copper sulphate pentahydrate 
(CuSO4.5H2O, 0.075); Manganese sulfate monohydrate (MnSO4.H2O, 0.75); Boric acid 
(H3BO3, 0.15); Sodium Molybdate Dihydrate (Na2MoO4.2H2O, 0.05); Sodium hydroxide 
(2 N NaOH) (adjusts BSM to an initial pH 7.0).    
Pseudomonas aeruginosa (NCIMB 8626) was maintained in BH broth and incubated at 37 
oC for 24 h at 150 rpm. The cells were washed twice in BSM by centrifuging the culture 
broth at 3000 rpm for 10 minutes, and then re-suspended in 40 ml of BSM. 0.6 ml of sterile 
glycerol was added and the preculture was incubated for 48 h. 250 ml of BSM in a 1 L 
Erlenmeyer flask was inoculated with 2 ml of the preculture. 6 ml of glycerol was added 
and the flask incubated at 37 oC, 150 rpm for 5 days. The culture broth was centrifuged at 
4750 g for 20 min twice and the supernatant ultra-filtered under pressure using 0.45µm 
membrane filters (Millipore, UK) to obtain cells-free supernatant (crude biosurfactant 
extract).  
2.2.9.2 Characterisation of biosurfactant 
The protein concentration of the crude biosurfactant extract was measured by the Bradford 
reagent method as described in section 2.2.8.2.2.  The biosurfactant concentration was 
measured by the orcinol method for determination of rhamnose (Chandrasekaran and 
Bemiller, 1980). Biosurfactant (200 µl) sample was mixed with 1.8 ml  solution containing 
0.19 % orcinol (orcinol monohydrate, Acros, USA) made up in 53 % H2SO4. The mixture 
  
47 
was boiled in hot water bath for 20 min. After cooling at room temperature for 15 min, the 
samples were vortexed and the absorbance measured at 421 nm. Rhamnose standard curve 
was prepared with L-rhamnose (L (+)-rhamnose monohydrate from Acros) for a range 0-1 
mg/ml to determine the rhamnose equivalent of the biosurfactant. The rhamnose values can 
be expressed as rhamnolipid values by multiplying them with a coefficient of 3.4 obtained 
from the correlation of pure rhamnolipid/rhamnose (Chandrasekaran and Bemiller, 1980).  
2.2.9.2.1  Effect of biosurfactant on keratinase activity 
To determine the effect of the crude biosurfactant on keratinase activity, biosurfactant was 
added to crude keratinase and the procedure performed as described in section 2.2.8.2.6.   
2.3  Degradation of keratin substrates and scrapie prions by keratinase 
2.3.1 Degradation of keratin azure 
Characteristically, keratinases are able to degrade keratin azure by cleaving keratin causing 
release of azure dye into solution which is measured as absorbance change. To determine 
the ability of crude keratinase to degrade keratin azure, a test-tube containing 0.01g of 
treated keratin azure in 3 ml of 10 mM Tris HCl was inoculated with 1 ml of crude 
keratinase extract and incubated at 50 oC for 24 h. The reaction mixture was then 
physically observed for the release of azure dye into the solution. In the control 
experiment, the crude keratinase extract was denatured by boiling to destroy its activity.  
2.3.2 Degradation of melanised feather 
Melanised feather are highly resistant to degradation by keratinases than white feathers due 
to melanin pigment reported to inactivate keratinase (Gunderson et al, 2008). Therefore, 
keratinases that degrade melanised feather are potentially able to degrade highly stable and 
resistant keratins or keratin-like materials. To investigate the keratinolytic activity of N22 
keratinase, native (non-autoclaved) melanised feathers (dove feather) were trimmed (4 cm 
x 2 cm) and washed twice with sterile distilled water, oven dried at 50 oC and weighed. 
The final wash effluent was inoculated on nutrient agar plates and incubated at 50 oC to 
check for possible microbial presence. The feathers were incubated at 50 oC overnight and 
250 rpm in 8 ml of sterile distilled water and 2 ml of crude keratinase and compared to the 
negative control containing 10 ml of distilled water. A further experiment was carried out 
to compare the activity of denatured and normal crude keratinase. The enzyme was 
denatured by boiling for 30 min. The crude and denatured enzyme (10 ml) was each added 
to the melanised feather as described above. All experiments were carried out in 
duplicates. The extents of degradation of the feather substrates after 48 h were evaluated 
  
48 
by visual observation and quantitatively by measuring the residual dry weight by the 
weight loss method.  
2.3.3  Degradation of scrapie prion by keratinase 
2.3.3.1 Materials 
Mouse-adapted ME7 scrapie infected brain homogenate (IBH) was used in this study for in 
vitro and in vivo experiments. The scrapie prion BH was obtained from Drs Stephen 
Whatley and Oduola Abiola at the Institute of Psychiatry (IOP), King’s College London. 
Normal brain homogenate (NBH) from the batch of mice used for bioassay in this study 
was harvested and homogenised in phosphate buffered saline (PBS). All scrapie 
degradation experiments were conducted at Prof. Roger Morris Laboratory at the Wolfson 
Centre for Age Related Disease (CARD), King’s College London, Guy’s Campus. 
Handling of infectious scrapie material was carried out according to the World Health 
Organisations infectious control guideline for transmissible spongiform encephalopathies 
(WHO, 1999: http://www.who.int/csr/resources/publications/bse/whocdscsraph2003.pdf).  
The following monoclonal primary antibodies were used to detect PrPSc in Western Blot 
analysis: SAF83 (SPI-Bio, Massy, France), and 98A3, 9A2, 12B2, and 6C2 (Courtesy of 
Dr Jan Langeveld, Central Veterinary Institute of Wageningen UR, The Netherlands). 
SAF83 (IgG1):[from hamster brain SAF (scrapie associated fibrils)] in mouse host, 
recognises solid-phase immobilised peptide 126-164. Monoclonal antibody 98A3 (IgG2a) 
was elicited with recombinant bovine PrP and recombinant human PrP mapped to 
KRPRKP. The antibody 9A2 (IgG1) was elicited with bovine peptide of N-terminus PrPres 
boPrP97-115 (GGGGWGQGGTHGQWNKPSK) mapped to WNK. 12B2 (IgG1) was 
elicited with bovine peptide of N-terminus PrPres boPrP97-115 
(GGGGWGQGGTHGQWNKPSK) mapped to WGQGG and 6C2 (IgG2b) was elicited 
with bovine peptide boPrP 117-130 (KTNMKHVAGAAAAG) mapped to HVAGAAA. 
All mappings described above were performed with pepscan (Dr Jan Langeveld, Personal 
communication).  
2.3.3.2 Western blot 
Western blot (WB) is a commonly used biochemical method for the immunodetection of 
proteins using specific antibodies after the protein sample have been separated by gel 
electrophoresis and transferred onto membrane (Kurien and Scofield, 2006). WB analysis 
was used to establish the presence or absence of prion protein in brain homogenate 
samples, and hence to evaluate the enzymatic degradation of scrapie prion. 
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2.3.3.2.1  Sample preparation and gel electrophoresis 
Brain homogenate (5µl) containing either 1 % normal brain homogenate (NBH) or 1 % 
ME7 scrapie infected brain homogenate (IBH) were mixed with 5µl PBS, or 10 µl brain 
homogenate (specified as used), and incubated with proteinase K (PK), keratinase or 
keratinase combined with biosurfactant at digestion times (10 min to 2 h) as specified for 
each experiment. The digestion was terminated by addition of 1 µl of 50 mM Phenyl 
methyl sulfonyl fluoride (PMSF) followed by the addition of 11 µl of 2× sample buffer and 
heated at 100 oC for 10 min on a dry block (Techne). Digested samples (10 µl) were run on 
SDS-PAGE gel as described in section 2.2.8.2.1.  
2.3.3.2.2  Transfer of sample to membrane 
Polyvinylidene fluoride (PVDF) membrane was briefly soaked in methanol and then 
placed on filter paper which was immersed in transfer buffer (composed of glycine, 2.9 g; 
Tris, 5.8 g; SDS, 0.7 g;  and methanol, 200 ml, made up to 1000 ml with distilled water). 
The separated protein bound-SDS PAGE gel was placed on the PVDF membrane and 
carefully sandwiched between filter papers. The sandwich was wrapped with tissue paper 
and gently pressed together with a roller to drain excess transfer buffer and to remove 
trapped air bubbles. The sandwich was placed in a transfer cell [Trans-Blot SD, semi-dry 
transfer cell (Biorad)] and run at 15 V and 200 mA for 50 min for a single membrane 
transfer. 
2.3.3.2.3  Immunodetection 
After the transfer, the membrane was carefully removed and blocked with 5 % skimmed 
milk (incubated for 1 h at 30 rpm), and then probed with the primary antibody [ SAF 83 
(0.2 µg/ml)] in 1 % skimmed milk (1:5000) and incubated for 1 h at 30 rpm. Primary 
antibodies such as 98A3 (5 µg/ml), 9A2 (0.5 µg/ml), 12B2 (0.2 µg/ml) and 6C2 (1 µg/ml) 
were also used in order to determine the antibodies of most affinity to the linear epitopes of 
the ME7 scrapie prion. The membrane was quickly washed twice with 0.1% Tween in 1× 
PBS (PBST) followed by six 5-min washes. The membrane was then probed with 
secondary antibody (Amersham ECL Anti-mouse IgG Horseradish peroxidase linked 
whole antibody (from sheep); GE Healthcare, UK) in 1 % skimmed milk (1:5000) and 
incubated at room temperature, 30 rpm for 50 min and washed as described above. 5 % 
Bovine Serum Albumin (BSA) was also used as membrane blocking buffer (incubated for 
1 h at 30 rpm) in order to determine the most suitable blocking agent that will not cross 
react with keratinase and will block undesirable background signals. 
Prion protein was detected by using Amersham™ ECL™ Plus Western Blot Detection 
System (GE Healthcare, UK). Lumigen PS-3 detection solutions: A (1.5 ml) and B (37.5 
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µl) were mixed and poured over the membrane which had been drained and placed on foil 
wrapped glass plate, and allowed to stand for 5 min. The secondary antibody conjugate, 
Horseradish peroxidase (HRP) catalyzed the oxidation of luminol in the presence of 
hydrogen peroxide, and the luminol decays via a light-emitting pathway, and was 
photographed on Kodak film, and developed with Mediphot 937 X-ray film processor 
(Colenta Labortechnik, Austria).  
2.3.3.3 Optimisation of enzymatic degradation of scrapie prion 
Optimisation of an enzymatic degradation procedure enables the identification of suitable 
degradation conditions. To optimise the enzymatic degradation of ME7 scrapie, factors 
such as the state and concentration of keratinase, digestion temperature, incubation time, 
and the addition of detergents were investigated as reported below. 
2.3.3.3.1  Degradation with keratinase fractions and enzymatic composition 
ME7 scrapie brain homogenate (5 µl) samples mixed with 5 µl PBS were digested 
separately with 1 µl of crude keratinase extract (S), concentrated crude keratinase (CS), 
and PSC, BF and EF collected as fractions from the purification procedure and incubated 
at 50 oC for 2 h to determine the most effective fractions for degrading ME7 scrapie prion. 
A replicate experiment was conducted with the keratinase fractions mixed with 1 µl of 
crude biosurfactant extract (BS) (EF+BS) and digested at 50 oC for 1 h to determine the 
effect of biosurfactant on ME7 prion degradation. Furthermore, ME7 scrapie brain 
homogenate (10 µl) was digested at 50 oC for 2 h with the enzymatic composition 
(EF+BS). Digestions of ME7 by BS, EF and EF+BS at 65 oC for 1 h were carried out. All 
control experiments were not enzyme digested. 
PrPC is immunologically indistinguishable from PrPSc, but it is degraded by proteinase K 
(PK). In the degradation of normal brain homogenate or degradation of infectious brain 
homogenate to digest PrPC (control experiments), PK was used at the final concentration of 
10, 50, 77 or 100 µg/ml. 
2.3.3.3.2  Optimisation of enzymatic composition and incubation conditions 
ME7 scrapie sample was digested with EF+BS in which EF composite was diluted in PBS 
as 1:50; 1:100; and 1:200.  Also, to optimise the incubation time, ME7 scrapie BH (10µl) 
was digested at 50 oC for 30, 45, 60, 90 and 120 min with EF (1 µl) +BS (2 µl). Digestions 
were also carried out at 65 oC for 10, 30 and 45 min. 
2.3.3.3.3  Degradation of other scrapie prion samples  
In order to investigate the efficacy of EF+BS on other scrapie strains, brain homogenate 
samples (1%) of ME7, PG 300/97, SSBP/1, PG 2413/98, PG 467/07, PG 241/97 scrapie 
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prions (Kindly provided by Animal Health and Veterinary Laboratories Agency, UK) were 
digested with EF+BS at 65 oC for 1 h, and analysed by Western blot for PrPSc.  
2.4 Residual infectivity evaluation of keratinase-digested scrapie prions 
2.4.1 Standard scrapie cell assay (ex vivo assay) 
The standard scrapie cell assay (SSCA) is an important quantitative, highly sensitive cell-
based infectivity assay for characterising scrapie prions using suitable susceptible cells 
(Klohn et al, 2003). Prion infection of cells have been shown to occur within 1 min of 
exposure (Goold et al, 2011). Susceptible cells infected with scrapie prion accumulate 
PrPSc and infectivity, hence SSCA was used to evaluate residual infectivity of enzyme-
digested SSBP/1 scrapie prion infected brain homogenate. The SSCA was carried out at 
Animal Health and Veterinary Laboratories Agency, New Haw, Weybridge, UK with 
Michael Neales who have a lot of experience with SSCA and performed as described in 
Neale et al (2010). 
2.4.1.1 Cell line and culture medium 
Sheep scrapie brain pool/1 (SSBP/1) scrapie susceptible Rov9 cells (Kindly provided by 
Animal Health and Veterinary Laboratories Agency, UK) were used in the SSCA as ME7 
scrapie susceptible cells were unavailable. The Rov9 cells were maintained in Eagle’s 
minimal essential medium (EMEM, Gibco) supplemented with 10 % fetal calf serum and 2 
% HEPES. Rov9 infection was cultured in OptiMEM medium (Invitrogen) supplemented 
with 10 % serum (Gibco) and antibiotics/antimyotic (Penicillin, 100 units; Streptomycin, 
100 µg and Amphotericin B, 0.25 µg).  
2.4.1.2 Infection of cells with SSBP/1 
Approximately 20000 susceptible cells in 180 µl medium/well were plated wells of a 96-
well plate and cultured for 16 h (to allow cells to adhere) at 37 oC in a humified 5 % CO2 
atmosphere in a cell culture incubator. 20 µl of 1:10 dilution of inocula was further diluted 
to 10-4 concentration and added to the cell culture. The inocula were 1 % SSPB/1 digested 
with EF, BS and EF+BS at 65 oC for 1 h and the reaction was terminated with PMSF. The 
positive controls included incubated and non-incubated SSBP/1 to monitor the effect of 
incubation temperature.The cells were cultured for 3 days, trypsinised with 60 µl ATV 
[standard trypsin (0.05 %)/EDTA (0.02 %)] at 37 oC to detach cells, and split 1:6 into fresh 
96-well plates. The cells were split every 3 days for three times and grown to confluence 
following the third split.  
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2.4.1.3 ELISPOT Assay 
Enzyme-linked immunospot assay (ELISPOT) plate (Multiscreen-IP filter plates, 
Millipore) was activated with 50 µl of ethanol (70 %) added to each well and suctioned off. 
Each well was washed twice with 160 µl PBS. 100 µl of media containing 10 % serum was 
added to each well to inhibit trypsin in the cell suspension and to prevent wells from drying 
out while trypsinising (at 37 oC) to detach cells. Cells in the 96-well plate were trypsinised 
with 60 µl ATV in each well at 37 oC and ensuring that cells were detached by tapping the 
plate and pipetting vigorously but avoiding foam. 10 µl of the cells was passaged into fresh 
media in 96-well plates to maintain the challenge and 30 µl of the cells were plated into the 
ELISPOT plate. PBS (180 µl) was added to the remaining cells and 30 µl plated into 
Trypan blue plate. The plates were drained by vacuum and the wells allowed dry for 1 h. 
The ELISPOT plate was briefly digested with 60 µl of PK (10 µg/ml) solution prepared in 
lysis buffer (50 mM Tris HCl (pH8), 150 mM NaCl, 0.5 % Na deoxycholate, 0.5 % Triton 
X-100, H2O) and incubated at 37 oC for 30 min. The PK was vacuumed off and the wells 
washed twice with 160 µl PBS on vacuum. 160 µl of 1 mM PMSF was added to each well 
to stop the reaction and vacuumed. 120 µl Tris-guanidinium thiocyanate (GSCN) was 
added and plate incubated at room temperature for 10 min and the GSCN flickered off unto 
absorbent paper in an autoclave bag and the wells washed with 160 µl PBS (4 washes) and 
another 3 washes on vacuum.  
2.4.1.4 Immunodetection 
Blocking buffer (120 µl of superblock per well) was added to the ELISPOT plate and the 
plate incubated at room temperature for 1 h and suctioned off. 60 µl of anti-PrP (Sha31) in 
TBST/ 1 % milk powder was added and incubated for 1 h at room temperature and the 
supernatant discarded. The wells were washed 4 times with 160 µl TBST and flickered off. 
60 µl goat anti-mouse alkaline phosphatase conjugated in TBST/ 1 % milk powder was 
added to each well and incubated for 1 h at room temperature, and the supernatant 
discarded. The wells were washed 4 times with 160 µl TBST and flickered off. The plastic 
underdrain was removed and the membrane dried by pressing the bottom of the wells 
against a tissue, and the plate dried under a hood at room temperature. Alkaline 
phosphatase dye (Alkaline phosphatase conjugate substrate kit, Sigma) prepared according 
to manufacturers instruction was added to each well (54 µl) of the filter plate and incubated 
for 16 min at room temperature while avoiding air bubbles on the filter membrane. The 
supernatant was discarded and the wells washed twice with 160 µl water and the 
supernatant discarded. The plate was completely dried and the infected cells were 
visualised and read on plate reader. Positive cells (spots) were counted using a Zeiss KS-
ELISPOT imaging system running Wellscan software (Image Associates); the images were 
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photographed.  
2.4.1.5 Determination of cell number with trypan blue assay 
The trypan plate prepared and dries in 2.4.1.3 containing 1:10 of the cells used in the 
ELISPOT assay was stained by placing the plate on vacuum device and flushing the wells 
with 100 µl 0.04 % Trypan Blue in lysis buffer (a few seconds exposure). The wells were 
rinsed twice with 160 µl PBS and dried. Cells were counted using the ELISPOT 
equipment. 
2.4.1.6 Analysis of scrapie cell culture assay 
Bar chart of the number of spots detected (infected cells) were plotted for the treatment 
groups: IBH, Incubated IBH, EF, BS and EF+BS. Test of difference in the number of 
infected cells in the EF, BS, EF+BS and IBH groups were compared with those of the 
incubated IBH group using Two-Sample T-Test.  
 2.4.2 Mouse bioassay (in vivo assay) 
Mouse bioassay is an experimental method for transmission of infectivity to recipient 
animals and is considered as the gold standard for residual prion infectivity evaluation and 
validation of prion decontamination methods (Collinge, 2001). A normal (healthy) mouse 
challenged with the prion agent is expected to become infected and eventually die of the 
disease. The absence of clinical signs of disease and PrPSc in hosts challenged with 
degraded prion inoculum would imply complete degradation of the infectious agent. To 
test for residual infectivity and transmission of disease, mice were inoculated with enzyme-
digested ME7 scrapie inoculum and observed for clinical signs of disease, and analysed for 
PrPSc.   
2.4.2.1 Preparation of mice and experiment setup 
Mouse bioassay for evaluation of residual infectivity was conducted at the animal facility 
at Biological Services Unit, Franklin Wilkins Building, King’s College London. All animal 
experiments were performed in compliance with standard procedure for use of animals, 
and according to UK Home Office Animal (Scientific procedure) Act 1986. Transgenic 
(Tga20) mice (courtesy of Prof. Charles Wiessmann) overexpressing PrPC were outbred for 
6 generation to C57BL/6 mice. The mice used for the bioassay were selected by 
immunohistochemistry method.  Freshly clipped ears and tails were sectioned by cryostat 
onto poly-lysine coated slides and allowed to airdry overnight. The slides were rinsed with 
5 % milk PBS buffer and 2S Alexa-Fluor-594-Fab applied for 15 min and then washed 3 
times with 1 % milk PBS. The samples were fixed with 4 % paraformaldehyde (PFA) and 
viewed under fluorescent microscope to detect PrPC (positive staining). Positive and 
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negative control tails were included in the experiments. Selection of animals was carried 
out by Angela Jen at Prof. Roger Morris’ Laboratory, Kings College, London. 
 
 The experimental setup of the mouse bioassay (Table 2.1) shows the different treatment 
groups according to mice groups injected with normal brain homogenate (NBH), ME7 
infected brain homogenate (IBH), log-dilutions of IBH or IBH digested with the enzyme 
preparation (EF+BS) at 65 oC for 1 h. Brain homogenates were used as 1 % and all mice 
were inoculated intraperitoneally with 100 µl inocula except for the IBH (1:10 dilution) 
group which were inoculated with 70 µl in order to inoculate more mice. All inoculations 
were carried out by Prof. Roger Morris in compliance with the UK Home Office Animal 
(Scientific procedure) Act 1986. 
 
Table 2.1: Experimental layout of mice bioassay including the treatment groups and the number of 
mice inoculated. 
 
Treatment groups 
No. of mice  
inoculated 
Inoculated with normal brain homogenate (NBH) Negative 
control 
5 
Inoculated with infectious brain homogenate (IBH)  
Neat 
8 
Inoculated with infectious brain homogenate (IBH)  
1:10 dilution 
9 
Inoculated with infectious brain homogenate (IBH)  
1:100 dilution 
13 
Inoculated with infectious brain homogenate (IBH)  
1:1000 dilution 
Positive 
controls 
6 
Inoculated with infectious brain homogenate (IBH)  
digested with enzymatic treatment (EF+BS) 
Experimental 
group 
15 
 
2.4.2.2 Analysis of bioassay 
Prion infected mice characteristically accumulate PrPSc and prion infectivity in their brain, 
hence, detection of PrPSc is an important parameter to determine if challenged mice have 
been infected. Survival times post inoculation were recorded when challenged mice died or 
developed signs of clinical disease and were culled. Their brains were harvested and 
homogenised in sterile phosphate-buffered saline (PBS) as 1 % (w/v) brain homogenates. 
Samples were digested with PK (77 µg/ml final concentration) and analysed for presence 
of PrPSc in the brains by western blot. Only mice that were dead or culled at ≤ 550 days 
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and those that showed positive PrPSc were included in the survival time analysis. Boxplot 
of the individual and mean survival times for the treatment groups were plotted. Test of 
difference in survival times for the different treatment groups were analysed by One-Way 
ANOVA. Test of significant increase in the survival times for the IBH-digested group 
compared to IBH neat group was analysed by Two-Sample T-Test.  
 
2.4.2.3 Comparing PrPC expression in C57BL/6 mice and Tga20 mice used 
 for bioassay 
The Transgenic (Tga20) mice used for the mice bioassay showed survival time 
characteristic of C57BL/6 (wild-type) mice and hence were compared for their levels of 
PrPC expression. Tga20 overexpressing PrPC propagates prion disease faster than wild type 
mice as a result abundant PrPC substrate resulting in shortened incubation time of disease. 
The level of PrPC in C57BL/6 (Charles River) brain homogenate sample was compared 
with 4 random samples of Tga20 mice used in this bioassay. Undigested brain 
homogenates (1 %) were analysed by western blot as already described. Two 1/3 dilutions 
of each sample was included in the gel. βeta-actin (Cell Signaling Technology) was used as 
internal control to check for uniformed loading of sample. 
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Chapter 3: Results 
 
3.1 Isolation and characterisation of proteolytic microorganisms, 
keratinase and biosurfactant 
3.1.1  Isolation of microorganisms from environmental samples  
A total of thirty-two bacteria were isolated on feather meal agar from primary effluent, 
poultry and animal wastes. These isolates were selected and identified based on their 
colony morphology, size, shape, texture, structure, pattern and colour. Single colonies of 
the isolates were obtained by re-streaking on feather meal agar plates. The purified isolates 
stored in liquid nitrogen reached a cell density of up to 108 CFU/ml in 24 h when cultured 
in nutrient broth and plated on nutrient agar plates. 
3.1.2  Screening of proteolytic microorganisms 
3.1.2.1  Spot inoculation assay 
The spot inoculation assay detects the proteolytic properties of bacterial strains by their 
ability to grow on casein-agar, hydrolyse casein and form hydrolysis ring. Results of 
screening test of isolate N22, compared to bacteria species; Pseudomonas aeruginosa NCTC 
10662, Escherichia coli NCTC 10418, Staphylococcus aureus NCTC 6571, Bacillus subtilis NCTC 
10400 and Bacillus stearothermophilus NCTC 10007 (Fig. 3.1) show that isolate N22 was 
highly proteolytic.  
 
Fig. 3.1: Screening for proteolytic microorganisms by spot inoculation assay. Isolated strain N22 
(1) shows higher proteolytic activity than Pseudomonas aeruginosa NCTC 10662 (2), Escherichia 
coli NCTC 10418 (3), Staphylococcus aureus NCTC 6571 (4), Bacillus subtilis NCTC 10400 (5) 
and Bacillus stearothermophilus NCTC 10007 (6).  
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3.1.2.2  Hydrolysis ring assay 
Hydrolysis ring assay enabled screening of crude enzyme extract for proteolytic activity by 
their ability to hydrolyse casein. A validation experiment of hydrolysis ring assays showed 
an inverse correlation between casein ring formation and concentration of keratinase for 
crude keratinase dilutions of 1:0 (neat); 1:10; 1:100; 1:1000 (Pearsons correlation = 0.761, 
p = 0.239). The diameters of the hydrolysis ring were 20 mm, 16.3 mm, 12.5 mm and 6.3 
mm respectively (Fig. 3.2).  
 
 
Fig. 3.2: Relationship between keratinase activity and hydrolysis ring. Clockwise from top left are 
inoculations with keratinase dilution of 1:0, 1:10, 1:100 and 1:1000 incubated at 50 oC for 24 h.  
3.1.3  Standardization of keratin azure substrate 
Standardisation of keratin azure (KA) substrate yielded a homogeneous substrate by 
removing excess azure dye and debris, thus enabled consistent and reliable keratinase 
activity measurement. In the treatment of KA, the highest dye release occurred when it was 
incubated with sterile distilled water as measured by the absorbance reading of 0.069 ± 
0.030 compared to 0.022 ± 0.026 when incubated in 10 mM Tris HCl buffer. Distilled 
water was more efficient in removing loosely bound azure dye. However, in both cases, a 
large variation in absorbance changes occurred among sample replicates. In typical 
keratinase assay controls using unwashed and washed keratin azure, the mean absorbance 
± SD measured were 0.116 ± 0.020 and 0.046 ± 0.000 respectively (Table 3.1). The 
absorbance reading with the washed samples was not different from distilled water blank 
in the same batch of cuvette used. The large standard deviation for the unwashed keratin 
azure revealed significant disparity for the sample replicates compared to treated keratin 
azure. There was a significant difference in absorbance reading between treated 
(homogeneous) and untreated (heterogeneous) keratin azure (p = 0.005 at 95.5 % 
confidence interval; Mann-Whitney Test).   
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Table 3.1: Validation of standardisation protocol for the preparation of keratin azure (KA) substrate 
Treated keratin azure is highly homogeneous with insignificant variation within sample replicates 
(n = 6), and is suitable as substrate for keratinase assay. 
 
Substrate 
 
Absorbance 
range 
Mean absorbance 
± SD 
Untreated 
KA 
0.048 0.116 ± 0.020 
Treated 
KA 
0.002 0.046 ± 0.000 
 
3.1.4  Screening for keratinolysis and selection of isolates 
Keratinolytic isolates were specifically screened and selected by measuring the activity of 
their keratinases, and those that are potentially prion degrading were identified by their 
activity relative to proteinase K (PK) used to characterise prion. Results of keratinase 
activities of 32 isolates and a reference strain Bacillus licheniformis PWD-1 as evaluated 
by keratinase assay showed that isolate number 22 (N22) demonstrated the highest mean 
keratinase activity (Fig.3.3), and hence was selected for further study. Isolate N22 showed 
58 % higher keratinase activity than the reference strain B. licheniformis PWD-1. 
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Fig. 3.3: Keratinase activity (Mean ± SD, n = 3, each data point) for 32 microbial isolates tested by 
the keratinase assay using keratin azure as substrate. A number of isolates including number 22 
showed significant activity relative to reference strain Bacillus licheniformis PWD-1 (Labelled R).  
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Keratinase activity equivalent to 0.2 mg/ml concentration of proteinase K determined from 
PK calibration curve (Fig. 3.4) was ≈ 5.9 U/ml, therefore, keratinase activity for crude 
culture extract of the isolates ≥ 5.9 U/ml were considered to be significant. PK of 0.2 
mg/ml was reported to fully degrade prions under denaturing conditions to undetectable 
limit as assayed by Western blotting (Langeveld et al, 2003). Crude keratinase extract of 
isolate 22 showed 54 % more activity than 0.2 mg/ml of PK on keratin azure. 
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Fig. 3.4: Calibration curve for keratinase activity equivalent of Proteinase K degradation of keratin 
azure. PK concentration of 0.2 mg/ml is equivalent to 5.9 U/ml keratinase activity and was 
considered as a significant cut-off for keratinolytic microorganisms. Activity represents mean ± SD 
(n = 5, each data point). 
3.1.5  Identification and characterisation of strain N22 
A number of morphological, physiological, biochemical and molecular properties were 
used to identify, classify and characterise bacteria isolates. Isolate N22 was found to be a 
Gram positive rod bacterium displaying a number of characteristics matching the Bacillus 
species listed in the Bergey’s Manual of Determinative Bacteriology (Holt et al., 1993; 
Table 3.2). This isolate was confirmed by full gene sequence analysis of the 16S rDNA 
with 99.93 % similarity to Bacillus licheniformis ATCC14580.  Phylogenetic tree show 
isolate N22 within the same branch of Bacillus licheniformis species within the cluster of 
Bacillus species (Fig. 3.5). This isolate was named Bacillus licheniformis N22 strain and 
deposited with the National Collection of Industrial Food and Marine Bacteria (NCIMB) 
with designated ascension number NCIMB 41708. Mass spectral fingerprint for Bacillus 
licheniformis N22 and Bacillus licheniformis PWD-1 acquired by MALDI TOF-MS (Fig. 
3.6) show highly stable and reproducible characteristic peaks.  
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Table 3.2: Morphological, physiological and biochemical characterisation of isolate N22 
 
Tests Response 
Colony morphology Rod-shaped, opaque, rough edge, mucoid, 
and domed surface, creamy-white colour,  
Gram stain + 
Endospores formation + 
Anaerobic growth - 
Motility + 
Oxidase reaction + 
Catalase reaction + 
Triple Sugar Iron (TSI) 
Glucose 
Lactose 
Iron 
K/A* 
+ 
- 
- 
Reduction of nitrates to nitrites + 
Voges-Proskauer (VP) + 
Indole production 
Arginine DiHydrolase 
- 
+ 
Urease 
Hydrolysis of casein 
+ 
+ 
Onset of growth on nutrient agar plate 
( 37 oC) 
( 50 oC) 
 
9 h 
5 h 
Growth in nutrient agar at NaCl conc. 2-12 % + 
Growth in nutrient broth at pH 6-12 + 
* K- alkaline reaction; A-acid production. 
 
 
Fig. 3.5: Phylogenetic tree showing the top 10 hits generated from the 16S rDNA full sequence 
analysis of Bacillus licheniformis N22 within a cluster of Bacillus licheniformis specie. 
Bacillus subtilis spizizenii ATCC=6633 
 
Bacillus oleronius 
DSM=9356 
Bacillus mojavensis ATCC=51516 
Bacillus subtilis subtilis ATCC=6051 
Bacillus amyloliquefaciens ATCC=23350 
 
Bacillus atrophaeus ATCC=49337 
 N22 
 
Bacillus licheniformis ATCC=14580 
 
Bacillus pumilus ATCC=7061 
 Bacillus firmus ATCC=14575 
 Bacillus sporothermodurans     
DSM=10599 
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Fig. 3.6: Spectral mass fingerprint for Bacillus licheniformis N22 (red) and Bacillus licheniformis 
PWD-1 (green) showing distinct protein peaks.which are used for identifying bacterial strains.  
3.1.6  Optimisation of keratinase production  
Optimisation of physiological conditions of fermentation cultures such as temperature, pH 
and substrate concentration resulted in optimum keratinase synthesis and keratinase 
activity. The strongest casein hydrolysis ring expression by Bacillus licheniformis N22 in the 
spot inoculation assay was observed at 50 oC (Fig. 3.7), which is the optimum temperature 
for growth and production of keratinase. The relative hydrolysis ring diameter (%) at 25, 
30, 37, 40, 50, 60, 70 and 80 oC were 0, 0, 33, 44, 100, 78, 67 and 44 % respectively, 
where the diameter at 50 oC was considered as 100 %. 
 
 
Fig. 3.7: Optimum temperature determination by casein-agar plate spot inoculation assay for 
temperature range 25 oC-80 oC. Casein hydrolysis was strongest at 50 oC which corresponds to it 
optimum temperature condition. 
Keratinase production by Bacillus licheniformis N22 occurred over a wide pH range of 6-
12, with a sustained optimum at initial culture pH 8-9 (Fig. 3.8) after incubation for 32 h. 
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One-way ANOVA for keratinase production in fermentation cultures at 10 h, 24 h and 32 h 
suggested that they were different ( p = 0.000).  
 
 
Fig. 3.8: Kinetics of keratinase activity (U/ml ± SD; n = 3, each data point) showing the robustness 
of keratinase synthesis over a wide pH range (pH 6-10) at 32 h incubation time. Significant 
differences (p = 0.000; one-way ANOVA) existed for keratinase production at 10 h, 24 h and 32 h 
over a range of pH conditions. 
The final pH of the fermentation culture broth was approximately pH 8.3 irrespective of 
the initial pH for pH (6-12) after incubation for 32 h (Fig.3.9). The pH 6-8 and pH 9-13 
were up-regulated and down-regulated respectively, with those of pH 7-12 stabilising at 
final culture pH ≈ 8.3, whereas initial culture pH ≤ 5 and ≥13 remained about the same at 
the end of 32 h incubation period. 
 
Fig. 3.9: pH kinetics in fermentation culture with final pH tending towards 8.3, which indicates the 
optimum pH for cell growth and synthesis of extracellular keratinase. The buffering effect was a 
response to metabolic products resulting from two possible pathways. Graph for final pH represents 
mean ± SD (n = 3, each data point). 
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The optimal substrate concentration for production of keratinase of highest activity was 
found to be 1.1 % (w/v) resulting in keratinase activity of approximately 11 ± 0.71U/ml. 
Higher substrate concentrations more generally tended to limit keratinase synthesis (Fig. 
3.10). Generally, keratinase production was higher at 50 oC than at 37 oC, and also at pH 
8.5 than at pH 7 or pH 10. Acidic pH (pH ≤ 4) and temperature up to 63 oC were found to 
be unfavourable for cell survival and growth of this strain and hence for keratinase 
production. Keratinase synthesis was induced by feather meal substrate. Keratinase activity 
in bacterial culture grown in nutrient broth was significantly lower (3.5 U/ml) than that 
grown in minimum medium supplemented with feather meal substrate (11 U/ml). An 
extended fermentation culture incubation up to 52 h resulted in a 30 % reduction in 
keratinase activity. 
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Fig. 3.10: Optimisation design for determination of optimum conditions for keratinase production 
for Bacillus licheniformis N22. Optimum production condition was achieved at pH 8.5, 
Temperature 50 oC and substrate concentration of 0.55 g/l (1.1 % w/v). Each bar represents mean ± 
SD (n = 3, each data point). 
3.1.7  Effects of chemical agents, biosurfactant and pH on keratinase activity 
Chemical and biological agents could activate or inhibit keratinase activity, thus these 
properties are used to classify keratinases and to infer their stability under various 
conditions. The reducing agent dithiothreitol (DTT) significantly enhanced keratinase 
activity by 86 % more than with crude keratinase, 34 % by the detergent Triton X-100 and 
 
37 °C at pH 7 
 
 
37 °C at pH 10 
 
 
50 °C at pH 7 
 
 
37 °C at pH 8.5 
 
50 °C at pH 10 50 °C at pH 8.5 
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12 % by EDTA. SDS showed an inhibitory effect on keratinase activity while biosurfactant 
slightly activated keratinase. These effects were measured relative to the crude keratinase 
activity (control) defined as 100 % (Table 3.3). 
Table 3.3: Effect of chemical agents (Chelators, reducing agents and detergents) and biosurfactant 
on the activity of keratinase on keratin azure substrate (n = 3, each data point).  
Agent Activity 
(Mean ± SD) 
Crude keratinase 11.00 ± 0.71 
EDTA (5mM) 12.3 ± 0.00 
DTT (5mM) 20.47 ± 4.56 
Triton X-100 (0.1 %) 14.77 ± 2.45 
SDS (0.1 %) 10.10 ± 1.91 
Biosurfactant 12.00 ± 0.50 
 
In order to achieve optimum keratinase activity, determination of the optimum pH 
condition for keratinase was required. The optimum activity for crude keratinase was 
measured at pH condition of 8.5 (Fig.3.11).  
 
 
 
Fig. 3.11: Determination of optimum pH conditions for N22 crude keratinase in keratinase assay. 
Optimum keratinase was achieved at pH 8.5. Each data point represents mean ± SD (n = 3, each 
data point). 
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3.1.8  Purification and characterisation of keratinase 
Keratinase secreted in fermentation culture was recovered and purified to enable 
determination of its biochemical properties. Crude keratinase extract (120 ml) was 
concentrated down to 12.5 ml in a Centriconplus-70 centrifugal device of molecular weight 
cut-off of 10 KDa. Fractions from the purification steps along with the crude and 
concentrated crude enzyme extract are shown in Fig. 3.12. The keratinase activity, protein 
concentrations, specific activity, purification factor and percentage yield are presented in 
Table 3.4.  The eluted fraction (EF2) of the second purification cycle had the highest 
specific activity (41.28 U/mg) and purification factor (1.97). The purified keratinase 
remained thermally stable, maintaining its activity for up to 8 weeks when stored in the 
fridge at 4 oC. 
 
Fig. 3.12: Pooled fractions of the crude keratinase extract, concentrated crude keratinase 
preparation and fractions PSC, BF and EF derived from the purification steps of the step-wise 
feedback purification model. 
 
Table 3.4: keratinase activity of crude keratinase and fractions from purification procedure, where, 
BF: fraction obtained with binding buffer; EF: fraction obtained with elution buffer; PSC: fraction 
obtained when sample is loaded; suffix numerals: number of cycles. 
 
Fractions 
Activity 
(U/ml) 
Protein  
conc.(mg/ml) 
Specific 
Activity (U/mg) 
Purification  
factor 
Yield 
(%) 
Crude keratinase  10.5 0.502 20.91 1 100 
Conc. crude keratinase 23 0.786 29.26 - - 
PSC1 17 0.839 20.26 0.98 161.84 
BF1 19.3 0.820 23.53 1.13 183.74 
EF1 3.5 0.128 27.34 1.31 33.32 
PSC 2 20 0.557 35.90 1.72 190.4 
BF2 11 0.368 29.89 1.43 104.72 
EF2 4.5 0.109 41.28 1.97 42.84 
PSC3 20 0.566 35.33 1.69 190.4 
BF3 15 0.387 38.75 1.85 142.8 
EF3 2 0.104 19.23 0.92 19.04 
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3.1.8.1  Molecular weight of purified keratinase 
The molecular weight of purified keratinase was determined as approximately 28 KDa by 
both SDS-PAGE (on a 12 % gel) and MALDI TOF MS, and appeared as a single band on 
gel and a single peak in mass spectrum respectively (Fig. 3.13 and 3.14). No band was 
detected in the lane loaded with loading buffer (control). Single molecular weight band and 
mass peak of N22 keratinase were detected by SDS-PAGE and MALDI TOF MS 
respectively. 
 
                                                                            MWM           1             2 
 
 
 
 
      
 
    
 
Fig. 3.13: Molecular weight band of keratinase at ≈ 28 KDa determined by SDS-PAGE (Lane 1) 
and matched against molecular weight marker (MWM) showing the 25 and 37 KDa bands. Lane 2 
contained loading buffer (control).  
 
Fig. 3.14: MALDI-TOF MS spectrum showing molecular weight of keratinase as ≈ 28KDa. Single 
peak depicts homogeneity of the sample. 
3.1.8.2  Peptide mass fingerprint of keratinase 
In order to establish peptide mass fingerprint for keratinase useful for its identification and 
characterisation, keratinase was digested for 2 h with 0.1 mg/ml of trypsin to generate 
tryptic peptides mass spectrum which was detected by MALDI-TOF MS (Fig.3.15 A-C). 
The original peak of ≈ 28 KDa was cleaved to generate a number of tryptic peptides. An 
  37 KDa 
  25 KDa 
MWM              1               2 
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overlap of trypsin-digested (blue) and non-trypsin digested (red) keratinase spectrum were 
used to establish the tryptic peptide peaks, and matched against trypsin spectrum to 
identify any background peaks. The tryptic peptide searched on mascot search engine 
showed no matches in any previously reported keratinases or keratinase producing 
organisms. 
(A) 
 
 
 
 
 
 
 
Fig. 3.15(A-C): MALDI-TOF MS spectrums of tryptic peptides of keratinase (Red colour represent 
spectrum before digestion and blue after digestion with 0.1mg/ml of trypsin). The spectrum was 
acquired in mass ranges (A) 12-30 KDa (B) 6-12 KDa (C) 0-6 KDa in order to zoom into the 
spectrum.  
(A) 
(B) 
(C) 
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3.1.9 Characterisation of crude biosurfactant  
To determine the biosurfactant concentration and total protein concentration, Pseudomonas 
aeruginosa NCIMB 8626 culture was ultra-filtered to obtain crude biosurfactant extract 
(Fig. 3.16). The concentration of crude biosurfactant extract was determined by the Orcinol 
method as 0.49 mg/ml (rhamnose equivalent) and the total protein concentration was 
measured as 0.72 mg/ml (BSA equivalent) by the Bradford reagent method. The pH of 
crude biosurfactant was measured as approximately pH 8.3. Crude biosurfactants remained 
effective when stored at 4 oC for more than a year. 
 
Fig. 3.16: Crude biosurfactant extract produced from Pseudomonas aeruginosa NCIMB 8626.  
3.2  Degradation of keratin substrates and scrapie prions by keratinase 
3.2.1 Degradation of keratin azure 
Degradation of keratin azure substrate by keratinases results in the release of azure dye 
(blue dye) into reaction solution. To determine the keratinolytic characteristic of 
keratinase, keratin azure was digested with keratinase at 50 oC for 24 h resulting in 
significant release of azure dye (Fig. 3.17). In the control experiment (treated with 
denatured keratinase), minimal amount of blue dye was released. 
 
 
                                                             a                    b 
Fig. 3.17: Degradation of keratin azure by crude keratinase showing release of azure dye 
following cleavage of peptide derivatives. Test tube (a) was treated with boiled crude 
keratinase (Control) and test-tube (b) with intact (non-denatured) crude keratinase. 
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3.2.2 Degradation of melanised feather 
Melanised feather are highly resistant to enzymatic degradation and the melanin pigment 
able to inactivate keratinase, so that only keratinases of high activity and stability are able 
to degrade melanised feather. To confirm that the feathers were free from microbial 
contamination which may aid degradation, the wash effluent was plated on nutrient agar 
plate and lacked microbial growth. To investigate the feather degrading ability of 
keratinase, melanised feathers was incubated with crude keratinase extract. The feathers 
were completely disintegrated and the mean feather weight was reduced from 52 ± 2 mg to 
10 ± 3 mg in 48 h (Fig. 3.18). Feather incubated with distilled water only (negative 
control) showed no visual sign of degradation and no change in dry weight of feather. In 
contrast, denatured crude keratinase reduced the dry weight of the feather from 52 ± 2 mg 
to 46 ± 3 mg.   
(A) 
   
                                     a                    b                        a                   b 
                                              0 h                                           48 h 
 
 
(B) 
  
                                        a                   b                      a                  b 
                                             0 h                                            48 h 
Fig. 3.18: Degradation of melanised feather by crude keratinase showing the state of feather at 0 
and 48 h. In photographs labelled (A), the feathers in test tubes ‘a’ and ‘b’ were incubated in 10 ml 
of distilled water and dilute crude keratinase (2 ml in 8 ml of distilled water) respectively. In 
photographs labelled (B), the feathers in test tubes ‘a’  and ‘b’ were incubated in 10 ml of 
denatured crude keratinase (boiled for 30 min) and undiluted crude keratinase respectively.  
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3.2.3  Optimisation of western blot 
Optimisation of western blot enables determination of procedural conditions and suitable 
materials such as membrane blocking buffer and membrane blocking duration that will 
produce and/or prevent cross-reactions, non-specific binding and unnecessarily long 
blocking duration. Keratinase (EF) cross-reacted with secondary antibody (anti-mouse IgG 
from sheep) when keratinase-bound PVDF membrane was blocked with 5 % BSA. This is 
shown by the detection of the molecular weight band of keratinase (≈ 28 KDa) on Western 
blot (Fig. 3.19, Lane 2).  However, this cross-reaction was eliminated when 5 % skimmed 
milk was used as the blocking buffer (Fig. 3.19, Lane 1). The primary antibody (SAF83) 
did not cross react with EF. Furthermore, when the membrane blocking step was skipped 
altogether, no detectable background noise or non-specific binding was observed on the 
Western blot profile. 
                                                                                1          2 
 
Fig. 3.19: Immunoreactivity of keratinase with secondary antibody (anti-mouse IgG from sheep) 
was absent when keratinase bound PVDF membrane was blocked with skimmed milk (Lane 1). 
Blocking with BSA resulted in immunoreaction indicated by the band at ≈ 28 KDa which is the 
molecular weight of keratinase. 
3.2.4 Degradation of prion protein 
PK completely degrades PrPC and partially degrades PrPSc. To determine the prion 
degrading efficacy of keratinase (EF), PrPC and PrPSc were digested with EF. 
3.2.4.1  Degradation of normal prion protein (PrPC)  
To determine the ability of EF to degrade PrPC, normal brain homogenate (NBH) PrPC was 
digested with EF at 50 oC for 1 h. PrPC was completely degraded to a level undetectable by 
Western Blot analysis (Fig.3.20). Similarly, PrPC was completely digested by PK but the 
sample that was not PK-digested (CNBH) remained undegraded (Fig.3.20).  
 
 
 
37 KDa 
25 KDa 
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                                                                                    1        2      3 
 
Fig. 3.20: PrPC of normal brain homogenate (1 %) was proteolysed by PK (final conc. = 77 µg/ml) 
(Lane 2) and EF (lane 3) to undetectable levels whereas the control experiment remained intact. 
Lane 1 is undigested normal brain homogenate (positive control). PrPC was probed with SAF83 
mAb.  
3.2.4.2 Degradation of scrapie prion 
To examine the degradation of ME7 scrapie by keratinase, and to determine the keratinase 
purification fraction with the most prion-degrading activity, ME7 scrapie prion infected 
brain homogenate (1 %) was digested with crude keratinase extract (S), concentrated crude 
keratinase (CS) and PSC, BF and EF (fractions from the keratinase purification procedure 
[section 2.9.1]) and PK at 50 oC for 2 h. Western blot profile (fig. 3.21) show the order of 
increasing effectiveness for scrapie degradation as: S, CS, PSC, BF and EF.  EF (purified 
keratinase) digested scrapie prion to levels of PrPSc undetectable by Western blot (Lane 8). 
PrPres remained after digestion with PK and the PrP signal of undigested scrapie positive 
control sample (CIBH) (Lane 1) remained fully detectable.   
                                                                 1      2     3       4      5        6      7     8 
 
 
Fig. 3.21: Lane 1 is neat ME7 scrapie BH (positive control) and lane 2 is empty (negative control). 
Lane 3 is PK treated sample (final PK conc. = 77 µg/ml). Lanes 4 and 5 are samples digested with 
crude keratinase(S) and concentrated crude keratinase (CS) respectively. The fractions PSC, BF 
and EF (Lanes 5, 6 and 7 respectively) are described in the step-wise purification model. Digestion 
was carried out at 50 oC for 2 h. PrPSc was probed with SAF83 mAb.  
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3.2.4.3 Optimisation of degradation conditions 
To further improve degradation of ME7 scrapie prion by keratinase, a biosurfactant (BS) 
was included in the reaction mixture and the digestion temperature, incubation time and 
enzyme concentration investigated to determine the optimum conditions for degrading 
ME7 scrapie with EF. ME7 scrapie digested with EF+BS enzymatic composition (1 µl 
each) at 50 oC for 1 h resulted in the significant degradation of PrPSc relative to the other 
fractions, but trace levels of PrPSc signal remained detectable (Fig. 3.22; Lane 7). However, 
increasing the digestion time 2 h, EF+BS digested ME7 scrapie to undetectable levels (Fig. 
3.23; Lane 3). 
  
                                                             1      2         3         4         5         6         7 
 
 
Fig. 3.22: Lane 1 is neat ME7 brain homogenate (positive control). Lane 2 is proteinase K (PK) 
treated sample (final PK conc. = 10 µg/ml). Lanes 3 and 4 are ME7 brain homogenate digested 
with crude keratinase (S) and concentrated crude keratinase (CS) respectively. Lanes 6, 7 and 8 are 
digests with keratinase fractions PSC, BF and EF respectively. EF+BS digestion showed the most 
PrPSc signal removal. Digestion was carried out at 50 oC for 1h and PrPSc was probed with SAF83 
mAb.  
 
              1      2       3 
 
 
Fig. 3.23: Lane 1 is ME7 brain homogenate (positive control) and lane 2 is proteinase K treated 
sample (final PK conc. = 10 µg/ml). Lane 3 is sample digested with EF+BS composition EF: BS 
(1:1). Samples were digested at 50 oC for 2 h. PrPSc was probed with SAF83 mAb.   
 
By increasing the incubation temperature to 65 oC, EF+BS digested ME7 scrapie brain 
homogenate (10 µl) in 1 h to undetectable level of PrPSc (Fig. 3.24). Under these 
conditions, EF alone was unable to completely degrade ME7 scrapie, resulting in typical 
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PrPSc glycosylation bands (Fig. 3.24; Lane 5).  BS alone showed no discernible activity 
towards PrPsc degradation (Fig. 3.24; Lane 4). 
 
                                                                          1       2       3        4        5 
 
Fig. 3.24: Lane 1 is neat ME7 brain homogenate (positive control). ME7 scrapie infected brain 
homogenate digested at 65 oC for 1 h with PK (100 µg/ml), EF+BS composition, BS and EF (Lanes 
2, 3, 4, and 5 respectively). Total removal of PrPSc signal was achieved with EF+BS but not with 
EF and BS working individually. PrPSc was probed with SAF83 mAb.   
 
Furthermore, digestion of scrapie prion with the enzymatic composition (EF+BS) at 50 oC 
over a time-course of 30, 45, 60, 90, and 120 min, resulted in the gradual reduction of 
detectable PrPSc signal intensity over time (Fig. 3.25), with barely detectable levels at 120 
min (Fig. 3.25; Lane 7). The diglycosylated (upper) band showed greater resistant to PrPSc 
degradation over the digestion period. Further optimisation showed a remarkably complete 
degradation of PrPSc to undetectable levels in 10 min (Fig. 3.26). PK also demonstrated a 
higher PrPSc digestion at 65 oC more than at 50 oC as shown by the PrPSc signal intensity in 
the lane with PK digested sample.  
                                                               1         2        3        4        5         6       7 
 
Fig. 3.25: Lane 1 is neat ME7 brain homogenate (positive control) and lane 2 is proteinase K 
treated sample (77 µg/ml final PK conc.). Lanes 3-7 are digested with EF +BS at 30-120 min 
respectively. Samples were digested at 50 oC with EF: BS ratio of 1:2. PrPSc was probed with 
SAF83 mAb. 
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                                                                         1        2       3     4    5     6 
 
Fig. 3.26: Lane 1 is neat ME7 brain homogenate (positive control) and lane 2 is proteinase K 
digested sample (77 µg/ml final PK conc.). Lanes 3-6 are digested with EF+BS at 10, 30, 45 and 60 
min. Samples were digested at 65 oC and PrPSc was probed with SAF83 mAb. 
Normal brain homogenate (NBH) was completely digested by PK at concentrations of 10, 
50 and 100 µg/ml (Fig. 3.27).  ME7 scrapie brain homogenate (IBH) digested with similar 
concentrations of PK remain highly resistant to degradation, having only a slight band shift 
compared to the control and a marginal change in PrPSc intensity over the PK 
concentrations 10-100 µg/ml (Fig. 3.27). Samples digested with the enzymatic composition 
(EF+BS)  at 1:50, 1:100 and 1:200 dilutions of the EF composite resulted in complete or 
nearly complete loss of PrPSc signal in order of increasing dilution (Fig. 3.27) which 
suggests a correlation between loss of PrPSc signal and concentration of EF.  
                                             CNBH  CIBH 
                1      2    3      4        5       6      7      8      9     10     11    12 
 
Fig. 3.27: Normal (CNBH) and infected (CIBH) brain homogenates digested at 65 oC for 1h with 
10, 50 and 100 µg/ml of proteinase K (lanes 2, 3, 4 and lanes 6, 7, 8 respectively), and EF+BS 
composition with 1:50, 1:100 and 1:200 dilutions of EF  (lanes 9, 10, 11, 12) probed with SAF83 
monoclonal antibody. Lanes 1 and 5 are undigested NBH and IBH respectively.  
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3.2.4.4  Immunodetection with various monoclonal antibodies (mAbs) 
To determine the monoclonal antibody (mAb) with high affinity for ME7 scrapie PrPSc and 
to ensure that no linear epitopes were missed out during immunodetection, enzyme 
digested ME7 scrapie PrPSc was immunodeteced with various antibodies: SAF83, 98A3, 
12B2, 9A2 and 6C2 (Section 2.12.1.2). Western blot (Fig. 3.28) show that SAF83 and 9A2 
significantly detected PrPSc with high affinity, and mAbs 98A3 and 12B2 detected PrPSc 
slightly but not at all by 6C2. Residual PrPSc was not detected in EF+BS-digested materials 
probed with the various antibodies (Fig. 3.28). 
                                                 1        2         3      4          5      6        7      8         9     10 
      
Fig. 3.28: ME7 scrapie prion digested with EF+BS at 65 oC for 1 h and PrPSc probed with SAF83, 
98A3, 9A2 and 6C2. Lanes 1 and 2, 3 and 4, 5 and 6, 7 and 8, and 9 and 10 were probed with 
SAF83, 98A3, 9A2 and 6C2 respectively Lanes 1, 3, 5, 7 and 9 are the corresponding positive 
controls. 
3.3 Residual infectivity evaluation of keratinase-digested scrapie prions 
3.3.1  Scrapie cell assay 
To investigate the efficacy of the enzymatic composition, EF+BS, to completely destroy 
prion infectivity, and to confirm if the complete loss of PrPSc signal as detected by Western 
blot correlated loss prion infectivity, SSBP/1 susceptible Rov9 cells were inoculated with 
enzyme-digested SSBP/1 scrapie and analysed for residual infectivity. SSBP/1 was used 
for the scrapie cell assay as ME7 scrapie is not susceptible to Rov9 cells and no ME7 
susceptible cells were available. ME7 and SSBP/1 (along with other scrapie strains) were 
similarly degraded to undetectable levels by EF+BS as determined by Western Blotting 
(appendix 4), hence their degradation by EF+BS were considered to be comparable. 
Immunodetection of infected Rov9 cells by ELISPOT assay confirmed that Rov9 cells 
propagated SSBP/1 scrapie prion but Rov9 cells inoculated with EF and EF+BS digested 
SSBP/1 scrapie did not propagate infectivity as shown by the absence of infected cells 
(detectable spots) in the ELISPOT assay (Fig. 3.29).  
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The number of infected cells (spots detected) per 5000 cells (in each well as confirmed by 
trypan blue assay) were significantly lower for both the EF and EF+BS treatment groups 
compared to the incubated IBH group (p = 0.009, Two-Sample T-Test; Fig. 3.30). 
Similarly, a significantly lower number of cells were infected in the BS treatment group 
compared to the incubated IBH group (p = 0.033, Two-Sample T-Test; Fig. 3.30) for BS 
treatment group, but was significant to propagate infection in Rov9 cells. Furthermore, 
SSBP/1 infectivity was significantly reduced by incubation at 65 oC as determined by the 
spots detected for incubated IBH compared to IBH (p = 0.044, Two-Sample T-Test; Fig. 
3.30). All experiments were repeated in quadruplet and the number of positive cells (spots) 
were counted using Zeiss KS-ELISPOT imaging system running Wellscan software.   
 
                                                 Incubated 
                                      IBH         IBH          EF           BS        EF+BS 
 
 
Fig. 3.29: Photograph of ELISPOT plate acquired with Zeiss KS-ELISPOT imaging system 
showing infected Rov9 cells in wells inoculated with IBH (SSBP/1), incubated IBH (heat treated 
SSBP/1) and BS (Biosurfactant digested SSBP/1). Wells inoculated with SSBP/1 digested with EF 
and EF+BS were completely devoid of infected cells. PrPSc was probed with sha31 mAb. 
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Fig. 3.30: Number of infected cells (spots) detected by Zeiss KS-ELISPOT imaging system for the 
different treatment groups; IBH (inoculated with neat SSBP/1), Incubated IBH (inoculated with 
SSBP/1 that was incubated at the digestion temperature), EF (inoculated with keratinase, EF), BS 
(inoculated with biosurfactant, BS) and EF+BS (inoculated with enzymatic composition, EF+BS). 
The number of infected cells were significantly reduced for EF (p = 0.009), BS (p = 0.033) and 
EF+BS (p = 0.009) treatment groups compared to Incubated IBH. Test of significance was 
calculated using Two-Sample T-Test. Each bar represents mean ± SD (n = 4, each data point).   
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3.3.2  Mouse bioassay 
In order to investigate whether the loss of PrPSc signal seen in in vitro Western blot was 
accompanied by a corresponding loss in prion infectivity, in vivo mouse bioassay was 
performed. The result of the bioasay is summarised in Table 3.5. Brain samples of 
culled/dead mice were homogenised in sterile PBS and analysed for residual PrPSc by 
Western blotting after PK digestion. The electrophoretic profiles are presented in appendix 
1.  
Table 3.5: Summary of mouse bioassay showing the different treatment groups (treated and control 
groups) and the number of mice challenged, number found dead/culled, number with detectable 
PrPSc, survival time range and mean survival time for PrPSc positive mice.  
Treatment  
Group 
Individual 
Survival Times  
(days) a 
PrPSc in 
Brain 
Incidence c 
(% Incidence) 
d
 Mean Survival 
Time (days ± SD) or 
(Survival Range) 
NBH (Digested) 
(-ve control) 
384, 496 
 
No 
 
0/2  
(0 %) 
ND 
 
IBH (Neat) 
+ve control) 
275, 275, 275, 269, 
276, 283, 296 
Yes 
 
7/7  
(100 %) 
278 ± 9  
(269 - 380) 
IBH (1:10 dilution) 
(+ve control) 
204, 217, 259, 303, 
321 
Yes 
 
5/5 
 (100 %) 
261 ± 52 
(204 - 321) 
 
IBH (1:100 dilution) 
(+ve control) 
328, 334, 334, 336, 
340, 343, 345, 369 
Yes 
 
8/8  
(100 %) 
341 ± 13 
(328 - 369) 
IBH (1:1000 dilution) 
(+ve control) 
> 550 ND b 
 
ND  ND 
IBH (Digested) 
 
181, 186, 191, 191, 
233, 233, 243 
296, 299, 321, 325, 
327, 332, 342, 431  
No 
 
 
Yes 
 
 
8/15  
(53 %) 
 
 
 
334 ± 42 
(296 - 431)  
 
a Only mice that were culled or found dead at ≤ 550 days were included in the analysis. 
b
 Animals survived longer than 550 days and their PrPSc status not determined (ND)  
c Incidence = number of animals affected/number of animals tested. 
d
 Only mice that were PrPSc positive were included in the survival time and range. 
  
Three (3) mice (60 %), 4 mice (44 %), 5 mice (38 %) and 6 mice (100 %) in the NBH 
digested, IBH 1:10, 1:100 and 1:1000 dilutions treatment groups respectively, survived 
beyond the termination of the experiment 550 days (see appendix 2). All the surviving 
mice were not tested for the presence of PrPSc in their brains and were not included in the 
survival time analysis to allow for direct comparison with IBH Neat (positive control) 
group. Similarly, all PrPSc negative culled/dead mice were not included in the analysis. The 
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Western blot analysis of dead/culled mice brain homogenates from the positive control 
groups (IBH Neat, IBH 1:10 and 1:100 dilutions of inocula) showed that all the mice tested 
positive for PrPSc (100 % disease incidence) whereas no PrPSc were found in those of the 
NBH digested group (negative control). Eight (8) mice were PrPSc positive in the IBH-
digested group (53 % disease incidence) with survival time post-inoculation ≥ 296 days 
(mean survival time = 334 ± 42 days), whereas all seven mice (47 % of inoculated mice in 
this group) that tested PrPSc negative had a survival time ≤ 243 days (mean survival time = 
208 ± 27 days) post-inoculation. A significant difference existed between the two sub-
populations in the IBH-digested group (p = 0.000, Two-Sample T-Test). There was a 
significant difference in the incubation times for the PrPSc negative mice in the IBH-
digested group compared to mice in the IBH neat (positive control) group (p = 0.000, Two-
Sample T-Test). The mean survival times for IBH (neat), 1:10 dilution, 1:100 dilutions and 
IBH (digested) groups were 278 ± 9, 261 ± 51, 341 ± 13, and 334 ± 42 days respectively. 
Significant difference in survival times existed for the treatment groups (p = 0.000, One-
way ANOVA). Furthermore, a significant increase in survival time (p = 0.008, Two-
Sample T-Test) was found between IBH (digested) group and IBH neat group (positive 
control). 
Boxplot of the survival times for the treatment groups showing the individual and mean 
survival times for each treatment group is presented in Fig. 3.31.  
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Fig. 3.31: Boxplot showing the survival times of infected (PrPSc positive) mice in the different 
treatment groups: IBH Neat, IBH 1:10 dilution, IBH 1:100 dilution and IBH digested. Survival 
times for individual mice are represented by the circles and circle with black fill is the mean 
survival times linked by the mean connect line. 
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3.3.2.1 PrPC expression in wild type and Tga20 mice used in bioassay  
Due to the long and dispersed survival times within and between the treatment groups of 
the bioassay (appendix 2), the levels of PrPC of the Tga20 test mice were compared with 
wild-type Charles River C57BL/6 mice as analysed by Western Blotting. The 
electrophoretic profile (Fig. 3.32) showed variable levels of PrPC in the Tga20 brain 
homogenate sample (265, 271, 291 and 281), and were generally comparable to the wild-
type mice.  
 
Fig. 3.32: Test of PrPC levels in brain homogenates samples of Charles River C57BL/6 wild type 
mice and the Tga20 mice used for the bioassay. 1, 2 and 3 were undiluted, 1/3 dilutions and 1/9 
dilutions respectively. WT were Charles River C57BL/6 and 265, 271, 291 and 281 were Tga20 
mice samples. PrPC was probed with SAF83 mAb.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    β -actin → 
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Chapter 4: Discussion 
4.1 Research overview 
Prions, the agent implicated in transmissible spongiform encephalopathies or prion 
diseases, are highly resistant to degradation by conventional sterilisation and inactivation 
method. Physical and chemical methods such as incineration and alkaline hydrolysis 
known to degrade prions are not compatible for use in many applications such as those that 
will require recovery of contaminated materials and those that are destroyed by corrosion. 
To overcome these limitations, enzymatic methods for prion degradation have become 
increasingly important.  
 
In this study, the enzymatic degradation of pathogenic prion protein by keratinase 
producing microorganisms was investigated. Microorganisms were isolated from farmyard 
wastes and primary effluent known to be rich sources of microorganisms and extracellular 
proteases (Semple et al, 2001; Torks et al, 2010). Prions are structurally similar to feather 
keratins in terms of their high β-sheet composition, which accords them with mechanical 
stability, insolubility and resistance to degradation by most proteases. Because some 
microorganisms are able to degrade feathers, feather meal agar was used for isolation of 
potential prion degrading bacteria. The isolates were further tested for proteolytic activity 
using casein-agar assays for the reason that casein is a highly stable substrate degraded 
only by proteases of high enzymatic activity. Furthermore, definitive test of keratinolytic 
activity was performed by keratinase assay using keratin azure as substrate. The keratinase 
assay was standardised and validated as a reliable test of keratinolysis. A highly proteolytic 
bacterium, designated Bacillus licheniformis N22, was identified and characterised, and the 
optimum temperature, pH and substrate concentration conditions for fermentation 
production of keratinase determined. Crude keratinase extract was recovered, purified and 
characterised by SDS-PAGE and MALDI-TOF MS to determine the molecular weight, 
purity and peptide mass fingerprint of the keratinase. The thermal stability and effects of 
chemical agents on the keratinase activity were also determined.  The N22 keratinase was 
further evaluated for keratinolytic ability on melanised feather; the melanin of which 
confers higher resistance to degradation by keratinases compared to white feathers, and 
coupled with the β-sheet content of feather keratin, makes it a suitable substrate for testing 
potential prion-degrading keratinases.  N22 keratinase completely degraded melanised 
feather and also degraded ME7 scrapie to levels undetectable by Western Blot analysis. 
Biosurfactant produced from Pseudomonas aeruginosa NCIMB 8626 was used to enhance 
degradation of scrapie prion. Test of residual infectivity by standard scrapie cell assay 
confirmed that complete loss of PrPSc signal in the Western Blot analysis was related to 
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loss of prion infectivity, although the result of mouse bioassay was not definitive. Overall, 
the results discussed in the following sections suggest that the experimental strategy has 
been successful in achieving the central aim of this research. 
 
4.2 Isolation and characterisation of proteolytic microorganisms, 
keratinase and biosurfactant 
4.2.1 Screening methods for proteolytic microorganisms 
The casein-agar assays are useful preliminary methods for detection of proteolysis, and are 
efficient, cost and labour effective for rapid and bulk screening as well as characterisation 
of proteolytic microorganisms and their proteases (Brandelli and Riffel, 2005, Joshi et al, 
2007; Lin et al, 1992; Olaguyigbe and Ajele, 2005). Casein is a highly stable, hydrophobic 
and an extremely slow-digesting non-fibrous protein, which is not coagulated or easily 
denatured by heat but is hydrolysed by certain proteases of high proteolytic activity 
(Fujiwara et al, 1993; Takami et al, 1992; Cheng et al, 1995). This characteristic was used 
in this study as a criterion for screening proteolytic microorganisms that are able to 
hydrolyse casein and similar structurally stable substrates such as keratins (Fig. 3.1). The 
formation of casein hydrolysis ring on casein-agar plates characterised proteolysis and was 
used for identifying proteolytic microorganisms. The size of the casein hydrolysis rings 
was used to compare proteolytic activity. A correlation of hydrolysis ring size and protease 
concentration was demonstrated (Fig. 3.2), which establishes the hydrolysis ring assay as a 
semi-quantitative method for measuring proteolytic activities and comparing proteolytic 
microorganisms. In addition to identifying proteolytic activity, the spot inoculation method 
was used for microbial characterisation in the determination of optimum temperature 
condition for cell growth and protease synthesis (Fig. 3.7). The hydrolysis ring assay 
enables the characterisation of extracellularly synthesised protease extracts, and the 
screening of purification fractions for proteolytic activity. However, since not all proteases 
are likely to be keratinolytic, evaluation of keratinolytic activity and identification of 
potential keratinase producers was performed with keratinase assay, which ideally utilises 
keratin azure as substrate and hence is highly specific for determination of keratinase 
activity.  
Comparing keratinase activity of the same or different keratinase producing microorganism 
within and across laboratories has been rendered impossible by variable assays for 
evaluating keratinase activity. The need for a standard assay that will enable quantitative 
comparison of keratinase activity has been previously suggested (Scott and Untereiner, 
2004; Gradisar et al, 2005), but until now no attempts have been made to address this 
problem. A reproducible and reliable keratinase activity measurement depends on a 
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number of critical factors such as homogeneity of test substrate and consistency of assay 
procedure.  The commonly used assay for keratinase activity measurement (keratinase 
assay) uses keratin azure (a blue fibrous compound made by impregnating sheep wool 
keratin with azure dye) as substrate (Apodaca and McKerrow, 1990; Letourneau et al, 
1997; Tadeusz, 1999; Bressollier et al, 1999; Scott and Untereiner, 2004; Esawy, 2007; 
Tapia and Simoes, 2008).  
Keratin azure is considered as a suitable substrate for keratinase assay because the intensity 
of azure-bound amino acids or peptides released into solution by proteolytic cleavage of 
keratin bonds is easily measured by spectrophotometry. It is highly resistant to 
denaturation and degradation by common proteases, but more specifically degraded by 
keratinases. However, it has been reported for the first time in this study that the dye 
distribution of commercial keratin azure (K8500) substrate is heterogeneous, resulting in 
inconsistent, irreproducible and unreliable measurements between sample replicates. This 
is evidenced by variable release of azure dye into reaction mixture as measured by 
spectrophotometry. In order to address this problem, commercial keratin azure was 
standardised prior to use in keratinase assay by picking out solid azure particles, and 
incubating and washing with distilled water. This procedure removed loosely-bound azure 
dye and dye particles adhering to the keratin fibres such that the resulting keratin azure 
became homogenous (Table 3.1). Thus, the dye released into the reaction mixture during 
keratinase assay was entirely as a consequence of keratin azure hydrolysis.  
Standardisation of commercial keratin azure to yield a homogeneous substrate (Table 3.1) 
enabled reliable comparison of keratinase activity and grading of keratinases according to 
their keratin degrading ability. As a model keratinaceous substrate, standardised keratin 
azure is important for assessing potential applications of keratinases for feather waste and 
hides processing and prion degradation. It will also enable comparison of keratinases in a 
more consistent manner across laboratories unlike the current practice of using 
heterogeneous keratin azure or different substrates types such as chicken feather (Anbu et 
al, 2007), azo-keratin (Lin et al, 1992) and keratin powder made from human sole 
(Gradisar et al, 2005). 
The procedure for keratinase assay is simple, reliable and reproducible, and hence, can be 
used as the standard assay for keratinase activity measurement. However, in order to 
achieve the optimum activity for specific keratinases, their optimum reaction conditions 
are required. In this study, the keratinase assay was carried out at 50 °C and pH 8.5 for 1 h, 
which were adequate to catalyse keratinase reaction and to achieve optimum activity. 
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Under these conditions, the standardised keratin azure was generally stable such that azure 
dye released into the reaction mixture was solely as a result of keratinase activity.  The 
optimum pH condition, for instance, was typical for most keratinases (approximately pH 8- 
8.5), which appears to be quite robust for the evaluation of the keratinase activity 
(Letourneau et al, 1998; Bressollier et al, 1999; Riffel and Brandelli, 2006; Gradisar et al, 
2005).  
4.2.2 Screening and selection of working isolate 
Since the first report on the isolation of extracellular alkaline serine protease from Bacillus 
sp strain 221 (Horikoshi, 1971), the quest for industrially relevant proteases from different 
environmental sources has not relented.  In the same vein, the central aim of this study was 
to isolate keratinase producing microorganisms of prion degrading ability from 
environmental sources such as farmyard wastes (e.g. chicken wastes) which is known to be 
a rich source of keratin degrading microbial populations (Tork et al, 2010), and sewage 
effluent which is an important source of extracellular proteases (Semple et al, 2001; 
Drouin et al, 2008). Since feather degrading microorganisms utilises feather keratin as a 
source of carbon and energy for growth and survival, potential keratin degrading 
microorganisms could be isolated on feather meal agar as have been previously reported 
(Brandelli and Riffel, 2005; Tapia and Simoes, 2008). A total of thirty-two microbial 
isolates were selected and differentiated based on their ability to grow on feather meal agar 
and their distinctive characteristic features. These isolates were screened for proteolytic 
and keratinolytic activity by the casein-agar plate assays and keratinase assay respectively. 
One isolate identified as isolate number 22 demonstrated the highest keratinase activity 
(Fig. 3.3) and was selected for further study.  
Evaluation of the microbial isolates for potential prion degrading activity was performed 
using the proteinase K calibration curve which was established in this study to compare 
keratinases with PK for prion degrading potentials. The proteinase K calibration curve was 
plotted based on PK activity on keratin azure substrate (Fig. 3.4). PK was selected as the 
active protease because it is a keratinolytic protease of broad specificity and is commonly 
used for prion digestion and characterisation (Prusiner et al, 1983; McKinley et al, 1983; 
Pastrana et al, 2006). Keratin azure is highly stable against common proteases, and is the 
primary substrate of PK.  Most importantly, keratins are structurally similar to prions in 
terms of their β-sheet content.  
PK concentration at 0.2 mg/ml has been reported to fully degrade prion under denaturing 
conditions (preheated at 115 oC) to levels undetectable by Western blot analysis 
(Langeveld et al, 2003). Therefore, a reference PK activity cut-off on the PK calibration 
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curve at PK concentration of 0.2 mg/ml was adopted as minimum criteria for selecting 
keratinases of significant prion degrading activity. Keratinases of activities equal to or 
greater than the reference PK activity cut-off were considered to be potentially prion 
degrading, at least under denaturing conditions. By this criterion, about 68 % of the 
selected strains were adjudged to be potentially prion degrading, suggesting that the 
screening and isolation strategy for selection of potential prion degrading keratinolytic 
isolates was successful.The isolate number 22, significantly exceeded the PK activity 
reference cut-off by 54 %, and was selected for further investigation. 
It is important to note that this criterion for selecting potentially useful prion degrading 
keratinases does not undermine the specificity and affinity of individual keratinases for 
prion degradation or their interactions in the presence of other agents. For example, it has 
been reported that the total proteolytic activity of an organism does not necessarily 
correlate with its ability to degrade PrPSc (Muller-Hellwig et al, 2006), which suggests that 
specific proteases are required for PrPSc degradation, although proteases of high proteolytic 
activity are potentially more likely to degrade PrPSc more efficiently. Therefore, 
confirmation of prion degrading ability is best carried out by degrading actual prion 
substrate. Furthermore, the PK calibration curve method for selecting potential prion 
degrading microorganisms provides an important start-off point, and has indeed proven to 
be useful in this study. 
4.2.3 Identification and characterisation of isolate 
The selected isolate number 22 was identified and designated Bacillus licheniformis N22 
strain (section 3.1.5) and was deposited with the National Collection of Industrial Food and 
Marine Bacteria (NCIMB) with designated ascension number NCIMB 41708. Bacillus 
licheniformis N22 is a gram-positive, endospore-forming, mostly alkalophilic, mildly 
thermophilic and halotolerant bacterium (Table 3.1). This bacterium gave very strong 
catalase reaction as similarly reported for Bacillus licheniformis PWD-1 (William et al, 
1990). Such strong catalase reaction suggests high levels of the membrane protein 
cytochrome oxidase which is important in pH homeostasis, and ensures the organism’s 
survival over wide range of pH environments. The growth response at 50 oC was faster 
than growth at 37 oC, reaching visible growth on nutrient agar 4 h earlier than at 37 oC. 
Bacillus licheniformis N22 grows aerobically and at moderate temperature (37-60 oC) and 
pH (6-10) conditions. Hence it is attractive from the technological and practical point of 
view for the production of N22 keratinase and biotechnological applications in general. 
The MALDI TOF-MS microbial mass spectrum acquired for Bacillus licheniformis N22 
(Fig. 3.6) differed from those previously reported for other Bacillus species (Pusch and 
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Kostrzewa, 2006) and hence contributes to the developing database of this fast, robust and 
reliable microbial identification method. These microbial mass peaks found within the 
mass range of 2000-20000 Daltons represent mainly ribosomal proteins (Suh et al, 2005; 
Maier and Kostrzewa, 2007), and are sufficient to distinguish microbial strains (Pusch and 
Kostrzewa, 2006).  
The prolific keratinase producing potential of Bacillus licheniformis N22 is characteristic 
of most Bacillus licheniformis species (Kitada et al, 1987; William et al, 1990; Manczinger 
et al, 2003).  Bacillus licheniformis N22 differs from the other well characterised 
keratinase producing Bacillus such as Bacillus licheniformis PWD-1 (William et al, 1990) 
and Bacillus sp PW (Joshi et al, 2007). For example, Bacillus licheniformis PWD-1 
produces acid from lactose but Bacillus licheniformis N22 does not, while Bacillus sp PW 
produces both acid and gas. These characteristics may represent important differences in 
their molecular constitution. 
4.2.4 Optimisation of keratinase production 
The interplay of various factors such as temperature, pH, substrate concentration, the 
nature and composition of carbon and nitrogen sources and the condition of inoculants, 
influences cell growth and survival, and the levels of protease synthesis and secretion in a 
microbial culture (Singh et al, 1975; North, 1982). Optimisation of these factors results in 
optimum conditions of microbial growth and synthesis of bioproducts. The optimum 
condition for the fermentation production of N22 keratinase was achieved at substrate 
concentration of 1.1 %, pH 8.5 and 50 oC over a fermentation time of 32 h. The strongest 
limiting effect on keratinase synthesis was induced by low pH condition (pH≤4), followed 
by high temperature (≥63 oC) condition.  
The final pH of the fermentation culture as measured at the end of incubation time (32 h) 
was pH 8.3 irrespective of initial culture pH conditions (pH 6-12) (Fig. 3.9). A similar shift 
in pH from 7 to 8.5 has been reported for Bacillus licheniformis PWD-1 (William et al, 
1990). The microbial cell interactions in the Bacillus licheniformis N22 fermentation 
culture resulting in a buffering effect and the culture pH tending toward pH 8.3 suggests at 
least two possible metabolic pathways depending on the prevailing culture condition. One 
pathway which is able to synthesise metabolic products that tend to up-regulate (acidic 
product) the culture pH, and the other which is able to synthesis metabolic products that 
down-regulate (alkaline products) the culture pH. A decreased culture pH during 
cultivation of Bacillus species has been attributed to the production of organic acids 
(Paavilainen et al, 1995). Formic acid has been reported to stabilise β-sheet structure 
(Aluigi et al, 2007). Considering that the feather meal substrate consists of keratin of high 
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β-sheet content, it is possible that destabilisation of β-sheet structure of feather keratin 
substrate results in the release of formic acid into the culture medium thereby increasing 
acidity. On the other hand, increased pH in fermentation cultures have been associated 
with the mechanism of microbial utilisation of protein substrates such as has been 
described for Chryseobacterium sp. Kr6 in feather meal culture (Riffel and Brandelli, 
2006), and Bacillus pumilus grown in bovine hair culture (Kumar et al, 2008). Also, 
production of ammonia caused by the deamination peptides and amino acids during the 
degradation of keratin has been reported to increase culture pH (Kumar et al, 2008). 
Increases in fermentation culture pH have also been related to some level of keratinolytic 
activity (Kunert, 2000; Kaul and Sumbali, 1997). In general, one can argue that the 
regulatory mechanism that enables Bacillus licheniformis N22 to strive at both alkaline and 
slightly acidic environment suggests wide utilitarian potential capacity for this bacterium. 
The buffering pH level measured in the Bacillus licheniformis N22 fermentation culture 
medium closely mimics the optimal pH for keratinase synthesis which could suggest that 
setting the initial fermentation culture at the optimum pH would avert possible energy 
dissipation in establishing a physiological balance for a suitable culture environment for 
optimum production of keratinase. The pH kinetic plot (Fig. 3.9) developed during this 
study clearly defined the pH threshold for fermentation culture, identified the optimum pH 
level and the extreme pH conditions. For Bacillus licheniformis N22, the extreme pH 
conditions (pH < 5 or >12) were intolerable and hindered cell growth, survival and 
keratinase production (Fig. 3.8). Extreme pH affects cell physiology as it tries to achieve 
pH homeostasis and survival resulting in poor enzyme production (Kitada et al, 1987). The 
results of pH and temperature characterisation for Bacillus licheniformis N22 as 
determined by both casein-agar (Fig. 3.7) and keratinase assays (Fig. 3.8) were within  the 
range of optimum conditions reported for some other keratinase producing microorganisms 
such as Bacillus licheniformis PWD-1 (pH 7- 8.5, 37 oC; Wang and Shih, 1999), Bacillus 
licheniformis K-508 (pH 7, 47 oC; Manczinger et al, 2003), Streptomyces (pH 8, 40 oC; 
Tapia and Simoes, 2008), Bacillus species (pH 8, 60 oC; Olajuyigbe, and Ajele, 2005) and 
Streptomyces strain BA7 (pH 8.5, 50 oC; Korkmaz et al, 2003).  
Keratin substrates such as feather meal and chicken feather induces keratinase production 
(Wang and Shih, 1999; Brandelli and Riffel, 2005; Thys et al, 2006; Letourneau et al, 
1998; Chao et al, 2007; Anbu et al, 2007). Similarly, feather meal substrate induced 
keratinase synthesis by Bacillus licheniformis N22 resulting in 68 % increase in keratinase 
production compared to culture grown in nutrient broth medium. Generally, the optimum 
keratinase production was achieved at feather meal substrate concentration of 1.1 % for 
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various conditions of pH and temperature (Fig. 3.10) except for culture growing at pH 7 
and 37 oC. Increasing the substrate concentration to 1.4 % resulted in reduced levels of 
keratinase production similar to previously reported repression of keratinase production at 
high substrate concentrations (Wang and Shih, 1999; Joo et al, 2002; Riffel et al, 2003a; 
Brandelli and Riffel, 2005; Cai et al, 2008; Lin and Yin, 2010). Growth substrates 
constitutes around 30-40 % of total production cost of enzymes (Kumar and Parrack, 
2003). Therefore, the use of low cost and readily available keratin substrates such as 
feather meal or chicken feather will enable production of N22 keratinase at industrially 
relevant scale. Currently, billions of tonnes of chicken feather waste is produced annually 
(American Chemical Society, 2011), making it a potentially important raw material. In 
addition, the use of feather waste as growth substrates for keratinase production will 
invariably serve as an efficient way to manage the large amount of feather wastes produced 
in the poultry industry. 
 Crude keratinase extract of Bacillus licheniformis N22 expressed 58 % more activity on 
keratin azure substrate compared to the well characterised and industrially useful 
keratinase of Bacillus licheniformis PWD-1 (section 3.1.4). Recently, it was reported that 
Bacillus sp PW keratinase remarkably expressed 39 % more activity than Bacillus 
licheniformis PWD-1 (Joshi et al, 2007). Therefore, it can be argued that Bacillus 
licheniformis N22 keratinase has a relatively much higher keratinolytic activity than both 
keratinases.  
4.2.5 Purification and characterisation of keratinase 
The purification of N22 keratinase was performed by a step-wise feedback model (Fig. 
2.2) executed over three purification cycles using commercially available HiTrapTM Blue 
HP column in which the column material consisted of resin/dye ligand complex to which 
keratinase adsorbed either biospecifically or less specifically by electrostatic and/or 
hydrophobic interaction.  The step-wise feedback purification strategy enabled substantial 
recovery of purified keratinase over multiple purification cycles by reintroducing eluted 
excess crude extract into the column after each cycle, suggesting the possible abundance of 
active keratinase in the crude extract. The fractions eluted with the elution buffer (EF) 
herein referred to as the purified fraction were collected from each purification cycle and 
pooled. The EF fraction from the second purification cycle showed the highest specific 
activity and purification factor (Table 3.4) which suggests that the most active purified 
keratinase fraction was collected in this cycle. Therefore, EF fraction of the second cycle is 
most suitable for characterisation purposes.  
  
89 
The molecular weight of Bacillus licheniformis N22 keratinase was determined to be ≈ 28 
KDa by SDS-PAGE with 12 % gel (Fig. 3.13) and MALDI TOF-MS (Fig. 3.14). The 
single band and mass peak obtained by SDS-PAGE and MALDI TOF-MS respectively, 
indicates that the purified keratinase is homogeneous and monomeric (has no subunits). 
The obtained molecular weight of Bacillus licheniformis N22 keratinase is very close to 
that of Bacillus pseudofirmus FA30-10 (27.5 KDa; Kojima et al, 2006) but significantly 
different from that of Bacillus licheniformis PWD-1 (33 KDa; Lin et al, 1992). However, 
how the molecular weight of keratinases influences their functionality and activity, for 
instance in prion degradation, have not been described. It is interesting to note that 
proteinase K (28 KDa; Jany and Mayer, 1985), keratinase of Bacillus licheniformis PWD-1 
and keratinase of Bacillus licheniformis N22 shown to degrade prion protein are within the 
molecular weight of the protease-resistant prion (27-30 KDa). It has been suggested that 
the chemical structure of keratinases with molecular weight <35 KDa may consist of only 
catalytic domain (Kim et al, 2004), hence may be more catalytically active. 
Peptide mass fingerprint of trypsinised N22 keratinase (Fig. 3.15 A-C) was unmatched in 
Mascot search engine suggesting that this keratinase has not been previously characterised 
and documented. Therefore, the mass fingerprint provides useful reference information for 
comparison with other keratinases. Currently, there are no reports on the characterisation 
of keratinases by MALDI-TOF MS except for our earlier report on the determination of 
molecular weight of N22 keratinase (Okoroma et al, 2008) and recently the determination 
of molecular weight of Bacillus sp 50-3 keratinase by Zhang et al (2009).   
Bacillus licheniformis N22 keratinase was stable at 4 oC for up to 8 weeks (section 3.1.8) 
compared to Bacillus licheniformis PWD-1 keratinase reported to loss 22 % of its activity 
after 19 days when stored at 4 oC (Shih and William, 1992). Hence, Bacillus licheniformis 
N22 keratinase has a considerably longer shelf life. Keratinase of Streptomyces fradiae has 
also been reported to retain its activity for several weeks at 4 oC when stored at pH 7 but 
rapidly lost its activity at pH 8.5 (Nickerson and Noval, 1961). Therefore, temperature and 
pH are important physical factors that affect the activity and stability of keratinases. 
Typically, proteases of Bacillus licheniformis species are known to be highly stable and 
retain their activity in environments containing potentially inhibitory chemical agents 
(Veith et al, 2004), and are therefore quite robust for various applications. 
The chemical agents such as EDTA and Triton X-100 were found to enhance N22 
keratinase activity (Table 3.3) similar to observed effect on keratinase of Streptomyces 
BA7 (Korkmaz et al, 2003; Tapia and Simoes, 2008). The biochemical interaction of 
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different keratinases with chemical agents varies, and is used to classify keratinases 
(Giongo et al, 2008; Tatineni et al, 2008).  For example, while EDTA enhances keratinase 
N22, it has been reported to partially inhibit keratinases of Bacillus licheniformis HK-1 
(Rozs et al, 2001) and Streptomyces sp. S.K1-02 (Letourneau et al, 1998).  Interestingly, 
EDTA has been reported to enhance keratinolytic activity and at the same time inhibit 
proteolytic activity (Chao et al, 2007), suggesting that keratinolysis and proteolysis are 
different process and may indeed occur via different degradation pathways. The most 
significant enhancing effect on N22 keratinase activity was measured with DTT. On the 
contrary, SDS slightly inhibited N22 keratinase activity similar to some other keratinases 
(Korkmaz et al, 2003; Riffel et al, 2007; Tatineni et al, 2008; Tapia and Simoes, 2008). 
This suggests that SDS or similar chemical surfactants/detergents may inhibit keratinase 
activity in enzyme-surfactant/detergent formulations used for prion degradation, and hence 
it is necessary to determine their specific effects in such compositions.  
4.2.6 Biosurfactant as a suitable biological detergent 
The role of chemical surfactants/detergents in enhancing enzymatic prion degradation 
efficiency has been widely reported (Cho, 1983; Langeveld et al, 2003; Jackson et al, 
2005; Suzuki et al, 2006; Croud et al, 2008; Pilon et al, 2009). However, it has been 
suggested that for the enzymatic method of prion degradation to be effective and 
economically viable for potential large scale application, low cost biological (natural) 
alternative to chemical detergents are desirable, for instance, in the decontamination and/or 
derivation of animal protein from animal by-products (Langeveld et al, 2003). This 
important knowledge gap has been filled by the use of biosurfactants as natural additive in 
enzymatic degradation of prion herein reported. Biosurfactants are particularly useful and 
advantageous because of their environmentally friendly properties (e.g. low toxicity, high 
biodegradability) and their biochemical properties enabling lowering of surface tension and 
unfolding of prion structure, and hence subsequent keratinase access and prion scission. In 
addition, the property of biosurfactants in inhibiting pathogen adhesion and formation of 
biofilms on steel surfaces (Muthusamy et al, 2008; Brzozowski et al, 2011), therefore 
provides a double advantage for their use in decontamination of prion contaminated steel 
surfaces such as medical devices. The use of biological detergents also prevents 
undesirable chemical load in enzymatic degradation processes, especially in large scale 
applications, and hence forestall chemical effluent entering the environment, or the need 
for additional facilities for effluent treatment.  
The major limitations of use of biosurfactants in large scale applications include the low 
levels of production, and the high recovery and purification costs associated with 
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derivation of pure biosurfactants. Pseudomonas aeruginosa NCIMB 8626 crude 
biosurfactant was used in this study, providing substantial savings on cost and labour 
associated with purification regimes. This crude biosurfactants was stable and remained 
active for more than a year (section 3.1.9), which is beneficial in terms of laboratory time 
and cost savings in preparing fresh stocks. Crude biosurfactants may basically consist of 
protein, polyscaccharide and phosphate in different ratio (Brzozowski et al, 2011). The 
protein and rhamnose (polyscaccharide) concentrations of this crude biosurfactant 
preparation measured as BSA and rhamnose equivalents respectively (section 3.1.9). In a 
previous study, this biosurfactant was used to enhance the biodegradation of polycyclic 
aromatic hydrocarbon (Okoroma, 2006).  
4.3  Degradation of keratin substrates and scrapie prions by keratinase 
4.3.1 Degradation of keratin substrates 
Keratinases are able to disassemble the tightly packed structure of β-keratin, exposing 
cleavage sites to proteolytic attack and hydrolysis (Kim et al, 2004). Bacillus licheniformis 
N22 keratinase extensively degraded keratin azure substrate, releasing substantial amount 
of azure dye into the reaction solution (Fig. 3.17), suggesting that this keratinase is 
potentially able to degrade other highly stable keratineous substrate such as feather keratin 
and hair. To further investigate this, melanised feather was digested with N22 keratinase in 
a feather degradation experiment.  
Melanised feather was cleaned by washing with sterile distilled water in order to retain the 
keratin structure in its native state (Cortezi et al, 2008). Thus, the feathers used remained 
structurally uncompromised and free from microbial contamination (data not shown) 
which may aid degradation. Sterilisation by autoclaving denatures and degrades feather 
keratin making them lose their insolubility and resistance, hence become more susceptible 
to proteolytic attack (Suzuki et al, 2006; White et al, 1950; Gunderson et al, 2008). The 
feather substrates used in the feather degradation experiments were melanised (coloured) 
feathers.  Melanised feathers are generally more resistant to enzymatic attack than white 
feathers as a result of the pigment, melanin, which has been reported to bind and inactivate 
keratinases and help to protect feather degrading bacteria (Goldstein et al, 2004; 
Gunderson et al, 2008) and other proteases (Suh and Lee, 2001; Kuo and Alexander, 
1967). In addition, distal end (containing mainly barbs and barbules) of relatively mature 
melanised feather substrates were used instead of the proximal region where the rachis and 
calamus (see physical structure of feather: appendix 3) make up most of the mass 
(Gunderson et al, 2008). There are hardly any reports on the evaluation of keratinolytic 
activity using melanised feather substrate, and in most reported feather degradation 
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experiments, the feather substrate used were usually young and downy white feathers 
(Korkmaz et al, 2003; Bockle et al, 1995; Brandelli and Riffel, 2005; Cao et al, 2008; 
Zhang et al, 2009).  
The cell-free crude keratinase extract of Bacillus licheniformis N22 fully degraded 
melanised feather (Fig.3.18). The residual feather (mainly rachises) was nonetheless soft 
and brittle and therefore handled with care during drying and weighing. The rachis 
constitutes most of the total feather mass and has been reported to be resist degradation by 
Bacillus licheniformis (Ramnani et al, 2005). The feather in the negative control 
experiment (incubated in distilled water) retained its weight after incubation suggesting 
that the feather was not degraded or dissolved in the distilled water. However, the feather 
in the control experiment containing denatured crude keratinase weighed slightly less than 
the starting mass after incubation suggesting that the feather may have been digested by 
residual keratinase activity. Interestingly, both diluted and undiluted crude keratinase were 
equally effective in degrading native melanised feather, suggesting that this keratinase is 
highly efficacious (Fig 3.18 A-B).  
Feather degradation by keratinases has been mostly performed in the presence of suitable 
reducing agents such as live cells or chemical reductants (Brandelli and Riffel, 2005; 
Ramnani and Gupta, 2007; Liang et al, 2010). Cell-free keratinases of Streptomyces BA7 
(Korkmaz et al, 2003), Streptomyces S7 (Tatineni et al, 2008)  and Bacillus licheniformis 
ER-15 (Tiwary and Gupta, 2010) have been reported to degrade feather in 24 h, 97 h and 
12 h respectively. However, only about 10-20 % degradation is reportedly achieved by 
cell-free keratinases in the absence of reductants (Hossain et al, 2007). In addition, most 
purified keratinases are unable to effectively degrade native keratin for reasons which 
include: (1) the high degree of disulfide bonds in the keratin molecules (Bockle et al, 1995; 
Bressollier et al, 1999; Ramnani et al, 2005; Gupta and Ramnani, 2005; Riffel et al, 2007), 
and (2) removal, during purification, of fermentation culture constituents capable of 
reducing or breaking disulphide bonds (Cao et al, 2008). The later suggests that the 
presence of a consortium of enzymes in crude fermentation broth may be required to 
enhance feather keratin degradation (Sharma and Gupta, 2010). However, purified 
keratinase of Bacillus licheniformis N22 was able to fully degrade melanised feather in the 
absence of reducing agents, suggesting that this keratinase does not require reducing agents 
in order to effectively degrade highly stable keratin structure. 
Considering that feather keratin and prions are structurally similar in terms of their β-sheet 
composition (Shih, 2002; Langeveld et al, 2003), degradation of melanised feather by N22 
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keratinase indicated its potential for prion degradation. Although the mechanism of 
enzymatic degradation of β-sheets of silk keratin and β-amyloids of prion have been 
reported to be significantly different (Numata et al, 2010), feather keratin as a model 
substrate for studying keratin degradation mechanisms and for identifying potential prion-
degrading microorganisms remains highly relevant.  
The extremely large amount of feather waste produced by the poultry industry poses 
serious disposal and pollution problems. In the United States, around 4 billion pounds of 
feather waste is generated annually (Parkinson, 1998; Schmidt, 1998) and the United 
Kingdom generates about 330 million pounds of feather waste (United Kingdom Food and 
Drink Processing Mass Balance (2004). Feather is highly stable and has a melting point of 
around 230-240 oC (Schmidt, and Line, 1996). The disposal of feather waste by burning is 
a tough and an environmentally polluting process, and land filling requires a lot of land 
space which is not economically viable and environmentally sustainable as feathers 
decompose very slowly in the environment. However, feather wastes are potentially 
valuable and readily available raw material for the production of livestock feed 
supplements and amino acids (Onifade et al, 1998; Odetallah et al, 2003). Current feather 
waste processing methods such as steam pressure, chemical treatment and feather milling 
are cost and labour intensive, diminish product nutritional value and destroy important 
amino acids. For example, chicken feather conversion to feed supplement by cooking and 
sterilisation at high temperature and pressure followed by drying and grounding into 
powdered feather meal reduces the overall protein quality in addition to being a time 
consuming process (Wang and Parson, 1997; Shih, 1993; Dalev et al, 1997). Similarly, the 
current dehairing process in leather processing involves the use of extremely toxic sodium 
sulphide which also emits obnoxious odour as well as being expensive. Indeed, an 
estimated $1 million is spent daily for treatment of tanneries waste worldwide (Macedo et 
al, 2005).  
 
In recent times, attention has been drawn to microbial/enzymatic degradation as a desirable 
and valuable alternative for keratin waste processing (Yamamura et al, 2002; Korkmaz et 
al, 2003; Brandelli and Riffel, 2005; Gunderson et al, 2008). Enzymatic feather 
degradation is particularly important because it is simpler to operate than bacterial 
fermentation that requires maintaining the cell growth conditions (Ramnani and Gupta, 
2007). The use of enzymes for dehairing is not destructive and does not modify the dermis 
hence results in high-value leather. Furthermore, low levels of organic matter results in the 
wastewater, thus reducing effluent treatment cost and risks of environmental pollution. The 
ability of Bacillus licheniformis N22 keratinase to degrade feather keratin therefore 
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suggests its potential for use in the conversion of feather waste to useful bio-products, as 
well as in the processing of other keratinized wastes. 
4.3.2 In vitro degradation of prion protein 
4.3.2.1 Western Blot analysis and optimisation 
Prion protein in cell and tissue samples is commonly detected by Western blot using 
suitable anti-prion antibodies and characterised according to PrP-immunoreactive signal, 
PrP band pattern and size shift in molecular weight. The loss of or significant reduction in 
the PrP signal normally suggests a prion degradation event. PrPSc usually associated with 
prion infectivity is immunodetected after digesting prion sample with proteinase K, which 
readily digests PrPC.  
 
The PrPSc intensity on Western blot may depend on the the concentration and amount of 
sample assayed, the type of antibody used for detection, the procedures adopted and 
materials used. Optimisation of Western blot enabled determination of procedural 
conditions and suitable materials such as membrane blocking buffer and membrane 
blocking duration, which prevented cross-reactions, non-specific binding and unnecessarily 
long blocking duration, and improves sensitivity. Bacillus licheniformis N22 keratinase- 
bond Polyvinylidene Fluoride (PVDF) membrane blocked with BSA cross-reacted with the 
secondary antibody (anti-mouse IgG horseradish peroxidase from sheep) (Fig. 3.19). 
Interestingly, this cross-immunoreaction was eliminated when skim milk was used as the 
blocking agent. The reason for such cross-reaction has not been identified but may be 
related to epitopes binding (Kim, 1993). Because this reaction is specific to BSA, bio-
conjugation of certain constituent of BSA with keratinase may have resulted in the 
observed cross reaction. Furthermore, the membrane blocking step in WB is usually 
considered an important step for preventing non-specific binding. However, skipping this 
step did not seem to diminish the quality of the blots obtained but rather shortened the 
overall experiment time by 1 h. It is possible that sufficient membrane blocking may have 
been achieved with the 1 % skim milk solution in which the primary antibody was diluted. 
 
PrPSc signal intensity on Western Blot profile is related to its abundance in a prion sample. 
Therefore, undetectable PrPSc signal generally suggest the absence, or where enzyme-
digested, the complete degradation of PrPSc.  However, it is not uncommon for PrPSc 
intensity to increase following partial proteolysis, as a result of increased epitopes 
exposure due to protein unfolding and partial PrPSc disintegration (Brun et al, 2004; 
Jackson et al, 2005; Thackray et al, 2007; Ramos-Vara et al, 2008 and Karapetyan et al, 
2009). Similarly, increased PrPSc intensity was observed in this study when prion sample 
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was digested with low PK and keratinase concentrations, and at short digestion times. 
However, increasing the enzyme and digestion time resulted in higher degradation activity 
and loss of PrPSc intensity. Therefore, it can be argued that the increased PrPSc intensity 
captured the early stages of degradation activity (Fig. 3.23 and 3.24: Lane 2).  
Monoclonal antibodies (mAbs) detect prion protein at different affinity levels and 
sensitivities by targeting and binding specific linear epitopes, and therefore recognise prion 
proteins from different species differently (Laffont-Proust et al, 2006). SAF83 mAb for 
instance recognises solid-phase immobilised peptide 126-164 (in the central region) but 
does not bind peptide 142-160 (Féraudet et al, 2005). SAF83 has high affinity for PrP to 
which it rapidly binds within 10 min as tested for recombinant human PrP (rhPrP) (Axela 
biosensor). High affinity to PrP results in high immunoreactive intensity, and hence shorter 
primary antibody incubation time (Ramos-Vara et al, 2008). SAF83 has been shown to be 
unable to recognise PrP in microcebus, marmoset, macaque and baboon, although it detects 
PrP in species used as animal models for study of prion diseases such as hamster, rat and 
mouse (Laffont-Proust et al, 2006). Therefore, SAF83 was adequate for detecting ME7 
scrapie prion. 
In addition, different monoclonal antibodies (mAbs) were evaluated for immunodetection 
of digested ME7 scrapie PrPSc in order to identify one of high affinity, and to ensure that 
no possible epitopes of PrPSc were missed (Fig. 3.28). The mAbs SAF83 and 9A2 
demonstrated outstanding immunoreactivity with PrPSc compared to mAbs 12B2 and 6C2. 
The electrophoretic profiles of ME7 detected with mAbs SAF83 and 9A2 were similar, 
although the concentration of 9A2 used was 2.5 times higher than the concentration of 
SAF83 (section 2.3.3.2.3). The mAb SAF83 was selected for this study because of its high 
affinity and because it probes the central region of PrP.  
4.3.2.2 Degradation of ME7 scrapie prion 
The crude keratinase of Bacillus licheniformis N22 and the different fractions of the 
purification steps degraded scrapie prion differently; increasing in efficacy from the crude 
keratinase extract (S) through to the purified fraction (EF) (Fig. 3.21), indicating greater 
prion degrading activity with purity.  While the purified keratinase (EF) was able to 
effectively digest ME7 scrapie prion at 50 oC in 2 h (Fig. 3.21), a combined purified 
keratinase (EF) and biosurfactant (BS) composition effectively degraded ME7 scrapie 
prion in a shortened digestion time of 10 min at 65 oC to levels undetectable by western 
blot analysis (Fig. 3.26), indicating the effects of the interplay of digestion time, 
temperature and biosurfactant in enzymatic prion degradation. EF alone was unable to 
fully digest ME7 prion at 65 oC in 1 h compared to complete digestion with EF+BS (Fig. 
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3.24), suggesting the significant effect of BS in the degradation mechanism.  Furthermore, 
EF+ BS partially degraded ME7 prion at 50 oC in 1 h (Fig. 3.25) but completely degraded 
it to undetectable levels of PrPSc in 10 min by increasing the digestion temperature to 65 oC 
(Fig. 3.26), clearly indicating the significant thermal effect on ME7 prion degradation. 
However, ME7 scrapie has been reported to be thermally stable up to 84 oC (Somerville et 
al, 2002). Whether digestion at 65 oC destabilised ME7 scrapie material or increased 
keratinase activity or both, temperature appears to be a critical factor in the interactions of 
the EF-BS-ME7 reaction complex. The catalysis of keratinases under thermophilic 
conditions and solubilisation of prions by biosurfactant certainly enhanced the degradation 
process. The degradation mechanism for the EF-BS-ME7 complex probably includes 
unfolding the PrPSc structure, weakening the structural bonds, facilitating PrPSc 
solubilisation and allowing increased proteolytic access and PrPSc susceptibility to 
keratinase activity (Langeveld et al, 2003; Bolton et al, 1984; Oesch et al, 1994). 
Specifically, biosurfactant may be involved in lowering surface tension of the reaction 
mixture, solubilising the prion substrate and increasing its surface area, thereby allowing 
keratinase greater access in cleaving the prion substrate. Therefore, the hydrophobic 
moiety of the biosurfactant may be attach to the prion molecules and pulled by the 
hydrophilic head causing disruption of intact PrPSc aggregates and stretching it out to allow 
easier scission of the stabilising disulphide bonds by keratinase.  The disulphide bond 
normally stabilises the folded form of protein by forming a nucleus of hydrophobic core. 
Although proteases such as PK cleave proteins non-specifically, they show preference to 
cleave hydrophobic and aromatic amino acids (Kraus et al, 1976).   
Crude biosurfactant (BS) alone was unable to degrade ME7 scrapie prion as detected by 
Western blot analysis (Fig. 3.24), suggesting that it lacked proteolytic activity and prion 
degrading potential. Although some Pseudomonas strains produce keratinases (Sharma and 
Gupta, 2010; Tork et al, 2010), and a Bacillus licheniformis strain have been reported to 
concomitantly produce alkaline protease and biosurfactant (Ramnani et al, 2005), the crude 
biosurfactant of Pseudomonas aeruginosa NCIMB 8626 exhibited no significant 
keratinase activity and keratinase of Bacillus licheniformis N22 lacked biosurfactant 
properties. Therefore, the EF and BS appeared to play different but specific roles which 
resulted in an interestingly remarkable synergistic enzymatic degradation of ME7 prion.  
In the time-course experiment, the loss of the glycosylation band (Fig. 3.25) suggests the 
extent of cleavage of PrPSc by the enzymatic preparation (EF+BS) and illustrates the 
interplay of incubation time and temperature in the prion degradation process. The decision 
to choose a shorter incubation time over higher temperature or vice versa for enzymatic 
  
97 
prion degradation will depend on the type of application (e.g. decontamination of sensitive 
surgical device and remediation of prion contaminated soil) and on economic 
considerations.  
Significant level of PrPSc degradation at low concentrations of keratinase (EF) (up to 1:50 
dilutions) (Fig. 3.27), and the effective degradation of feather at dilute crude keratinase 
extract (1:5 dilutions) (Fig. 3.18A) suggests the efficacy of this keratinase. This is also 
important in economic terms as much less material is required to achieve similar levels of 
result such that using higher concentrations is a waste of resources. It has been reported 
that higher protease concentration does not necessarily increase the rate of PrPSc 
degradation (Lawson et al, 2007; Yoshioka et al, 2007),  
The enzymatic degradation at mild digestion conditions is of general interest in the 
decontamination of sensitive medical devices, animal products [Meat and Bone Meal 
(MBM) and Specific risk materials (SRM)] and the prion contaminated environment. The 
inability to achieve efficient prion degradation at mild digestion conditions (neutral pH, 
moderate temperature, and low enzyme concentration), currently limits the use of 
enzymatic decontamination methods in economic and operational terms (Pilon et al, 2009). 
The enzymatic degradation method described here, degraded ME7 scrapie prion under 
moderate physical condition (pH 7 and 65 oC) and short digestion time (10 min) (Fig. 
3.26). In addition, it did not require a truncated multi-step approach (e.g. Langeveld et al, 
2003; Jackson et al, 2005; Croud et al, 2008) in which the infectious material is either pre-
treated and/or digested with multiple enzymes or in the presence of chemical surfactants or 
alkali carrier such as NaOH. This enzymatic method is efficient and practical, and the 
constituent agents (N22 keratinase and biosurfactant) are purely biological agents of 
potentially low production cost. Therefore this method could provide a good, 
environmentally acceptable, economically sound and safe alternative to existing prion 
decontamination methods.  
4.4 Residual infectivity evaluation of keratinase-digested scrapie prions 
4.4.1 Scrapie cell assay 
Scrapie cell-based scrapie assay has become an increasingly important and reliable method 
for evaluating residual infectivity, characterising prion infectivity, prion strain typing and 
infectious titre estimation (Klohn et al, 2003; Mahal et al, 2007; Edgeworth et al, 2009; 
Neale et al, 2010; Edgeworth et al, 2011). Cell-based assay is particularly attractive for its 
advantages of high sensitivity, short assay time (about three weeks) compared to mouse 
bioassay, and reduced labour and cost requirement. While Western blot analysis is the 
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most common biochemical method for prion immunodetection, the presence of prion 
infectivity in the apparent absence of detectable levels of PrPSc (Berardi et al, 2006; Barron 
et al, 2007; Lasmezas et al, 1997) limits its use for evaluating residual prion infectivity. 
Therefore, more consistent and sensitive methods such as scrapie cell assay and bioassay 
are necessary to validate results from Western blot analysis and to determine the efficacy 
of prion degradation methods.  
The Western blot analysis of ME7 scrapie digested with the enzymatic treatment suggests 
the complete degradation of PrPSc (Fig. 3.27). To establish that the absence of PrPSc was 
accompanied by complete loss of infectivity, enzyme-digested samples were evaluated by 
scrapie cell assay using Rov9 cell line. The Rov9 cell line is susceptible to a number of 
scrapie strains including SSBP/1 (Neale et al, 2010). Since cell lines susceptible to ME7 
prion strain were not available for this study, SSBP/1 scrapie infectivity was evaluated by 
standard scrapie cell assay (SSCA) using Rov9 cells. Both ME7 and SSBP/1 scrapie strains 
were completely digested by EF+BS enzymatic treatment to levels of PrPSc undetectable 
by Western blot (appendix 4), suggesting similar levels of prion degrading activity. 
Therefore, the results of enzymatic digestion of SSBP/1 and ME7 were considered to be 
comparable.  
The result of the scrapie cell assay demonstrates that the enzymatic treatment effectively 
destroyed prion infectivity as shown by the inability of the enzyme digested SSBP/1 brain 
homogenate to infect Rov9 cells (Fig. 3.29 and 3.30). Keratinase alone effectively 
destroyed SSBP/1 infectivity similar to the total loss of PrPSc signal intensity in Western 
blot profile following extended digestion of ME7 scrapie. Digestion of SSBP/1 with BS 
resulted in a significant reduction in the number of infected cells which suggests that 
SSBP/1 infectivity was significantly attenuated but not enough to prevent infection of 
cells. This is particularly interesting as Western blot analysis of BS-digested ME7 scrapie 
did not indicate detectable loss of PrP signal intensity relative to undigested control. This 
may be explained by a higher sensitivity of the scrapie cell assay. In addition, SSBP/1 
scrapie prion infectivity was significantly attenuated at the incubation temperature (65 oC) 
of the enzymatic digestion, but not significantly to completely destroy prion infectivity 
(Fig. 3.30). The number of spot counts detected in the EF and EF+BS treatment groups 
(Fig. 3.30) were probably background noise as confirmed by absence of visually detectable 
infected cells on the photographic image of the ELISPOT plate (Fig. 3.29).   
The inability of the enzyme-digested scrapie substrate to propagate infectivity in the 
susceptible Rov9 cells suggests the complete loss of SSBP/1 infectivity. Therefore, the 
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efficacy of this enzymatic treatment method for complete destruction of prion infectivity 
has been clearly and reliably validated by the scrapie cell assay. This result suggests that 
the loss of detectable levels of PrPSc signal in the enzyme-digested scrapie prion as 
determined by Western blot correlated with loss of prion infectivity as determined by the 
scrapie cell assay. Therefore, the scrapie cell assay is a potential method for evaluating 
residual prion infectivity. 
4.4.2 Bioassay  
The level of PrPSc present in prion sample homogenates is determinable by Western blot 
analysis and, cell culture assay is a reliable method for evaluating residual prion 
infectivity. Currently, rodent bioassay is considered the gold standard for the evaluating 
residual prion infectivity. Therefore, to further investigate the efficacy of the enzymatic 
treatment method described here for destroying prion infectivity, enzyme-digested ME7 
scrapie was evaluated for residual infectivity by mouse bioassay using transgenic (Tga20) 
mice. 
 
The incubation time of ME7 scrapie prion inoculated intraperitoneally has been reported to 
be approximately 94 days in transgenic mice (Karapetyan et al, 2009), and approximately 
274 ± 5 days in wild-type (C57BL) mice (Brown et al, 2009). The short incubation time of 
the disease in transgenic mice is attributed to high levels of endogeneous PrPC expression 
(about 8 fold more PrPC in heterozygous Tga20/wild type and 16-fold higher for those with 
diploid dose of Tga20). PrPC is a substrate for prion conversion and abundant levels of 
PrPc in transgenic mice results in higher rate of PrPSc conversion and prion propagation, 
and hence shortened incubation time of disease (Fischer et al, 1996).  
In the mouse bioassay, the long incubation times observed was characteristic of wild type 
rather than transgenic mice. Western blot profiles showed that the PrPC intensity of the 
Tga20 were variable, and were not significantly higher than those of the wild type mice 
(Fig. 3.34). While the Western Blot may also suggest slight differences between loading of 
PrP and β-actin (loading control), which was less likely, the slight differences may simply 
reflect more or less areas of the brain stem with low PrP and actin high axon fibre tracts 
hence the PrP in the Tga20 cannot reflect 8 or 16 times higher PrP such that the test mice is 
C57BL/6 (Prof. Roger Morris-Personal Communication). It is possible that the Tga20 mice 
may have lost their transgene during outbreeding to C57BL/6 mice over several 
generations, resulting in characteristically wild-type mice. Therefore, the loss of transgene, 
genetic shifts and variable levels of PrPC expression in the experimental mice may have 
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significant effects on their susceptibility to prion infection and propagation of disease as 
this experiment has shown. 
To allow for direct comparison of the survival time data in the bioassay, only mice that 
were culled/died at ≤ 550 days, and those that were PrPSc positive as determined by 
Western blot analysis of brain homogenates were included in the survival time analysis. 
The incubation time in IBH Neat group was found to be 278 ± 9 days which is in close 
agreement with 274 ± 5 days reported by Brown et al (2009) for ME7 inoculated 
intraperitoneally in C56BL (wild-type) mice.  
 
Two clearly distinct sub-populations of mice with highly significant difference in survival 
time occurred in the IBH digested treatment group. One sub-population (47 % of all the 
mice inoculated) had a mean survival time of 208 ± 27 days. Such shortened incubation 
time would suggest rapid progression of disease incubation with accompanying PrPSc 
accumulation. However, the mice in this sub-population were all PrPSc negative suggesting 
that they were either infected or may be habouring undetectable trace levels of infectivity. 
Disease incidence < 100 % is considered to suggest presence of undetectable or trace levels 
of infectivity (Brown et al, 2009), and IBH digested group had a disease incidence of 53 
%, suggesting possible undetectable trace levels of infectivity. The mean survival time in 
this sub-population was significantly lower than that of IBH Neat group suggesting that 
they are likely to have died of other causes or the mice were mistakenly culled too early 
(Fryer and McLean, 2011), which further justifies their exclusion in the survival time 
analysis. Significant increase occurred in the survival time for the IBH digested group 
(PrPSc positive sub-population) compared to the IBH Neat (positive control) group.  
 
Put together, it can be concluded that enzymatic digestion of ME7 substantially destroyed 
infectivity as lack of detectable levels of PrPSc in the brain of challenged mice in the IBH 
digested group would suggest, or ME7 prion infectivity was considerably reduced 
following enzymatic digestion resulting in significantly increased survival time in 
challenged mice from 278 ± 9 days to 334 ± 42 days. Therefore, EF+BS has not only 
degraded PrPSc in the form seen on Western Blot, but also substantially destroyed or 
reduced the infectious titre of digested ME7 prion.   
4.5 Potential applications of this enzymatic treatment method 
Keratinase of Bacillus licheniformis N22, especially in a composition with biosurfactant of 
Pseudomonas aeruginosa showed a remarkable efficacy for prion degradation at mild 
temperatures and short incubation. The potential applications of this enzymatic method 
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may include the decontamination of delicate and reusable surgical and dentistry 
instruments, processing of SRM and MBM, composting of animal carcases and animal 
wastes as fertilisers, disposal of sheep scrapie, decontamination of infected materials and 
all forms of clinical wastes prior to disposal, remediation of prion contaminated 
environment (soil, water and wastewater), degradation of feather waste into poultry feed, 
organic fertilisers and amino acid production, and dehairing of hides in the leather 
industry. 
A recent report comparing the efficacy of three commercially available prion 
decontamination reagents (HAMO 100 [HPID Steris]; Rely+ On PI [DuPont Corporation] 
and Prionzyme [Genencor]) demonstrated high variability in their effectiveness 
(Edgeworth et al, 2011). Rely+ On PI and Prionzyme decontaminated steel-bound scrapie 
to levels of infectivity undetectable by standard steel-binding assay (SSBA) at 50 oC and 
65 oC respectively. Rely+ On PI is composed of a mixture of three different undisclosed 
packs of substances and Prionzyme was composed of 2M NaOH (commonly reported 
chemical method), which on its own was able to decontaminate steel-bound scrapie. This 
report suggests that an effective and truly biological (enzymatic) treatment method remains 
highly desirable. Therefore, the enzymatic treatment method reported in this research holds 
significant commercial prospect. 
4.6 Conclusion 
A standardisation protocol for commercial keratin azure has been reported which results in 
a highly homogeneous substrate, making it a reliable substrate for consistent and 
reproducible keratinase activity measurement useful for evaluation and comparison of 
keratinases. Also, two simple but useful assays (spot inoculation and the hydrolysis ring 
assays) have been introduced for the screening and characterisation of proteolytic and 
keratinolytic microorganisms and their proteases. Keratinase assay and a PK calibration 
curve baseline method established for selecting potential prion degrading microorganism 
proved to be successful.    
A novel strain of keratinase producing Bacillus licheniformis has been isolated and 
characterised. This bacterial strain identified and designated as Bacillus licheniformis N22 
has been deposited with National Collection of Industrial Food and Marine Bacteria 
(NCIMB) with ascension number NCIMB 41708. The keratinase of Bacillus licheniformis 
N22 completely degraded melanised feather and was able to degrade ME7 scrapie prion. 
N22 keratinase formed a remarkable synergistic activity with biosurfactant of 
Pseudomonas aeruginosa NCIMB 8626 and effectively degraded ME7 and SSBP/1 scrapie 
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strains under mild digestion conditions and short incubation time.The complete destruction 
of sheep scrapie infectivity is particularly important in terms of disposal of sheep scrapie. 
In a preliminary test, other field scrapie prions have also been successfully degraded by 
this enzymatic treatment (appendix 4). These results suggest that this enzymatic treatment 
method has potential application in feather processing as well as prion decontamination, 
and could be integrated into existing medical devices sterilisation process. 
4.7 Recommendations for future work 
To further evaluate the efficacy of this enzymatic treatment method on ME7 scrapie and 
other scrapie strains, it is recommended to carry out bioassay using transgenic (Tga20) 
mice that has been genetically profiled and confirmed to produce high levels of PrPC, and a 
statistically significant number of mice (at least 16 mice) is required per treatment group 
(Dr Oduola Abiola- Personal Communication). In addition, the robustness of this 
enzymatic treatment method on other types of field prion (BSE, CWD and vCJD) strains 
should be investigated.  
 
It is also recommended to investigate the efficacy of this enzymatic method for treatment 
of prion contaminated steel material. This is particularly important for purposes of 
application in decontamination of medical devices and laboratory equipments. 
Furthermore, the remediation of prion contaminated soil is becoming increasingly 
important, hence it is recommended to investigate the potentials of this enzymatic 
treatment method for the treatment of prion contaminated soil for the purposes of 
application in the remediation of farms with the history of TSE occurrence and landfills 
that may have received prion contaminated carcasses, such as during the onset of BSE 
outbreak in the UK. In addition, other potential biotechnological applications of this 
enzymatic treatment method such as feather to feather meal conversion and hides 
processing for leather production could be explored. 
 
Finally, it is recommended to carry out detailed structural mapping of keratinase N22 to 
gain in-depth knowledge of the biochemical nature of this enzyme, and also to investigate 
the mechanism of the interactions between keratinase, biosurfactant and prion in the 
enzymatic degradation reaction. In addition, analysis of the constituents of the enzymatic 
degradation product will help to identify at what points the enzyme cleaves specific prion 
strain and provide insight into the mechanism of the alteration of prion infectivity. 
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Appendices 
Appendix 1: Western blot profiles of brain homogenates of culled mice from the different 
treatment groups of the mouse bioassay. Key: NBH (Normal brain homogenate); IBH 
(Infectious brain homogenate); PK (Proteinase K) and Number (Brain homogenate of mouse 
identified by that number). All immunodetection were carried out with SAF83. Appendix 1 is 
refered to in section 3.3.2 (mouse bioassay). 
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Brain homogenates of animals inoculated with neat IBH 
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Brain homogenates of animals inoculated with IBH digested with enzymatic treatment 
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Appendix 2: Summary of bioassay mice indicating individual mouse identification, sex 
type, inoculation batches, survival time post-inoculation and PrPSc status of brain 
homogenates from culled mice. A total of 55 mice were inoculated out of which 37 mice 
were culled /died. All mice that survived beyond 550 days were not tested for PrPSc.  
Appendix 2 is referred to in section 3.3.2 (mouse bioassay). 
 
Treatment 
groups 
Identification no. and sex 
of mice inoculated 
Survival time 
(days) 
Detected PrPSc 
(-/+) 
260               M 384 - 
261               M >550 Not tested 
262               M >550 Not tested 
263                F    496 - 
NBH (Digested) 
(-ve control) 
264                F >550 Not tested 
248                F 296 + 
249                F 283 + 
251                F 276 + 
254                F 275 + 
255                F 275 + 
257                F 269 + 
IBH (Neat) 
(+ control) 
258                F 275 + 
287                F 204 + 
288                F 259 + 
289                F 303 + 
290                F >550 Not tested 
295                F >550 Not tested 
283               M 217 + 
284               M 321 + 
285               M >550 Not tested 
 
 
IBH  
(1:10 dilution) 
(+ control) 
286               M >550 Not tested 
231               M 343 + 
232               M 340 + 
233               M >550 Not tested 
234                F 334 + 
235                F >550 Not tested 
236                F >550 Not tested 
256                F 345 + 
273               M 334 + 
274               M 336 + 
275               M >550 Not tested 
276                F 328 + 
277                F 369 + 
IBH  
(1:100 dilution) 
(+ control) 
278                F >550 Not tested 
IBH  244               M >550 Not tested 
  
140 
245               M >550 Not tested 
246               M >550 Not tested 
247               M >550 Not tested 
252               M >550 Not tested 
(1:1000 dilution) 
(+ control) 
253               M   Not tested 
269                F 325 + 
271                F 296 + 
272                F 299 + 
265               M 181 - 
266               M 186 - 
267               M 321 + 
268               M 332 + 
279               M 191 - 
280               M 243 - 
281               M 342 + 
282               M 431 + 
291                F 191 - 
292                F 233 - 
293                F 233 - 
 IBH (Digested) 
(Experimental 
Group) 
294                F 327 + 
M- male; F- female; ‘+’ PrPSc positive mice; ‘-’ PrPSc negative mice or below detection limit 
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Appendix 3: The physical structure of feather which typically consists of a central shaft 
with a proximal end (calamus or quill) and a distal end (rachis). Attached to the rachis are 
barbs, to which barbules are attached. Tiny hooklets tie the barbules and consequently, the 
barbs together. Appendix 3 is referred to in section 4.3.1 (degradation of keratin substrate).  
 
 
 
 
http://www.birds.cornell.edu/AllAboutBirds/studying/feathers/feathers 
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Appendix 4: Western Blot analysis of various various scrapie strain (1 % brain 
homogenate) samples digested with EF+BS and immunodetected with SHA31 mAb. Lanes 
2, 4, 6, 8, 10 and 12 are undigested samples (Controls) and lanes 3, 5, 7, 9, 11 and 13 are 
the replicate corresponding samples digested with EF+BS. ME7 (lane 3) and SSBP/1 (lane 
7) scrapie strains were completely degraded following digestion with EF+BS. Appendix 4 
is referred to in section 4.4.1 (scrapie cell assay). 
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Abstract  
Background: Significant amount of keratins in the form of feather, hair, hoof and horn are 
generated annually by the livestock industry. Keratinases are increasingly important in the 
reprocessing and environmental pollution control of keratin wastes. The aim of this study 
is to isolate a microbial strain of high keratinase activity and to evaluate its feather 
degrading potential.   
Results: Thirty-two keratin degrading microbial strains from farmyard wastes and primary 
effluent were isolated using a selective medium containing feather meal at 30, 37 and 50 
°C. The proteolytic activities of the isolates were determined using a casein medium and 
their abilities to degrade keratin were evaluated by the keratinase assay using keratin azure 
as the substrate. One of the isolates, which demonstrated the highest keratinolytic activity 
(11.00 ± 0.71 UmL-1) was identified as a species of Bacillus licheniformis based on the 
16S rDNA analysis and designated Bacillus licheniformis N22. Its keratinase activity was 
58% higher than that of the reference strain B. licheniforms PWD-1 (ATCC 53757). 
Optimum keratinase production by this bacterium was achieved in 32 h using a minimum 
growth medium at 50 °C, pH 8.5 and containing 1.1% (w/v) feather meal. The molecular 
weight of the keratinase was ≈ 28 KDa as determined by mass-assisted laser 
desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). The MALDI-
TOF MS spectrum of the tryptic peptides of this enzyme did not match any previously 
reported keratinases. 
Conclusions: There are few reports on the evaluation of feather degrading ability of 
keratinases using highly resistant melanised feather. The keratinase reported here 
significantly degraded melanised feather in 48 h in the absence of reducing agents and may 
offer an environmentally friendly solution to the keratin and feather waste problem.  
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Background  
The poultry processing industry produces a significant amount of feather waste; the United 
States and the United Kingdom generate about 4 billion pounds [1] and 150,000 tonnes 
(331 million pounds) [2] of feather waste per annum respectively. The disposal of such 
considerable quantities of waste by landfill requires large areas and the alternative option 
of incineration creates additional pollution burden. Neither method is economically viable 
or environmentally sustainable. In addition, feather wastes are potentially valuable raw 
materials for the production of nutrient-rich animal feed supplements and amino acids [3, 
4]. Feather waste processing methods such as steam pressure, chemical treatment and 
feather milling are cost and labour intensive and may reduce the product’s nutritional value 
by destroying important amino acids [3, 5].  
Feather is composed of approximately 90% pure keratin; predominantly in the form of β-
keratin [6]. The tertiary structure of β-keratin is highly organised: the cross-linking of 
disulfide and  hydrogen bonds along with hydrophobic interactions stabilises the structure 
and  together with its aggregated amyloid-like fibrillar form confer mechanical strength as 
well as chemical and enzymatic resistance [7- 9].  Interestingly, despite these highly 
stabilising characteristics, an increasing number of enzymes, isolated from certain 
environmental microbial strains are found to degrade feather keratin [10-12].  Enzymatic 
degradation of feather is particularly important because it provides an operational 
advantage over bacterial fermentation that requires controlled conditions for cell growth 
[13].  
Keratinases have been found to efficiently hydrolyse keratin and degrade feathers into 
useful livestock feeds [4, 14, 15] and organic fertilizers [16]. In addition, keratinases are 
useful for removing hair from hides in the leather processing industry [17-19] and for the 
degradation of prions [20, 21]. Thus they have important applications in biotechnology and 
waste management. 
A number of keratinase producing microorganisms (e.g. fungi [22], actinomycetes [23], 
Streptomyces [24], Bacillus [25] and Pseudomonas [26] species) have been isolated from 
various environmental sources such as soil, poultry farm wastes and raw feather [27, 28]. 
The great potential for keratinase in the biotechnology industry demands the most efficient 
and environmentally friendly sources be identified and exploited for maximum production. 
Farmyard wastes are characterised by a rich and diversified microbial ecology [24, 28, 29]. 
Thus they constitute an excellent source of prolific keratinase producing microorganisms. 
In the present work, a number of keratinase producing organisms from farmyard wastes 
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have been isolated and a prolific keratinase producer was identified and designated as 
Bacillus licheniformis N22. This strain produced a distinct MALDI-TOF MS spectrum 
which was different from that of the reference strain B. licheniformis PWD-1. The 
keratinase has a unique peptide spectrum and was able to significantly degrade melanised 
feather. 
Results  
Isolation and identification of feather degrading bacteria  
Microbial strains from primary effluent, poultry and animal wastes were isolated on feather 
meal agar (FMA) plates. The proteolytic and keratinase activities of the isolates were 
determined by the casein agar assay and keratinase assay respectively. 
The hydrolysis ring assay enabled the identification of microorganisms that have the ability 
to hydrolyse casein. The diameter of hydrolysed casein ring for the neat, 1:10; 1:100; 
1:1000 dilutions of crude enzyme were 20 mm, 16.3 mm, 12.5 mm and 6.3 mm 
respectively (Figure 1).The casein ring diameter was inversely correlated to the dilution of 
crude keratinase (Pearson correlation = 0.761, p=0.239). Based on the casein ring analysis, 
thirty-two best performing microbial strains were isolated for further study. 
Results from the keratin azure assay are presented in Figure 2. Of the thirty-two isolates 
strain number 22 produced the highest activity (11.00 ± 0.71 UmL-1). Kertinase produced 
by the reference strain B. licheniformis PWD-1 (ATCC 53757) was also analysed; the 
activity of Strain N22 was 58% higher than PWD-1.  
Isolate N22 was found to be a Gram positive rod bacterium displaying a number of 
characteristics similar to the Bacillus species listed in the Bergey’s Manual of 
Determinative Bacteriology [30] (Table 1). Gene sequence analysis of the 16S rDNA 
revealed 99.93% homology with B. licheniformis ATCC14580.  A phylogenetic tree which 
was generated by MicroSeq TM (Figure 3) showed that strain N22 was within the same 
branch of B. licheniformis. The characteristic peaks in the mass spectral fingerprints were 
stable, reproducible and different from those of the reference strain PWD-1 (Figure 4). We 
have isolated a new strain of B. licheniformis and designated it as B. licheniformis N22. It 
has been deposited with the National Collection of Industrial Food and Marine Bacteria 
(NCIMB):  its ascension number is NCIMB 41708.  
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Optimisation of keratinase production and characterisation of keratinase 
In order to optimise the enzymatic production of N22, the optimum conditional for 
microbial  growth and enzyme production  were investigated.  
Keratinase production by B. licheniformis N22 occurred over a wide pH range (6-12), with 
the optium lying between 8 and 9 over 32 h. Optimum substrate concentration and 
temperature for keratinase production were 1.1% (w/v) and 50 °C respectively. Keratinase 
production was greatly inhibited at acidic pH (pH ≤4), substrate concentration above 1.1% 
and a temperature of 65 o C and above (Figure 5). 
With respect to keratinase activity, the maximum activity of 11 ± 0.71UmL-1 was attained 
at pH 8.5, feather meal concentration of 1.1% (w/v) and a temperature of 50 o C. 
Conditions that were averse to the production of this keratinase had similar effects on its 
activity. 
The purified keratinase was analysed by MALDI-TOF MS and a single peak was obtained 
in the mass spectrum (Figure 6) showing that the molecular weight of this keratinase was 
approximately 28 kDa. The single peak depicts homogeneity of the sample. The activity of 
this keratinase was maintained at 11 UmL-1 after 8 weeks storage at 4 °C. 
The peptide mass fingerprint of the purified keratinase is presented in Figure 7. The 
original peak of ≈ 28 KDa was cleaved to generate a number of tryptic peptides. An 
overlap of trypsin-digested (blue) and non-trypsin digested (red) keratinase spectrum were 
used to establish the peptide peaks and matched against trypsin spectrum to identify any 
background peaks. A tryptic peptide search on Mascot Search Engine (Matrix Science) did 
not yield any match to previously reported keratinases. 
Degradation of melanised feather 
The catalytic activity of crude keratinase was investigated by its effect on melanised 
feather. Melanised feather was significantly degraded by crude keratinase (Figure 8). A 
mean reduction of about 80% in the weight of melanised feather (52 ± 2 mg to 10 ± 3 mg) 
was obtained when treated with crude extract for 48 h as compared to 12% (52 ± 2 mg to 
46 ± 3 mg) reduction for control which was made up of crude keratinase that had been 
boiled at 100 o C for 30 minutes   (P = 0.038; 2- Sample T-test).  
Discussion  
Since the first report on the isolation of extracellular alkaline serine protease from Bacillus 
sp. strain 221 [31], the search for industrially relevant proteases from different 
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environmental sources such as farmyard wastes [28] and sewage sludge [32] has been 
continuous. For mass screening of keratinase producing microorganisms, the casein-agar 
assay was a useful preliminary tool to detect proteolytic microorganisms. Casein is a 
highly stable and hydrophobic non-fibrous protein. It does not coagulate or easily 
denatured by heat but can be hydrolysed by certain proteases [33, 34]. These 
characteristics informed our choice of the method used in this study to identify proteolytic 
microorganisms that can hydrolyse casein and other structurally similar substrates such as 
keratins. The casein hydrolysis ring assay is similar to the method described by Tork et al 
[28] where the diameter of the clear zone was used to determine the microbial growth rate. 
In this study a correlation between the sizes of the hydrolysis rings and the protease 
catalytic activity was demonstrated (Figure 1). This confirms the hydrolysis ring assay as 
an efficient, cost and labour effective semi-quantitative method for measuring proteolytic 
activities. However, since not all proteases can degrade keratin, an evaluation of 
keratinolytic activity of potential keratinase producers should be confirmed by the keratin 
azure assay which is highly specific for determination of keratinase activity. 
Of the thirty-two isolates, strain N22 demonstrated the highest keratinase activity and was 
selected for further study. It was identified as a Gram-positive, endospore-forming, mostly 
alkalophilic, mildly thermophilic and halotolerant bacterium (Table 1). The aerobic and 
mild and easily manageable growth conditions (37-60 °C and pH 6-10) make this 
bacterium an attractive candidate for biotechnological applications. Gene sequence 
analysis using 16S rDNA indicated that strain N22 is closely related to B. licheniformis. 
Other B. licheniformis are also known to produce keratinase [25, 35], but strain N22 differs 
from the well characterised B. licheniformis PWD-1 [25] as the former is unable to ferment 
lactose. Furthermore, these two strains produced distinct spectra when analysed by 
MALDI-TOF MS (Figure 4), suggesting N22 and PWD-1 are two different species. The 
crude keratinase produced by B. licheniformis N22 also expressed 58% higher activity than 
the keratinase from B. licheniformis PWD-1 on keratin azure substrate (Figure 2).  
The interplay of various factors such as temperature, pH, substrate concentration, the 
nature and composition of carbon and nitrogen sources as well as the condition of 
inoculants, influences cell growth and survival, and the levels of protease synthesis in a 
microbial culture [36]. Thus, optimisation of these factors is important for an effective 
synthesis of biological entities such as keratinases. The optimum production of keratinase 
by strain N22 was achieved at a substrate (feather meal) concentration of 1.1%, pH 8.5 and 
50 °C over 32 h. The most important limiting factors affecting keratinase synthesis 
appeared to be low pH (pH≤4) and high temperature (≥65 °C). As B. licheniformis is 
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mildly thermo- tolerant with its optimum temperature of 50 °C, it may be adapted for 
microbial composting of organic wastes. 
Feather meal substrate induced keratinase synthesis by B. licheniformis N22 resulted in a 
68% increase compared to its culture grown in Nutrient Broth (results not shown). This 
study confirmed that high substrate concentration reduced keratinase production (Figure 4) 
which was previously reported by Brandelli and Riffel [27], Wang and Shih [37] and Lin 
and Yin [38]. 
Approximately 40% of total cost of enzyme production is due to the cost of growth 
substrates [39]; the use of low cost and readily available feather meal or chicken feather 
substrate will enable the sustainable production of strain N22 keratinase on an industrial 
scale. In addition, the use of feather waste as growth substrates for keratinase producing 
microorganisms will invariably serve as an efficient way of managing the significant 
amounts of chicken feather wastes produced by the poultry processing industry [40]. 
The molecular weight of B. licheniformis N22 keratinase was found to be ≈ 28 KDa 
MALDI TOF-MS (Figure 6). The single mass peak obtained by MALDI TOF-MS 
indicates that the purified keratinase is homogeneous and monomeric (has no 
subunits).This molecular weight is very close to that of Bacillus pseudofirmus FA30-10 
(27.5 KDa; [41]); it is different from that of B. licheniformis PWD-1 (33 KDa; [42]). This 
suggests that B. licheniformis N22 keratinase is a distinct entity. Peptide mass fingerprint 
of trypsinised N22 keratinase (Figure 7) did not produce any matches in the Mascot Search 
Engine (Matrix Science) confirming that this is a novel keratinase: it has not been 
previously characterised and documented. 
The purified keratinase was stable at 4 °C after 56 days compared to the keratinase 
produced by B. licheniformis PWD-1 which had been reported to lose a quarter of its 
activity after 19 days when stored at the same temperature [43]. Keratinase from 
Streptomyces fradiae also retained its activity for several weeks at 4 °C when stored at pH 
7 but rapidly loses its activity at pH 8.5 [44]. Feather degradation generally occurs under 
alkaline conditions as a result of deamination [45]; this is within the optimum pH range for 
the keratinase reported in this study. Thus it appears to have a more robust potential for 
biotechnology exploitation especially in feather waste management. 
In the present study, melanised feathers were cleaned by agitation with sterile distilled 
water to ensure that they remained structurally uncompromised and free from microbial 
contamination [46]. Sterilisation by autoclaving denatures feather keratin and causes the 
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feather to be susceptible to proteolytic attack as they lose their insolubility and resistance 
to enzymatic degradation [47, 48]. There are relatively few reports on the evaluation of 
keratinolytic activity using melanised feather substrate. Rather, in most reported feather 
degradation studies, the feather substrates are usually young, downy white feathers [27, 49, 
50]. Notably, melanised feathers are generally more resistant to enzymatic attack than 
white feathers due to the presence of the pigment melanin which binds to and inhibits 
keratinases [48, 51] as well as other enzymes [52]. The cell-free crude keratinase of B. 
licheniformis N22 significantly degraded melanised feather (p = 0.038; Figure 8). The 
residue (mainly rachises) was soft and brittle and had to be handled with great care during 
drying and weighing. The rachis constitutes most of the total feather mass and has been 
reported to resist degradation by B. licheniformis [53]. Our study has shown that at 
optimum conditions the reported enzyme demonstrated a much more profound catalytic 
activity than any of the known keratinases.  
Feather degradation by keratinases has been mostly performed in the presence of suitable 
reducing agents such as live cells or chemical reductants [27, 13, 54]. Cell-free keratinases 
of Streptomyces BA7 [55], Streptomyces S7 [56] and B. licheniformis ER-15 [19] have 
been reported to degrade feather in 24 h, 97 h and 12 h respectively. However, only 10-
20% degradation is reportedly achieved by cell-free keratinases in the absence of 
reductants [57]. Most purified keratinases are unable to effectively degrade native keratin 
for reasons which include: (a) the high degree of disulfide bonds in the keratin molecules 
[58, 59] and (b) the removal, during purification, of fermentation culture constituents that 
are capable of reducing or breaking disulphide bonds [49]. The latter suggests that the 
presence of a consortium of enzymes may be required to enhance feather keratin 
degradation [26]. In contrast, the purified keratinase of B. licheniformis N22 was able to 
significantly degrade melanised feather in the absence of reducing agents. 
Conclusions  
We have isolated a novel strain of B. licheniformis from farmyard waste which has a 
profound ability to produce keratinase of prolific activity: it significantly degraded 
melanised feather within 48 h in the absence of reducing agents. The keratinase has a 
trypsin peptide MALDI-TOF MS spectrum not previously reported. By optimising its 
production and activity, this keratinase has great a potential in providing new, rapid and 
cost-effective methods for the management of feather and other wastes of similar 
molecular structure.  
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Methods 
Isolation and identification of microoganisms 
Minimum Growth Medium (MGM) containing (in gL-1): NaCl, 0.5; KH2PO4, 0.7; 
K2HPO4, 1.4;   MgSO4.7H2O, 0.1; pH 7 [37] was used as the basic growth medium. 
Microbial strains were isolated from primary effluent (Deepham Sewage Treatment 
Facility, Thames Water, Edmonton North London, UK) and poultry/animal wastes (A.K 
Woods Poultry Farm, Fold Farm Partners and Leamon Pig Farm Ltd, UK). Sample of 
wastes (1 g) were serially diluted in a quarter-strength Ringer’s solution (Oxoid, UK), 
plated out on feather meal agar [10% commercial feather meal (Chettles Ltd, UK) in MGM 
and 1% agar] plates and incubated at 30 °C, 37 °C or 50 °C for 24, 48 and 72 h. Single 
colonies were passaged twice on feather meal agar (FMA ) plates to obtain microbial 
monoculture. The purified isolates were grown in Nutrient Broth (Oxoid, UK) and stored 
in liquid nitrogen in 0.5 mL aliquots. 
 
Screening for proteolytic and keratinolytic activity  
A number of wells were aseptically punched onto a casein agar (Oxoid, UK) plate surface, 
using a sterile 7 mm diameter puncher. The wells were inoculated with 100 µL of the 
bacterial culture and incubated at 30 °C, 37 °C or 50 °C for 24 h. The diameters of the 
hydrolysis rings produced by the isolates were measured; those that produced the highest 
diameters were selected for further examination. A validation experiment for hydrolysis 
ring assays was carried out using the crude enzyme extract at 1:0; 1:10; 1:100; and 1:1000 
dilutions. 
 
Strains selected for high activity were further cultured in 50 mL MGM containing 1.1% 
feather meal. The crude enzyme extract was recovered by centrifugation at x 4750 g for 20 
min in a Rotina 420R Centrifuge (Hettich, Germany). The supernatant was collected and 
vacuum filtered through 0.45 µm sterile membranes (Pall Corporation, USA).  
Keratinase activities of the crude enzyme extracts were determined using the method 
described by Letourneau et al 1998 [60]. One unit of keratinase activity (U) was defined as 
the amount of enzyme producing an absorbance change of 0.01 units (A595). The keratin 
azure substrate was treated prior to the assay to ensure uniformed release of the azure dye 
and reliable absorbance measurement.  Briefly, keratin azure was incubated with 5 times 
the displaceable volume of distilled water for 1 h at 50 °C and 250 rpm in a rotary 
incubator. The resulting keratin azure was washed thrice with sterile distilled water by 
shaking vigorously for 1 min and allowed to dry at 30 °C in an oven. 
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Initial identification of the microorganism was performed based on their morphological, 
physiological and biochemical characteristics [30]. Molecular identification using 
MicroSeq TM based on the 16S rDNA full gene sequence was performed at the National 
Collections of Industrial Food and Marine Bacteria (NCIMB), UK. 
To generate the microbial mass spectral profile, a single bacterial colony was selected and 
the whole cell protein was extracted with 1 mL mixture of acetonitrile and 70 % formic 
acid (1:1 v/v). The extracted protein sample (1µL) was conjugated with 1µL of the α-
cyano-4-hydroxycinnamic acid matrix (Sigma, USA) and analysed by the MALDI-TOF 
MS (AXIMA CFR, Shimadzu Biotech). 
Keratinase production and characterisation 
Keratinase production was optimised using the following parameters: temperatures at 37 
°C or 50 °C; pH 7, 8.5 or 10) and feather meal concentration of 0.8%, 1.1% or 1.4% (w/v). 
All experiments were carried out in triplicates. 
Cell-free crude keratinase extract was concentrated using a Centriconplus-70 centrifugal 
filter device (Millipore Inc.) with a 10 KDa molecular weight cut-off and purified using a 
HiTrap Blue HP purification column (GE Healthcare Bio-sciences). To determine the 
stability of the purified keratinase, samples were stored at 4 °C and its activity reassessed 
after 8 weeks. 
The molecular weight of the purified keratinase was determined by MALDI-TOF MS 
(AXIMA CFR, Shimadzu Biotech).. The purified keratinase sample (1 µL) was conjugated 
to sinapinic acid matrix (1 µL) (Sigma-Aldrich, USA) on a sample metal plate and allowed 
to crystallise at room temperature.  
The purified keratinase was digested with 0.1mg/ml of trypsin (Sigma, UK) at 37 °C for 1 
h to obtain the peptide mass fingerprinting. The resulting MALDI-TOF MS spectrum was 
searched on Mascot Search Engine (Matrix Science) to identify any possible matches. 
Degradation of melanised feathers 
Melanised feathers were washed with sterile distilled water and tested for microbial 
contamination. These were dried (50 °C) to obtained dry weight, suspended in distilled 
water and incubated at 50 °C with crude or denatured crude keratinase for 48 hours in a 
rotary incubator (Stuart, UK) at 250 rpm. The differences in weights indicated the extent of 
degradation of the feather substrates. The data were analysed using a two-sample t-test for 
their significance at the 95% confidence interval. 
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Figures 
Figure 1 - Casein hydrolysis ring assay 
 
Casein agar plate showing the relationship between keratinase activity and the casein 
hydrolysis rings. Clockwise from top left are inoculations with keratinase dilution at 1:0, 
1:10, 1:100 and 1:1000. The casein agar plate was incubated at 50 °C for 24 h. 
Figure 2 - Keratinase activity for microbial isolates  
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Designation of the isolates 
 
Keratinase activity (U mL-1 ± SD) for the 32 microbial isolates as measured by the keratin 
azure assay. The bacterial cultures were incubated in MGM supplemented with 1.1% 
feather meal for 48h, at their isolation temperatures: strains 3-9, 13, 25 d. The reference 
strain Bacillus licheniformis PWD-1 (labelled R) were incubated at 50 °C while all the 
remaining strains were grown at 37 °C.   
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Figure 3 - Phylogenetic tree showing isolate N22 within a cluster of Bacillus 
licheniformis strains 
 
Phylogenetic tree (built with MicroSeq TM database, NCIMB, UK) showing the top 10 hits 
generated from the 16S rDNA full sequence analysis of Bacillus licheniformis N22 within 
a cluster of Bacillus licheniformis specie. 
Figure 4 – The mass spectral fingerprints for Bacillus licheniformis N22 and Bacillus 
licheniformis PWD-1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The MALDI-TOF MS spectra showing distinct protein peaks (fingerprints) for strains N22 
(in red) and PWD-1 (in green). 
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Figure 5 - Optimisation of fermentation culture for keratinase production 
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Substrate concentration (% w/v) 
 
 
 
 
 
 
The effects of temperature, pH and substrate concentration, on keratinase production by B. 
licheniformis N22. Optimum production was achieved at 50 °C, pH 8.5 and a substrate 
concentration of 1.1% (w/v). Each pattern represents a specific pH and temperature (°C) 
used. The X-axis denotes the concentration (% w/v) of the feather meal in the medium. 
Figure 6 – Molecular weight of B. licheniformis N22 keratinase 
 
 
MALDI-TOF MS spectrum showing molecular weight of keratinase as ≈ 28KDa. Single 
peak depicts homogeneity of the sample. 
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Figure 7 - MALDI-TOF MS spectrums of tryptic peptides of keratinase 
 
 
 
 
 
 
 
 
 
The spectra were acquired in mass ranges (A) 12-30 KDa; (B) 6-12 KDa; (C) 0-6 KDa. 
Red colour represents the spectrum before digestion while the blue colour represents the 
spectrum after digestion in each range. Digestion was done with 0.1mg/mL of trypsin. 
 
(B) 
(C) 
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Figure 8 - Degradation of melanised feather by crude keratinase showing the state of 
feather at 0 and 48 h.  
(A) 
   
                                     a                    b                        a                   b 
                                              0 h                                           48 h 
 
 
(B) 
  
                                        a                   b                      a                  b 
                                             0 h                                            48 h 
 
Degradation of melanised feather by crude keratinase showing the state of feather at 0 and 
48 h. In photographs labelled (A), the feathers in test tubes ‘a’ and ‘b’ were incubated in 
10 mL of distilled water and dilute crude keratinase (2 mL in 8 ml of distilled water) 
respectively. In photographs labelled (B), the feathers in test tubes ‘a’  and ‘b’ were 
incubated in 10 ml of denatured crude keratinase (boiled for 30 min) and undiluted crude 
keratinase respectively.  
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Table 
Table 1 - Morphological, physiological and biochemical characterisation of isolate 
N22 
Tests Response 
Colony morphology Rod-shaped, rough 
edge, mucoid, domed 
surface, creamy-white 
colour 
Gram stain + 
Endospores formation + 
Anaerobic growth - 
Motility + 
Oxidase reaction + 
Catalase reaction + 
Glucose 
Lactose 
Iron 
+ 
- 
- 
Reduction of nitrates to nitrites + 
Voges-Proskauer (VP) + 
Indole production 
Arginine DiHydrolase 
- 
+ 
Urease 
Hydrolysis of casein 
+ 
+ 
Onset of growth on nutrient agar plate 
( 37 oC) 
( 50 oC) 
 
9 h 
5 h 
Growth in nutrient agar at NaCl conc. 2-12 % + 
Growth in nutrient broth at pH 6-12 + 
 
